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ABSTRACT 
_____________________________________________ 
 
Medicinal plants used for wound healing and skin diseases are the key to unlocking the doors 
to combating resistance of pathogens to pharmaceuticals and allopathic management. This 
study was aimed at investigating the antimicrobial efficacies, phenolic content, cytotoxicity 
and antioxidant effects, as well as the anti-inflammatory and wound healing capacity of 
traditional medicinal plant extracts commonly used for treating skin conditions and wound 
healing in traditional medicine within KwaZulu-Natal. A preliminary survey was conducted at 
the Umlazi and Durban herbal markets with traditional healers and eleven medicinal plants 
commonly used for dermatological conditions were identified and selected. These medicinal 
plants were obtained with the assistance of an experienced horticulturalist at the Silverglen 
Nursery Conservation Garden, Durban, KwaZulu-Natal. The antimicrobial activity of the 
selected plant extracts were tested against common disease-causing skin microorganisms; 
seven Gram-positive bacterial species (Actinomycetes brasielensis, Micrococcus species, 
Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Staphylococcus 
epidermidis and Bacillus subtilis); seven Gram-negative bacterial species (Proteus vulgaris, 
Proteus mirabilis, Shigella sonnei, Klebsiella pneumoniae, Escherichia coli, Pseudomonas 
aeruginosa and Enterobacter aerogenes) and four fungal species (Candida albicans, Candida 
tropicalis, Trichophyton mentagrophytes and Trichophyton rubrum). The pathogenic strains 
used in the study are the ones associated with wound healing problems. It has been reported 
that there are more than 250 000 species of plants, however, only 5-10% have been studied 
chemically for the presence of biologically active compounds. Natural-derived compounds are 
reported to be the most relevant compounds for future drug discovery, yet the biological 
activity of much of the world’s biodiversity remains scientifically untested. This is particularly 
true for many indigenous traditional medicines of South Africa. In rural communities of South 
Africa, the treatment of various skin conditions such as burns, bruises, cuts and scratches, when 
left untreated at the initial stages, result in consequences such as microbial infections, sepsis 
and in more severe cases death.  
 
Eleven plant species were selected and separated into different plant parts (bulbs, roots and 
leaves) and extracted with different solvents (methanol, chloroform, dichloromethane, acetone 
and methanol). The extracts were assessed for their antimicrobial activity using disc diffusion 
and microdilution techniques. Extracts from Aloe ferox, A. arborescens and Hypericum 
x 
 
aethiopicum were the most active against almost all of the tested bacterial and fungal strains. 
All plant species exhibited some degree of antimicrobial activity. The observed antimicrobial 
efficacy demonstrated by some plant species and the general lack of cytotoxic effects of all the 
tested extracts presents some promising and beneficial aspects of these medicinal plant extracts 
in the treatment of skin and wound infections. The Aloe species, A. ferox, A. arborescens, A. 
aristata and H. aethiopicum were among the best extracts that exhibited consistently good 
antimicrobial activity and warrants further investigations and possible isolation of bioactive 
principles.  
 
Total phenolic levels, flavonoids and tannins were also higher for A. ferox, followed by A. 
arborescens, A. aristata and H. aethiopicum respectively. The cytotoxicity results of all plant 
extracts were in the range of 90-100% survival after 24 h in the Brine shrimp assay. Extracts 
considered lethal had > 50% shrimp death. The MTT cytotoxicity test yielded LC50 values of 
> 1 mg/mL for all extracts indicating that the extracts were not cytotoxic. The extracts were 
assessed for anti-inflammatory activity using the nitric oxide release and lipoxygenase 
inhibition assays. All plant species exhibited some degree of anti-inflammatory activity. The 
observed antioxidant results (DPPH, FRAPS, CLAMS) was significant for many of the plants.  
In the anti-inflammatory assays the LOX revealed that five of the medicinal plant extracts, 
Bulbine natalensis, Eucomis autumnalis, Hypericum aethiopicum, Tetradenia riparia and 
Zantedeschia aethiopica were effective as anti-inflammatory agents with IC50 values below the 
quercetin control and ranged from 3.55+0.11 to 9.52+0.11 µg/ml.  
 
Plant extracts are associated with several antimicrobial properties including anti-inflammatory 
and antioxidant. The use of bioactive extracts or phytochemicals from a variety of plants 
contributes to public health care. The interplay between free radicals and antioxidants is 
important in maintaining health, ageing and age-related diseases. Free radicals generated in 
excess may accumulate and outweigh the protective effects of antioxidants. Values of the IC50 
for the flavonoid control, quercetin was 6.30 µg/ml. Plant extract values were considered in 
relation to this control. Those values greater than 100 µg/ml indicated less active anti-
inflammatory agents and plant extracts that were within this range in the study were the leaf 
extracts of the three Aloe species (A. arborescens, A. aristata, and A. ferox) and H. limifolia. 
There seem to be a marked difference between the leaf and the stem extracts of T. riparia in 
terms of the inhibition potential of NO with the stem demonstrating an almost seven-fold 
difference to that of the leaf extract at an IC50 value of 13.99 µg/ml. Further significant IC50 
values were observed for H. aethiopicum leaf extract (22.47 µg/ml) and M. plumbea extract for 
xi 
 
the leaf at 29.35 µg/ml, the bulb at 22.04 µg/ml and the root extract at 26.93 µg/ml). In addition, 
the Bulbine species were observed to have an IC50 value for B. natalensis root extract at 28.64 
µg/ml and B. frutescens leaf extract at 26. 32 µg/ml showing significant anti-inflammatory 
characteristics towards NO inhibition.  
 
The results of the wound healing assay/protein precipitating activity were significant for the 
three Aloe species, two Bulbine species and support scientific evidence from previous research. 
In addition, medicinal plant extracts from E. autumnalis, H. limifolia, H. aethiopicum, T. 
riparia, and Z. aethiopica demonstrated promising and beneficial results for potential use in 
the treatment of skin diseases and wound healing. Antioxidant assays as well as anti-
inflammatory assays (nitric oxide release and lipoxygenase inhibition assays) and wound 
healing assays supports the dermatological and wound healing usage of these traditional 
medicinal plants and warrants further investigations and possible isolation of bioactive 
principles. The protein-precipitating capacity as a wound healing model was significant for 
Haworthia limifolia 82.71+0.74 % while the rest of the plant extracts had moderate to low 
values.  
 
Overall, the results from this multi-dimensional medicinal plant study provide extensive 
information on the eleven plant species and their various plant parts. Science needs to 
strengthen the multidisciplinary research mechanisms to support the evaluation of medicinal 
plants and effectively facilitate collaboration between traditional and conventional health 
practitioners. 
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CHAPTER ONE 
INTRODUCTION AND LITERATURE REVIEW 
 
 
1.1 Introduction 
 
Indigenous plants are a source of traditional medicines since the existence of mankind to treat, 
manage and prevent various health conditions (DOLD and COCKS, 2002a; 2002b). 
Traditional medicinal plants form part of the principal health care management systems for a 
significantly large number of the lower income populations in most developing countries. 
There is a worldwide demand for the many bioactive compounds produced by medicinal plants. 
A significant proportion of South Africa’s population is known to have a high preference for 
traditional medicinal health care systems over and above the allopathic or conventional health 
care management systems (MANDER, 1997; 1998; DOLD and COCKS, 2002a; 2002b; 
MOENG and POTGIETER, 2011; WILLIAMS et al., 2013). A broad spectrum of 
indigenous therapeutic plants are used for herbal medicines as they are abundant in natural 
bioactive products and metabolites such as the flavonoids, tannins, alkaloids and terpenoids 
(MANDER, 1997; 1998; DOLD and COCKS, 2002a; 2002b; MOENG and POTGIETER, 
2011; WILLIAMS et al., 2013). The practical assessment of the contents of medicinal plants 
for biological activity is important to validate their use and relevance particularly by traditional 
healers. 
 
Medicinal plants are utilised for the management and prevention of an extensive range of 
disease conditions. Many rural populations are prone to sores, wounds and other skin-related 
conditions and are without access to conventional health care thus relying mainly on traditional 
health care remedies (DOLD and COCKS, 2002a; 2002b). A notable factor in rural 
communities is that many of the treatments are sought and sourced from fresh or partially dried 
plant material (MOENG and POTGIETER, 2011; WILLIAMS et al., 2013). In urban 
communities relying on traditional medicines, the traditional herbal market is the source of 
these plant materials. Medicinal plant material may be stored in these markets over long 
periods. The effectiveness of these dried materials needs to be regularly checked/monitored for 
efficacy and potential toxicity as shelf life diminishes with time (MANDER, 1997; 1998; 
DOLD and COCKS, 2002a; 2002b; MOENG and POTGIETER, 2011; WILLIAMS et 
al., 2013). 
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Wounds are known as any form of damages to the body that may be the consequence of an 
opening or breakage in the skin. Healing ensues in a complex but well organized sequence of 
events involving the interaction of many cytokines and cell types (LI and LI, 2003). Chronic 
wounds are of major concern affecting many patients, significantly and gradually reducing 
their value of life (LI and LI, 2003). It has been recorded that an estimated six million people 
are sufferers of chronic wounds worldwide (KUMAR et al., 2007a; 2007b; COETZEE et al., 
2010). Chronic wounds by definition, are any damages that occur in the layers of the 
mammalian skin coherence when this breakage persists for longer than six weeks or is due to 
infection and non-healing recurs frequently. The leading reasons for these non-healing wounds 
include diabetic complications of the skin, post-operative complications from surgery, vascular 
insufficiency due to blockages and obstructions and skin damage due to pressure. According 
to KUMAR et al. (2007a) and COETZEE et al. (2010), chronic wounds are known to affect 
four million persons in Germany and almost three million patients between the ages of 45 and 
65 years in the United States of America (USA). The prevalence is 120 per 100,000 of the total 
population in these countries, increasing to a further 800 per 100,000 in patients of ages 75 
years and older of the total population (KUMAR et al., 2007a; COETZEE et al., 2010). The 
cost to healthcare systems in the management of consequences of untreated wounds and sores 
is enormous, amounting to billions of Dollars.  Almost two percent of the yearly health 
maintenance budgets of Germany, France and the United Kingdom are spent on the treatment 
of venous leg ulcers and thrombosis (JÄRBRINK et al., 2016). The USA spent almost two 
and half billion Dollars in 2005 on advanced wound care products and in Germany, the budget 
was five billion Euros yearly (JÄRBRINK et al., 2016). There are major impacts on the 
economy of many countries as wound lesions are socially isolating, taking an excessive length 
of time to heal and the rate of recurrence is more regular. The reduced value of life experienced 
is notably experienced by these patients and their relations. Even though the frequency of 
enduring wounds and wound care training is high, the management thereof is regarded as 
inadequate in Germany and the USA (KUMAR et al., 2007a; COETZEE et al., 2010). A 
study in Canada reported that many doctors, specifically family physicians, perceive 
themselves as unprepared in the management of conditions like pressure ulcers, suggestive of 
the fact that they do not receive an adequate amount of training for the consequences of this 
wound disorder. The Canadian nurses also indicated low levels of confidence in the familiarity 
of medical doctors who administered and would oversee the treatment of chronic wounds in 
patients who are presented at the health care facilities (JÄRBRINK et al., 2016). 
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Nursing personnel in South Africa, especially in primary health care services where ethics of 
care differ, are left responsible for patient chronic wound care and are known not to, nor 
frequently, seek help from the medical doctors (JÄRBRINK et al., 2016). The incorrect 
application of wound care and management frequently can lead to lengthy hospital admittances 
and extended therapeutic duration leading to depletion of constrained resources. Wound 
management training promotions have favourable effects on the use of assets and consequences 
for patients such as length of hospital stay and period to reach wound healing (JÄRBRINK et 
al., 2016). Chronic wounds execute a significant and unappreciated encumbrance on society as 
a whole, the national healthcare system and the individual. The knowledge of incidence and 
the prevalence of chronic wounds in conjunction with population characteristics is significant 
for advising resource allocation and healthcare planning. According to LALL and KISHORE 
(2014), the field of modern biomedical sciences research, is emerging the fastest in the area of 
wound healing management. In South Africa, many traditional specialists have valuable 
knowledge of less known wild plants used by healers for treating burns and wounds. Different 
pharmacological models and scientific tests on animals using various medicinal plants have 
been conducted with screening and evaluation of their wound healing properties (LALL and 
KISHORE, 2014). However, the capacity for using many of these medicinal plants remains 
largely unknown. Wound healing is important for the rebuilding of damaged tissues and 
correction of the malfunctioned status of the skin when damaged. This is a composite and 
complicated process commencing in response to any damage and proceeds to restore 
functionality and integrity of injured tissues (BEGUM and NATH, 2000; GOVINDARAJAN 
et al., 2007). Initial wound healing begins with agglutination which results in clotting of blood 
and scab formation to prevent the loss of blood. The ability to clot blood is of importance as 
this would indicate the ability of plant extracts to aid in wound healing. Collective processes 
for healing requires the interaction of various tissues and tissue lines. The process is an 
inflammatory response to injury and involves blood clotting, platelet aggregation and the 
formation of fibrin. An alteration occurs in the matrix substances and constituents, re-
epithelialisation and angiogenesis. Completed healing will only be achieved once the damaged 
frontages are sealed by a collagen network (BEGUM and NATH, 2000; GOVINDARAJAN 
et al., 2007). 
 
The intricate value of supreme wound healing is to decrease damage to the tissues and increase 
acceptable tissue oxygenation and blood flow levels, proper nutrition and a moist wound 
healing surrounding in order to re-establish the anatomical competence and functioning of 
those areas and parts affected (KARODI et al., 2009). According to MACKAY and MILLER 
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(2003), the key objective of wound management is to heal the injury in minimal time with least 
pain and discomfort. The requirement at the site of the wound is that the wound ought to have 
an elastic acceptable scar with the best ductile strength while the critical aim is to speed up 
wound healing. Scientists continue to use medicinal plant extracts to endorse the various phases 
of wound healing which are both successive and concomitant. These may include 
inflammation, coagulation, collagen formation, fibroblast proliferation, re-epithelialization, 
cellular growth and wound contraction. Medicinal plant extracts that promote fibroblast 
proliferation and collagen formation commonly used for wound healing in South Africa include 
Calotropis procera (RASIK et al., 1999), Aloe vera (CHITHRA et al., 1998a; 1998b; LEE 
and MOON, 2003; SUBRAMANIAN et al., 2006; 2011) and Centella asiatica (SHUKLA 
et al., 1999). 
 
According to a study by PURNA and BABU (2000), traditional plant medicines used in wound 
management do assist in the elimination of the foreign objects or damaged tissue from the 
wound or debridement. These also provide humidity to increase the formation of an appropriate 
environment for natural disinfection and the healing process. Most infections are a key reason 
for the high mortality and morbidity rates in wounded patients. Plant extracts may prevent or 
reduce infections that leads to high risk of sepsis and in so doing can reduce perpetuation of 
the inflammatory phase. Future research on the fractionation of bioactive compounds and the 
synergistic effects of plant extract components on pathogenic microorganisms will be able to 
make available an improved understanding of skin infection management in the process of 
wound healing (KARODI et al., 2009). A study by MUKHERJEE et al. (2003) on two herbal 
formulations evaluated for wound activity using both the excision and incision methods found 
that significant responses in both models occurred. SUBRAMANIAN et al. (2006; 2011) 
reported the action of Aloe vera leaf gel in its capacity for sealing properties and wound healing. 
 
Plants are known to contain and yield diverse chemical substances that are active in the human 
body. Scientific developments have isolated and evaluated numerous medicinal properties for 
a large number of plants including the extraction, isolation and analysis of their healing 
constituents. Traditional plant medicines are extensively used by African people and some 
plants used are known to have pharmacologically active compounds. Medicinal plants have 
become the attention of many studies due to the critical need for the evaluation of traditional 
methods of treatment with significant importance placed on the screening for active products 
(SPARG et al., 2002). In South Africa; a country where an opulent plant diversity exists, there 
is a strong demand for medicinal plants and it has been found that the traditional usage in health 
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care is high (JÄGER et al., 1996; MANDER, 1997; 1998). About 70% of the indigenous 
population in South Africa consult traditional healers for primary health-related sicknesses, 
preferring accepted herbal medications, many of which come from indigenous plant by-
products (JÄGER et al., 1996; MANDER, 1997; 1998). Medicinal plants may be acquired 
from either the herbal markets, gathered in the wild and/or from traditional healers. The 
challenge is that several of these medicinal plants are endangered or threatened species and 
thus indigenous species populations are decreasing due to extreme gathering for medicinal use 
which is characteristic for emerging countries (FARNSWORTH, 1984; SRIVASTAVA et 
al., 1996). Both developed and traditional applications are inclined towards the advancement 
in the recording of safe medicinal products. These processes are essential in the management 
of a broad range of disorders especially those due to various disease causing microorganisms 
becoming resilient to clinical treatment (AHN et al., 2001).  
 
Numerous plant species have been documented and acknowledged in the treatment of cracked 
skin, rashes, burns, insect bites, boils, mouth blisters and cold sores (RAINA et al., 2008; VAN 
WYK et al., 2009; NAGORI and SOLANKI, 2011). A number of screening and extraction 
procedures to isolate naturally active medicinal compounds have been established for 
distinguished medicinal plant species, many have revealed antimicrobial capacity (RABE and 
VAN STADEN, 1997; GRIERSON and AFOLAYAN, 1999a; 1999b; McGAW et al., 
2000; AFOLAYAN et al., 2002; MATHABE et al., 2006; COOPOOSAMY and MAGWA, 
2007; LATEGAN et al., 2009; DE WET et al., 2010). Systematic authentication for the 
separation of antifungal and antimicrobial products from plants has been highlighted for 
additional research whilst others are registered and patented productively (FARNSWORTH, 
1994; FOX, 1999; OFODILE et al., 2010). Traditionally, plants are a rich source of 
antimicrobial activity against various infectious agents. An isoquinoline alkaloid called 
emetine found in Cephaelis ipecuanha and related species have been used for a long time as 
an amoebicidal drug in the treatment of inflammation caused by Escherichia histolytica 
infections (ABDULLAH et al., 2009; KHORSHID et al., 2010; PATHER et al., 2011). An 
alkaloid called quinine, naturally occurring in the bark of Cinchona trees, is used to treat 
malaria. Phytochemicals studied throughout the world are known for their inhibitory effects on 
several types of microorganisms both in vivo (ABDULLAH et al., 2009; KHORSHID et al., 
2010; PATHER et al., 2011) and in vitro wound healing (COWAN, 1999). 
 
Bioactive compounds of medicinal plants identified for use as therapeutic agents were isolated 
for further investigation and have been used in the development of therapeutic drugs. The 
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compounds of known structures were used to produce patentable entities of higher medicinal 
activity and lower toxicity (FABRICANT and FARNSWORTH, 2001). According to 
BALANDRIN et al. (1993), NAHRSTEDT (2002) and NAHRSTEDT and 
BUTTERWECK (2010), of 250 000 species of plants approximately 5-10% had only been 
studied chemically for the presence of naturally occurring active compounds. International 
research laboratories are involved with screening of plants with therapeutic potential for 
biological activity and yet the potential for novel medicines from plants is still underexplored 
(HOSTETTMAN et al., 1996). The evaluation of the plants selected for this study is necessary 
to validate their use by the traditional healers and also to possibly uncover potential leads for 
therapeutic drug development and/or herbal preparations.  
 
1.2 Traditional Medicine 
 
The World Health Organisation (WHO, 2000; 2002; 2008) has published various reports on 
indigenous plant medicines which serve and highlight the health necessities of the world’s 
inhabitants in the extensive pastoral regions of developing and non-industrialized countries. 
The WHO Indigenous Treatment Programme has defined traditional medicine as the totality of 
practices and knowledge that are applied in the analysis, eradication and prevention of social, 
mental and physical disparities (RUKANGIRA, 2001). Internationally people depend on 
medicinal plants for their day-to-day well-being and health management needs (VAN WYK 
et al., 2009). The main reasons for rural populations being involved in traditional health care 
amongst others include strong beliefs in tradition, low cost and easy availability of traditional 
medicines (BANQUAR, 1993). The insightful understanding of plant therapies in traditional 
beliefs has developed and evolved over countless years and verbally transmitted from one 
generation to the next generation of healers. Over time the understanding of indigenous 
therapies from generation to generation depends mostly on the accuracy, observations and 
experiences of the people. The differences and similarities between the traditional communities 
is why we have such diverse plurality in traditional medicine. Diverse plurality in traditional 
medicine are circumstances within society in which communities of different racial, ethnic, 
social or religious affiliations maintain a self-sufficient involvement in the development of their 
traditional cultural practices in health care (HÖRBST et al., 2017). Pluralism symbolizes a 
diversity of understandings or viewpoints rather than a single approach or method. This is the 
existence of multiple healing systems. Cultural diversity and plurality of healing systems can 
be seen as identical twins! (HÖRBST et al., 2017). Modern medical science and alternative 
traditions from Africa are examples of traditional knowledge of diverse plurality practices and 
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exist throughout the world in traditional medicinal systems of the Chinese, Buddhists, Indian 
and Islamic origin.  
 
Historically, traditional systems throughout the world and in every region had its own unique 
combination of natural medicines. Tribes of Arabic, Chinese and African origin have their own 
traditional medicines rooted in their cultural contexts and vary from one to another (VAN 
WYK et al., 2009). In South Africa, Government has followed other developing countries by 
giving strong consideration to the importance of healthcare usage of indigenous medicines as 
an innovative course for the acknowledgement, venture and research strategy of programmes 
in Ethnopharmacology (RUKANGIRA, 2001). Plant-derived medicinal drugs are of economic 
and strategic significance for the African continent. Around 10% of the world’s varied plant 
population is encompassed within the southern African continent and moderate to minor 
biochemical work has been done (ELOFF, 1998a; 1998b). Even though people reside in the 
world where numerous disease-causing microorganisms are managed, the advent of various 
medicinal resistant strains of disease causing organisms is motive for severe concern 
(MADIGAN et al., 2015). Currently, the preservation and conservation legislation in South 
Africa effective since April 2008, allows researchers to have unrestricted right to use natural 
resources as long as the researcher has a gatherer’s permit and follows the terms and rules laid 
down. This allows the application and use of biological resources within regulation and control 
to avoid overexploitation (VAN SCHALKWYK, 2009). An integration of an export and 
bioprospecting permit is issued only when the minister responsible is satisfied that the 
processes are utilised for purposes that are in the interest of the public. These include economic 
development and conservation of South Africa’s biodiversity, improving scientific 
understanding and technical capability of South Africa’s people and relevant organizations 
(VAN SCHALKWYK, 2009). An extensive understanding of these plants is imperative as it 
has the probability to lead to findings of new alternate possibilities for the treatment of 
infections but also has the capacity of conservation of rare plant species that are overharvested 
and exported for traditional medicinal use. 
 
An association or national council of traditional healers in South Africa was established in 
1989, comprising minor organisations formed by the country’s traditional healers with over 
2000 registered members and is known as South African Healers Association (SOAHA). The 
NPO has steered various endeavours that resulted in the formation of regulatory and monitory 
authorities on traditional healers practices (LECLERC-MADLALA, 2002; LOUW AND 
DUVENHAGE, 2016).  
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They have practiced accomplishments through representation of experienced members and 
sustainability with collaborations and incorporation of various relevant stakeholders. The 
present regime intends to form associations between contemporary and indigenous medical 
systems. At present, in South Africa many organizations register and regulate the scope of 
practice of traditional healers (LECLERC-MADLALA, 2002; LOUW AND 
DUVENHAGE, 2016). If any plant types were discovered to be in danger and at risk due to 
an extensive requests for plants for medicinal use, these organizations can implement measures 
that ensure sustainability. Therefore it is imperative to record this information for prospective 
generations (HUTCHINGS, 1989; HUTCHINGS and VAN STADEN, 1994; 
HUTCHINGS et al., 1996). Amongst these communities, the indigenous women are known 
to have extensive understanding of medicinal plant usage due to their responsibilities as 
caregivers of youngsters at households (KOTHARI, 2003). In recognizing and restoring ethnic 
women’s understanding through organizational provisions and care, their efforts in passing 
significant knowledge to  future generations enhances the sustainability of the use of “natural 
capital” (MIKKELSEN, 2005). A study by ZOBOLO and MKHABELA (2006), conducted 
in the rural parts of Eshowe, Northern KwaZulu-Natal, that are of importance in dermatological 
use, reported how various medicinal plants were grown more often by women than men at their 
homesteads. Also, if Western medicinal facilities were accessible, the traditional South 
Africans continue to be subject to indigenous medicinal plants. An ill person with a medical 
condition is taken to a Western doctor as an alternative or last choice for care when an 
indigenous intervention has failed (ZOBOLO and MKHABELA, 2006). All the women that 
were interviewed had a broad understanding of the traditional Zulu nomenclature and naming 
of plants. Their applications in traditional healthcare, and their health care treatment 
combinations for a wide range of conditions include stomach-ache, coughs, tooth-aches, 
headache, asthma, diarrhoea, wounds and diabetes (ZOBOLO and MKHABELA, 2006). 
Modern allopathic medicine is rooted deeply in primeval prescriptions and medications; and 
today it is still expected that many essential novel medications will be commercialized when 
discovered in the imminent forthcoming years by ensuing the principals provided through 
indigenous information and experiences (VAN WYK et al., 2009).  
 
1.2.1 Global Context 
The WHO Reports (2000; 2002; 2008) on indigenous health care systems of medicine are 
adaptive and dynamic even though firmly rooted on past traditions. This vigour advocates that 
with suitable scientific recognition, support and basic traditional health care, traditional 
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medicinal systems will endure well into the next Century. Plants were once the only source of 
medicines for primary health care, however for many communities across the world they 
continue to provide mankind with new remedies Herbal medicine is an important element in 
most indigenous populations and in their traditional medicine systems. Almost 50% of 
allopathic drugs in clinical use worldwide are represented from plant derivatives and from 
natural plant products. While it is also known that 25% of allopathic drugs in medical 
applications are derived from higher plants (KINGHORN and BALANDRIN, 1993). Well 
known plant medicines include quinine (Cinchona pubescens), an alkaloid from the stem bark, 
which serves as an effective remedy for malaria; morphine, an alkaloid converted to codeine 
(Papaver somniferum), acting as a powerful analgesic is used to treat intense pain; with a world 
consumption of about 200 metric tons per annum (HOGSHIRE, 2009). Aspirin, atropine, 
reserpine and cocaine have all been sourced from plants (ALI and AZHAR, 2000). Plants are 
known as a source of essential new anticancer drugs for instance vincristine (Catharanthus 
roseus) and taxol (Taxus spps), a diterpenoid from leaves. Numerous plant constituents are 
currently manufactured for commercial use in large pharmaceutical laboratories. Examples 
include digitalis glycosides (a heart regulator drug), vincristine (an antitumor drug) and 
ephedrine (a bronchodilator drug used to decrease respiratory congestion); all of which were 
discovered through research on plants. Widespread and various international studies conducted 
in countries like India, (LODHI et al., 2006; KOKANE et al., 2009), Jordan (KHALIL et 
al., 2007a; 2007b) and Malaysia (ABDULLAH et al., 2009) on medicinal plants provide 
information on wound healing and antimicrobial activity. Despite the plethora of newly 
discovered secondary metabolites from microorganisms, allopathic medicines are developing 
widespread resistance and emerging microbial diseases are still on the increase in many nations 
of the world (OKEKE et al., 2005). 
 
1.2.2 South African Context 
A rich cultural diversity within South Africa is revealed in the formal and informal primary 
health care systems of remedies that are currently adept in different parts of the country. The 
natural, practical and verbal transmission from generation to generation of traditional 
therapeutic health systems of the Xhosa/Sotho and Zulu language people, and the Nguni and 
Khoi San tribes have not been adequately recorded nor standardised and are purely distributed 
by word of mouth from one generation to another from its early origins (HUTCHINGS, 1989; 
HUTCHINGS and VAN STADEN, 1994; HUTCHINGS et al., 1996). The official systems 
of medicine are well recognized and organized and have only been introduced into the country 
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over the last 300 years by European settlers in South Africa and are exemplified by modern 
Western medicine or allopathic medicines. South Africa’s rich diversity now incorporates the 
practice of a wide range of medicinal practices including those that have migrated into South 
Africa from Ayuverdic of Indian and Chinese homeopathic origin. Each medicinal system is 
an art and science that maintain health in its holistic sense of psychological, spiritual, social 
and physical aspects. For each culture solutions for health care that were found are in synchrony 
with the all-inclusive view of that culture. Doctors may make a diagnosis of a disease in terms 
of a causative pathogen and effectively treat it with antibiotics while a traditional healer may 
seek to understand the reasons behind the illness and treat the observed cause in addition to 
detailed treatments for the signs and indications of the condition (HUTCHINGS, 1989; 
HUTCHINGS and VAN STADEN, 1994; HUTCHINGS et al., 1996). 
 
South Africa has a projected 200 000 recognized indigenous traditional healers in practice and 
almost 60% of South Africans consulted these healers whilst simultaneously using 
contemporary allopathic and biomedical services (VAN WYK et al., 2009). An extensive 
number of daily used medicines are extracts of plants; harvested in large quantities and traded 
in the sought-after and informal markets. South Africa’s input to the international medicines 
market includes buchu (Agathosma betulina), the Cape aloes (Aloe ferox) and devil’s claw 
(Harpagophytum procumbens) but indigenous counterparts exist for many of the well-known 
remedies. There is emergent awareness in regular and indigenous treatments as a basis for many 
new commercial health products (GRIERSON and AFOLAYAN, 1999a; 1999b; McGAW 
et al., 2000; AFOLAYAN et al., 2002; LATEGAN et al., 2009). South Africa has developed 
through the Medical Research Council’s (MRC) Indigenous Knowledge Systems (IKS) Lead 
Programmes that redresses health traditions which has been a neglected health research priority 
in the country with intentions to be competitive globally. In South Africa, significant 
antimicrobial accomplishments continue to be reported from various medicinal plants 
(GRIERSON and AFOLAYAN, 1999a; 1999b; McGAW et al., 2000; AFOLAYAN et al., 
2002; LATEGAN et al., 2009). The traditional people of the Eastern Cape Province practice 
various wound causing cultural activities like skin cuts on the face and body. Circumcisions 
are an annual event, resulting in a notably high rate of mortality due to severe infections of the 
wounds (DILIKA et al., 1996).  
 
1.2.3 KwaZulu-Natal Context 
The extensive use of medicinal plants by the indigenous population in KwaZulu-Natal (KZN) 
Province, is the Province with the second largest population of 10.69 million (19.8%). The 
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African population in South Africa constitutes 80% (43.3 million) of the total population 
(CENTRAL STATISTICAL SERVICES, 2015/16) with an estimated population growth of 
2.4% per year. According to reports, in excess of 400 plants are vigorously merchandised at 
muthi markets throughout KZN (CUNNINGHAM, 1988; 1993; McKEAN, 1993). Due to the 
fragmented distribution, topography and climate in KZN, a large spatial population of 
consumers concentrate in urban centres resulting in the need to access more remote plant 
populations as local numbers diminish due to indiscriminate gathering and socio-economic 
factors that sustain and stimulate demand (MANDER, 1997; 1998).  
 
A survey conducted in 1995 reported that about 53% of sick African patients visited ethnic 
traditional healers once, with others having an average of three visits per year in Durban, KZN 
(MANDER, 1998). This lead to an estimation of the overall figure of black African patients in 
Durban to be around six million (MANDER, 1998). Traders in Durban are projected to trade 
approximately 950 tonnes per year with approximately 50% of medicinal plants acquired 
directly from plant collectors and the remaining from street traders. Other than a growing 
resident demand, there are suggestions of a fast growing demand from South Africa’s 
neighbouring countries particularly Namibia and Botswana (MANDER, 1997; 1998). 
Merwilla plumbea and Haworthia limifolia are of the nine popular and most harvested plants 
in KZN (MANDER, 1997). In addition a further 1000 plants are used for traditional medical 
purposes in KZN and approximately 500 species are sold in extensive volumes at local markets. 
The bioactive ingredients and plant extracts in plant parts like the bark, leaves, rhizomes and 
roots are used in various combinations and while one part may be harmful another could be 
quite harmless. Whole plants are often harvested but seldom used for medicinal purposes. 
Leaves, stems/rhizomes and the underground parts like bulbs, roots and tubers are commonly 
used.  
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1.3 Medicinal Plants Used in this Study 
The first research step was the selection of the eleven plants species which were collected based on ethnobotanical information; ethnodirected 
selection, including ethnobotanical and ethnopharmacological approaches and information about the traditional medicinal use of these plants to 
treat dermatological disorders and diseases specifically.  The plants were also selected based on verifying the use of many species that are used by 
local traditional healers. Many of the selected plants exhibit an array of medicinal uses, of which all have a common thread of being identified by 
traditional healers as used for skin diseases and the plants were identified by a horticulturalist at the Silverglen Nursery, Chatsworth, KZN.  
 
Table 1.1 The selected plants that are used for wound healing purposes, for treating skin diseases and skin conditions 
Plant species/ Family Plant parts 
used 
Voucher number Medicinal uses 
Aloe arborescens Mill. 
Xanthorrhoeaceae 
 
Leaves, bulbs  SG01/UKZN Leaves and bulbs are used for the management of HIV/AIDS, asthma, tuberculosis, gastrointestinal ailments, 
constipation, colds and fever, oesophageal cancer, stomach ache, burn wounds, abrasions, bruises; has 
significant wound healing, antibacterial, anti-ulcer, anti-inflammatory, anti-carcinogenic, hypoglycaemic 
properties, alopoeic properties and purgative effects; inhibits cell proliferation and is used during childbirth 
(HUTCHINGS et al., 1996; KLOS et al., 2009; VAN WYK et al., 2009; CROUCH et al., 2006).  
Aloe aristata Haw.  
Xanthorrhoeaceae 
 
Leaves SG02/UKZN Leaf juices are used to treat chronic and severe dermatitis, wounds, burns, cuts, eczema, sunburn, insect 
stings, poison ivy skin irritations, abrasions and numerous dermatological conditions. Sap eases pain and 
reduces inflammation, inhibits cell proliferation and promotes growth of skin and connective tissue (JIA et 
al., 2008; BEDINI et al., 2009; VAN WYK et al., 2009).  
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Aloe ferox Mill. 
Xanthorrhoeaceae 
 
Leaves SG03/UKZN Leaf gel is used for burns, wounds and various skin conditions like eczema and ringworm; arthritis, 
conjunctivitis, venereal sores, bruises, pimples, blisters, ringworm, boils (DIEDERICHS et al., 2009; VAN 
WYK et al., 2009). This group of plants is known to be excessively harvested for over 250 years (NEWTON 
and VAUGHAN, 1996; VAN WYK and SMITH, 2004).  
Bulbine frutescens (L.) Willd. 
Xanthorrhoeaceae 
Leaves, stems, 
roots 
SG04/UKZN Leaf sap is used for burns, rashes, blisters, insect bites, cracked lips, prickly heat pimples, acne, cold sores, 
mouth ulcers, cracked skin. Popular for skin and wound conditions, fever blisters, rashes, eczema and 
ringworm, and is antibacterial (DIEDERICHS et al., 2009; VAN WYK et al., 2009). 
Bulbine natalensis Baker. 
Xanthorrhoeaceae 
Leaves, bulbs, 
roots 
SG05/UKZN Leaf sap is directly smeared onto the skin to treat wounds, sores, burns, rashes, itches, ringworm, cracked 
lips and herpes, rheumatism, sunburn, mouth ulcers (VAN WYK et al., 2009). 
Eucomis autumnalis (Mill.) 
Chitt. 
Asparagaceae 
Stems, leaves, 
bulbs 
SG06/UKZN Bulb used for post-operative recovery, assist in healing fractures, emetics, treat fever, STI’s, facilitate 
childbirth. Backache, inflammation, pain, rheumatism (DIEDERICHS et al., 2009; VAN WYK et al., 
2009).  
Haworthia limifolia Marloth. 
Xanthorrhoeaceae 
Stems, leaves, 
roots 
SG07/UKZN Leaves are used to treat stomach complaints, sores, superficial burns, sun burn, purify blood, promotes 
fertility in women and cleans the digestive system. Enemas for internal tumours, sprains, fractures, boils, 
antischisomal and anthelminthic activity, antiseptic, anti-inflammatory properties (DIEDERICHS et al., 
2009; VAN WYK et al., 2009; COOPOOSAMY and NAIDOO, 2011a). 
Hypericum aethiopicum 
Thunb. 
Hypericaceae 
Leaves, roots, 
stems 
SG08/UKZN Leaf oil extracts are used as a cure for wounds and first degree burns, treat backache and loin pain as well 
as fevers (ROOD 1994; BRUNETON 1995; HUTCHINGS et al., 1996; VAN WYK et al., 2009). 
Merwilla plumbea (Lindl.) 
Speta. 
Asparagaceae 
Roots, leaves, 
bulbs 
SG09/UKZN 
 
Bulb decoctions used to treat boils, sores, wound healing and sprains; also get rid of scar tissue, emetic for 
detoxifying and revitalizing the body. Various skin ailments, sprains, fractures, infertility, male libido, 
internal tumours, anti-inflammatory, antiseptic (CROUCH et al., 2006; DIEDERICHS et al., 2009; VAN 
WYK et al., 2009). 
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Tetradenia riparia (Hochst.) 
Codd. 
Lamiaceae 
Leaves, stems SG10/UKZN Leaves used for colds, influenza, fever, malaria, swollen legs, headaches, chest complaints, diarrhoea, 
flatulence, nausea, respiratory problems, mouth ulcers, coughs, stomach ache and diarrhoea (WATT and 
BREYER-BRANDWIJK, 1962; DYSON et al., 1998; COOPOOSAMY and NAIDOO, 2011b).  
Zantedeschia aethiopica (L.) 
Spreng. 
Araceae 
Stems, 
bulbs/rhizomes 
SG11/UKZN Leaves soothes burns, insect bites, draws wounds, sores and boils; boiled rhizomes for bronchitis, asthma, 
heartburn, rheumatism; gargles for mouthwash. Treat wounds, inflammation, sores, boils, rheumatism, gout, 
bronchitis, asthma, heartburn, sore throat (DYSON et al., 1998; VAN WYK et al., 2009).  
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1.4 Dermatological Significance of Skin and Health 
 
The skin is the human’s largest organ and is essential for good health. Skin diseases occur in 
several forms and are categorised as non-contagious and contagious conditions; the principal 
reasons include a range of microorganisms like the bacterial, parasitic and fungal diseases. These 
are widespread mostly in the coastal and rural environments (DAVIS et al., 1980). SATO et al. 
(2013) found that ethanol extracts of some Chinese medicinal plants used in vivo resulted in 
reducing acne and dry skin (serosis) and had a protective role in forming a barrier on the skin. In 
India, NAGORI and SOLANKI (2011) reported on a number of plants and their role in wound 
healing. Plants displaying dermatological abilities are highly pursued for their ability to stop blood 
loss, increase healing and appease skin unprotected from burns and breakage (LEWIS and 
ELVIN-LEWIS, 1977). Studies on HIV-positive patients who seek medical treatment have a high 
frequency of skin diseases and it is advised that skin disease specialists be incorporated into their 
preliminary assessment and continuing long term health care. Skin conditions are known to occur 
in HIV immune-compromised patients in sub-Saharan Africa and a large percentage of skin 
diseases are found amongst those populations living in the rural communities of South Africa. 
Some of the common skin conditions associated with HIV/AIDS include those caused by Herpes 
viruses, Molluscum contagiosum, oral hairy leucoplakia Kaposi sarcoma, photodermatitis, thrush 
and Prurigo nodularis (NAAFS, 2004).  
 
1.5 The Management of Wound Healing and Skin Diseases 
 
Wounds and skin diseases are the most important causes of physical disabilities and mortality. 
Wound healing is a natural progression that commences with trauma and concludes with scar 
formation. According to the Wound Healing and Dermatological Societies, physical injury to the 
skin causes susceptibility to infection in both the anatomy and physiology of a human body 
(STRODTBECK, 2001). The goals of treating wounds and skin diseases are decreasing the risk 
factors that obstruct healing, increase the healing process and decrease the frequency of wound 
infections. Numerous medicinal plants are useful all over the world due to their therapeutic 
compounds. Wounds and skin diseases epitomize an important affliction worldwide. Nosocomial 
and hospital-related and facility-care-related infections are on the increase (WEINSTEIN, 1998; 
1991). Many skin infections are frequent in patients with poor nutrition and gastro-intestinal 
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infections exacerbated the problem, especially in unhygienic conditions and overpopulated 
communities. KUMAR et al. (2007b) reported that almost six million people worldwide suffer 
from chronic wounds and skin conditions. A study conducted in the Eastern Cape Province of 
South Africa, reported the importance of plant extracts for wound healing from circumcision 
rituals by the Xhosa people. The wounds were dressed and bandaged with a mashed plant material 
of Helichrysum species and Boophane disticha and were successful in the wound healing process 
(DILIKA et al., 1996). Traditional circumcision carries a high risk for infection and susceptibility 
to common bacteria which infect wounds, namely Staphylococcus aureus, Streptococcus species 
and Escherichia coli. The leaves of the plants listed in Table 1.1 exhibited the highest antimicrobial 
activity. In a study on Funtumia, Raphyostylis, Butyrospermum, Serataria, Parkia and Curculigo 
species used in the management of wound and skin diseases, the findings reported a high activity 
index for antimicrobial and antioxidant assays from various metabolite products with regards to 
the effects of the plant extracts for skin diseases (ADEBAYO-TAYO et al., 2010). In other 
studies, WADANKAR et al. (2011) and BHAT et al. (2012) screened the usage of Indian plants 
for treatment of skin disorders and wounds in a study conducted in Kannada District. It was found 
that 106 plants used in herbal medications for wounds and skin were based on indigenous 
knowledge. In the study conducted in Washim District, Maharashtra 39 plants were identified with 
wound healing properties. A study in South Africa (COOPOOSAMY and NAIDOO, 2011a; 
2011b) reported the antimicrobial use of Tetradenia riparia for common skin conditions like sores 
and wounds that could be used for secondary infections in HIV/AIDS infected patients. 
 
1.6 The Role of Plants in Wound Healing 
 
The human skin performs numerous vital functions primarily forming a barrier of protection 
against infection. When the protective wall is damaged infectious microorganisms have direct 
admittance into the skin and penetrate the body. Cutaneous wound repair is a series of events 
including inflammation, proliferation, maturation and remodelling. The normal skin anatomy and 
function when disturbed due to an opening, rupture or break of the skin surfaces which may be 
due to physical injuries are known as wounds (STRODTBECK, 2001).  
 
According to KUMAR et al. (2007b), the burden of chronic wounds is recorded in nearly six 
million sufferers worldwide. Wounds are an ideal substrate for infection and prolonged recovery 
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may have consequences on other organs of the body (ROBERTS et al., 1998). Wound conditions 
are the most frequent motive for compromised wound healing due to bacteria such as beta-
haemolytic Streptococcus Group A, S. pyogenes, S. aureus, E. coli, Corynebacterium species, E. 
faecalis, P. aeruginosa, K. pneumonia and Acinetobacter baumanii (RODGERS et al., 2000; 
CHURCH et al., 2006; KUMAR et al., 2006).  
 
Many medicinal plants registered as pharmaceutical drugs (AKERELE, 1988; CUNNINGHAM, 
1988; FARNSWORTH, 1994; AFOLAYAN and MEYER, 1995; 1997; KLOS et al., 2009; 
COOPOOSAMY, 2011; NAGORI and SOLANKI, 2011). Although there are many wound 
healing medicinal plants and bioactive compounds, characteristic events and chemical properties 
have not yet been adequately assessed; a knowledge of these could contribute to their traditional 
worth in skin healing management (GOLDSTEIN et al., 1980; 1994; SAITO et al., 1982; 
PUSZTAI, 1991; IMANISHI, 1993; COOPOOSAMY, 2010; STREET and PRINSLOO, 
2013). An example of a patented medication from traditional medicinal plants used for wound 
healing is that of a topical cream comprising a combination of Plectranthus amboinicus and 
Centella asiatica extract with salvigenin and asiaticoside. These two components promote wound 
healing in diabetic patients with foot ulcers (NAGORI and SOLANKI, 2011). 
 
1.7 Significance and Aims of the Study 
 
A number of organizations were formed by the contributions of the African Union Decade of 
Traditional Medicines (AU, 2005), together with the World Health Organisation (WHO, 2002; 
2008), and the Biodiversity Convention (DE SOUZA DIAS, 2016) in order to promote and 
regulate the use of traditional medicinal plants worldwide. These advocate the advancement of 
indigenous remedies through the progress in medicinal plants research, indigeneous knowledge 
preservation and sustainable applications in public health care (HEINRICH et al., 2004). A major 
concern of the Council for Medicines Control in South Africa was the lack of information on 
certifiable outcomes and statistics of traditional medicines from surveillance and knowledge 
systems. Models and practical data regarding the procedures for efficacy, safety and quality of the 
plant extracts to sufficiently safeguard public health do exist (SCOTT et al., 2004). Indigeneous 
healers are respected as main and supplementary therapeutic plant investigators for their expertise 
and experience of the medicinal usage of these plants (TIMMERMANS, 2003). 
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Research conducted in South Africa on indigenous plants medicines are antimicrobial and 
effective against pathogenic skin Gram-positive bacteria, Gram-negative bacteria and fungi. These 
include various medicinal plant species that are known to be antimicrobial and used for healing 
cold sores, insect bites, rashes, burns, boils, cracked skin and mouth blisters (RAINA et al., 2008; 
NAGORI and SOLANKI, 2011). A minimal availability of resources and information on 
remedies precisely for the management of wounds and skin diseases is of concern (LALL and 
KISHORE, 2014). Dematological studies are looked upon as a speciality that has equivalent 
medicinal and invasive characteristics known to treat illnesses broadly including cosmetic skin 
problems as well as conditions of the nails, scalp and hair. Cabuncles, boils and sores are related 
skin ailments with consequences of wounds that occur on the skin. Pathogenic infections are the 
leading challenge in the wound healing progression process of skin diseases (LALL and 
KISHORE, 2014). The availabilty of  cost effective and available access to wound and skin 
healing preparations and an evaluation of medicinal plants commonly used routinely for the 
management of skin disorders is of indispensable significance.  
 
Some of the plants included in this study namely Aloe aristata, Aloe arborescens, Aloe ferox, 
Bulbine frutescens, Bulbine natalensis, Merwilla plumbea, Haworthia limifolia, Hypericum 
aethiopicum, Zantedeschia aethiopica, Tetradenia riparia and Eucomis autumnalis  are on the Red 
Data List due to their high demand, over-exploitation and many of them are threatened with 
extinction (MANDER, 1997; 1998). The plants were collected from the Silverglen Conservancy 
Nursery in Durban, KZN for investigation and validated for their use in skin conditions and wound 
healing.  
 
The application of many plants for wound healing and dermatological diseases are crucial to 
unravelling the responses to questions around contesting challenging skin diseases when 
obstruction of pathogens by medications and allopathic treatment endures and resistance increases 
over time. The aim of this study was to conduct various ethnopharmacalogical assays on the 
extracts of 11 South African indigenous therapeutic plants that are commonly used in the 
management of skin-related conditions and wounds. These were measured for their management 
of antimicrobial activity, their effects found regularly associated with indications occurring in 
purulent sores, boils and wounds as well as an evaluation of their anti-inflammatory activity, 
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cytotoxicity effects and phenolic content was investigated. To achieve this, the purpose of the 
study was to:  
 
 Determine the antimicrobial activity of selected plant extracted with different solvents; 
 Evaluate the plant extracts for anti-inflammatory activity (Lipoxygenase and Nitrogen 
oxygenase assays); 
 Analyse the phenolic composition of the plant species; 
 Evaluate the cytotoxicity effects (Brine shrimp and MTT assays) of the extracts; 
 Determine the bioactivity of the plant extracts in various antioxidant assays (DPPH, FRAP, 
CLAMS); and  
 Evaluate the wound healing properties of the selected plants (protein binding capacity and 
wound healing assay).   
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CHAPTER TWO 
ANTIMICROBIAL ACTIVITY 
 
 
2.1 Introduction 
 
The knowledge of wound healing by many traditional physicians predominantly in countries like 
China and India holds treasured evidence for treating skin diseases, burns and wounds 
(BHARADWAJ and GAKHAR, 2005; KUMAR et al., 2007b; AYYANAR and 
IGNACIMUTHU, 2009; PATIL et al., 2009; KUVAR and BAPAT, 2010; SUBRAMANIAN 
et al., 2011). South African studies on wound healing plants are limited and further investigations 
are required (WIDGEROW et al., 2000; PATHER et al., 2011; VAN WYK, 2011). According 
to LIGHT et al. (2005), minimum information is available on the extensive number of plants used 
with wound healing capacities in South African plants. A survey taken at the Umlazi and Durban 
muthi markets in KwaZulu-Natal with traditional health practitioners resulted in a biological 
evaluation of a number of medicinal plants applied for wound healing and skin condition therapies 
(COOPOSAMY and NAIDOO, 2011b). The increase in studies on antimicrobial activity has 
demonstrated the increased global interest in medicinal plants and their antimicrobial potential 
(GHUMAN and COOPOOSAMY, 2011). Traditional populations of South Africa have used a 
variety of plants to treat infections and topical wounds (RABE and VAN STADEN, 1997; 
MULHOLLAND et al., 2016). Infectious diseases related with painful wounds, cuts and burns, 
and animal bites, or the permeation of foreign instruments indicate the presence of pathogens. 
Wounds and infections are frequently infected with a variety of disease-causing microorganisms 
related to the skin including anaerobic pathogens. Staphylococcus aureus is one common pathogen 
associated with wounds that are infected and have a pus-filled discharge (MADIGAN et al., 2015). 
 
Antimicrobial properties of the plants used in this study were tested against common bacteria 
infecting wounds, viz. Staphylococcus aureus, Streptococcus pyogenes and Escherichia coli. 
Wounds particularly from burns are also a susceptible site for opportunistic colonization by 
microorganisms and may lead to high mortality and morbidity. A study on wound stab cultures of 
bacteria in burn patients reported Pseudomonas aeruginosa as the organism most frequently 
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isolated (54%) (ARSLAN et al., 1999). Some of the bacteria isolated from burn wounds includes 
Proteus mirabilis, Klebsiella pneumonia, Escherichia coli and various Pseudomonas species 
(ARSLAN et al., 1999; BAGDONAS et al., 2003). In addition, wounds are commonly infected 
with fungal pathogens like Candida species. Infectious diseases are aggravated further by elements 
like insufficient public health practices, reduced hygiene and congested living circumstances 
(KERR and LACEY, 1995).  
 
2.2 Microbial Infections 
 
2.2.1 Bacterial Infections 
Many studies describe the following causative microorganisms: Klebsiella species, 
Staphylococcus aureus, Pseudomonas aeruginosa, Enterococcus species, Escherichia coli and 
Candida species being present in 11-31% of all burn wounds (BAGDONAS et al., 2003). The 
most common causative agent is Staphylococcus aureus, relatively pathogenic to humans and is 
found on the skin and mucosa of up to 40% of the population. Burn injuries are often infected in 
30% of cases with Staphylococcus species of which three are important in skin conditions; S. 
epidermidis, Staphylococcus aureus and Staphylococcus saprophyticus. (BAGDONAS et al., 
2003). The antibiotic resistance of these strains remains a global problem.  
 
2.2.2 Fungal Infections 
Fungi usually invade habitats in the damp parts of the human body where skin fasciae meet; these 
include areas that are in the genital area, between the toes and under the breasts. Frequently 
occurring fungal skin infections are caused by yeasts (Candida) or dermatophytes, such as 
Epidermophyton, Microsporum and Trichophyton. Many of these fungi reside in the uppermost 
stratum of the epidermis (stratum corneum) and do not infiltrate deeper (VAN HEES and NAAFS, 
2009). Obese and older individuals are more susceptible to these infections for one important 
reason, that they have areas in the body with many skinfolds. Diabetics have a tendency to be more 
vulnerable to fungal infections as well. Particularly important to note, is that fungal infections on 
one part of the body spread causing rashes on other uninfected parts of the body. A foot or fungal 
infection between the toes may cause bumpy and itchy rashes on the fingers (VAN HEES and 
NAAFS, 2009). Skin eruptions are allergic responses due to the fungus and are caused by touching 
the infected area. Physicians usually confirm fungal infections through symptoms of red, irritated, 
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or scaly rashes in one of the commonly affected areas and through diagnostics like the microscopic 
examination of scrapings from a small amount of skin or cultures grown in medium where the 
specific fungus can be identified. Almost 80% of all fungal infections are caused by Candida 
albicans (VAN HEES and NAAFS, 2009). C. albicans commonly lives on the mucosal and skin 
surfaces, any modifications in the host’s environment will lead to its propagation and ensuing skin 
disease. A severe skin infection, candidal vulvovaginitis of the perineum in women is caused by a 
fungus; the symptoms are characterized by reddish, scaly itchy skin and mucosa, marginal pustules 
and a creamy discharge. The equivalent in uncircumcised men is an infection called balanitis, 
characterized by shiny reddish plaques on the glans penis also affecting the scrotum (VAN HEES 
and NAAFS, 2009). Skin infections caused by Candida occur on just about any part of the 
mammalian body, but are more frequently occurring in areas where skin may touch or rub together 
like the skin folds, groin, armpits and the skin found between the toes and fingers. The fungus 
flourishes in environments that are warm, sweaty and moist (VAN HEES and NAAFS, 2009).  
 
2.3 Antibiotic Treatment of Skin and Wound Infections and Diseases 
 
Antibiotics are toxic compounds that are naturally formed by fungi and bacteria to eliminate 
competing microorganisms. The first antibiotic activity was discovered when anthrax bacteria 
were isolated and identified (JOHNSON, 2009). Antibiotics are natural products that differ from 
growth factor analogs which are artificial compounds. Historically, the most important antibiotic 
group is the β-lactams which include penicillin, cephalosporin and cephamycins. They share a 
distinguishing structural constituent, the β-lactam ring. Penicillin G was the first isolated β-lactam 
antibiotic; it is ineffective against Gram-negative bacteria as their cell walls are resistant to the 
antibiotic but are effective against Gram-positive bacteria (MADIGAN et al., 2015). Selectively 
antibiotics attack microorganisms short of harming the host cells by either one of two mechanisms. 
These mechanisms are the inhibition of cell wall synthesis through bactericidal antibiotics like 
penicillin and cephalosporin and damaging the cell wall by increasing permeability resulting in 
leaking of the cell contents causing cellular death. Mammalian cells lack cell walls and have 
membranous outer coverings, therefore antibiotics are unable to damage these cells. Those 
antibiotics that prevent bacterial growth, for example tetracycline and erythromycin, inhibit DNA 
and RNA formation or inhibit protein synthesis by ribosomes (MADIGAN et al., 2015). 
 
23 
 
Bacterial infections like meningitis and typhoid fever were commonly responsible for high death 
rates. Antibiotics have reduced the deaths of millions of people with minimal side effects 
(JOHNSON, 2009).  
 
Penicillin and erythromycin are widely used antibiotic drugs against those microbes which mutate 
easily. (JOHNSON, 2009). Prescription medications acquired over-the-counter, like clotrimazole 
or ketoconazole, belonging to a class of anti-fungal drugs called the azoles were found not to have 
debilitating effects on the patient when associated with other anti-fungal drugs like amphotericin 
B or nystatin. If the infection persists or becomes more severe, treatment will depend on the locus 
and severity of infection (MTHETHWA and DE WET, 2011). Trichophyton species causing 
tinea pedis, may be managed effectively with anti-fungal ointments such as terbinafine 
hydrochloride, butenafine hydrochloride, tolnaftate (a synthetic thiocarbamate), miconazole 
nitrate, clotrimazole and undecylenic acid. Severe, complicated infections use oral ketoconazole 
effectively in the management of T. rubrum infections, however its use is no longer advised 
resulting in liver damage. Oral terbinafine, itraconazole or fluconazole have all been shown to be 
safer, effective treatments (MTHETHWA and DE WET, 2011). Topical anti-fungal creams like 
terbinafine and naftifine are effectively used against tinea caused by T. rubrum. Trichophyton 
rubrum infections have been found to be vulnerable to photodynamic management like laser 
irradiation and photoactivation. Proteus. mirabilis is susceptible to many antibiotics except 
tetracycline while 20% of P. mirabilis strains are unaffected by first-generation cephalosporins 
and ampicillins (MTHETHWA and DE WET, 2011). 
 
Protein synthesis inhibitory antibiotics may cause side effects due to the similarity of human and 
animal ribosomes to bacterial ribosomes (JOHNSON, 2009). Classification of antibiotics is based 
on the type of bacteria affected. Gram-positive bacterial cell walls have a dense outer covering 
made up of peptidoglycan whilst bacteria that are Gram-negative are known to have a thinner 
stratum made up of peptidoglycan together with an inner and outer membranous layer. The 
structural variations in bacteria cell walls are significant for the effective antimicrobial action of 
antibiotics (JOHNSON, 2009).  
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2.4 Materials and Methods 
 
2.4.1 Plant Identification, Selection and Collection 
The identification, selection and collection of medicinal plants was based on their reported 
traditional uses and demand in treating wounds in the Province of KwaZulu-Natal. The collection 
of fresh samples allowed immediate processing of fresh plant material parts prior to extraction. All 
eleven of the plant species were available at, and collected from, the Silverglen Plant Conservancy, 
situated in Chatsworth, Durban, South Africa. Voucher specimens were prepared and verified by 
an experienced horticulturalist at the conservancy (Table 1.1). The voucher specimens were placed 
for storage at the John Bews Herbarium, University of KwaZulu-Natal (UKZN) in 
Pietermaritzburg. The medicinal materials were divided into component parts namely the leaves, 
roots and bulbs/corms prior to preparations made for drying in an oven at 50 °C for five days and 
were thereafter pulverized into fine particles using a Wareing Commercial blender and put in 
storage at room temperature in airtight glass bottles (NCUBE et al., 2011). 
 
2.4.2 Plant Extract Preparation 
A selection of five solvents (methanol, hexane, acetone, chloroform and dichloromethane) were 
each used to extract 20 g powdered ground samples of plant material. This process was carried out 
using a sonication bath with ice for an hour together with 20 ml/g (w/v) of extractant. Effective 
procedural determination of biologically active composites from plant materials depended on the 
type of solvent used in the extraction technique. The five solvents were selected based on varying 
polarity; these included non-polar hexane, chloroform, dichloromethane to more polar acetone and 
methanol. The crude plant extracts were clarified using a vacuum and filtered in a Büchner funnel 
through Whatman No. 1 filter paper and the extracts were then concentrated in vacuo at 35 °C with 
the aid of a rotary evaporator (Rotavapor-R, Büchi, Switzerland). All of the concentrated extracts 
were then dried at room temperature using a fan and then stored at 4 °C. These were stored for 
further use in the various assays that were performed in triplicate (ELOFF, 1998a; 1998b). The 
percentage yield of plant extract from the extracting solvents were calculated as the proportion of 
the dried extract mass to the mass of the ground plant sample. The plant extracts were subjected 
to two types of in vitro antimicrobial analysis conducted in triplicate. 
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2.5 Antimicrobial Activity Assays 
 
2.5.1 Microbial Stock Culture Preparation 
Fourteen stock strains of bacteria were used in the bioassay. These were cultured, then incubated 
overnight in McCartney bottles with 10 ml Mueller-Hinton (MH) broth at 37 °C. Thereafter the 
cultures were streaked onto Mueller-Hinton agar (Merck, Germany). Sterile (25 ml) MH agar was 
dispensed into plastic plates or petri dishes and permitted to gel at room temperature and cooled at 
4 °C overnight. The plates were streaked with stock strains of bacteria and sub-cultured. These 
bacterial-inoculated plates were placed into an incubator at 37 °C for 24 h and bacterial colonies 
allowed to grow. The plates were then stored at 4 °C to prevent overgrowth of bacterial colonies. 
The stocks were sub-cultured following the same procedure once a month in order to maintain 
viability. A similar procedure was followed for the maintenance of the four fungal strains with 
Yeast Malt (YM) broth and agar (Becton Dickinson, USA) used in place of MH broth and agar. 
 
2.5.2 Antibacterial Activity 
Hexane, chloroform, dichloromethane, acetone and methanol were the five extract solvents used 
for each of the eleven plant species to achieve preliminarily evaluation using the disc-diffusion 
method for antibacterial activity (YU et al., 2003).  
 
2.5.2.1 Bacterial Disc Diffusion Assay 
Five extracts from each of the eleven plants species were first evaluated using the disc diffusion 
method. The obtained plant extracts were tested for antimicrobial activity by using two mg/ml of 
each extract. Fifty microliters of each extract were transferred on each of three sterile six mm discs 
of Whatman No. 1 filter paper. Plant extracts were soaked in ethanol with water (95% v/v). The 
extracts obtained were evaporated to syrupy residues (ELOFF, 1998a) which were dried. The 
positive control used in the assay was streptomycin. Preparation of the stock solutions were carried 
out by preparing and dissolving 100 mg of dry extract in 1 ml of ethanol and water separately to 
obtain a concentration of 100 mg/ml dilutions of the stock solutions. The stock solutions were then 
mixed with phosphate buffer at pH six to evaluate the antibacterial activity (ELOFF, 1998a). The 
antibacterial activity of these extract solutions was then tested on the selected microbial cultures. 
The test organisms (Table 2.1) were tested on the probability of them being present in patients 
suffering with wounds and superficial skin disorders. Plates having only Mueller-Hilton agar 
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functioned as the controls. Zones of inhibition were measured and those >10 mm were considered 
as good activity and were selected for the MIC experiment outlined below. 
 
2.5.2.2 Antibacterial Microdilution Minimum Inhibitory Concentration Activity 
Those extracts that were observed to have zone inhibitions of > 10 mm were further investigated 
against the various Gram-positive and Gram-negative strains of bacteria related to skin conditions. 
Twenty plant extracts were selected from this assay for screening using the minimum inhibitory 
concentration assay. The microplate dilution method was used to determine the minimum 
inhibitory concentration (MIC) values for the antibacterial activity of the plant extracts (ELOFF, 
1998a; 1998b). Each resuspended extract (50 mg/ml) was selected and one hundred microliters 
was serially diluted two-fold with sterile distilled water in duplicate. A 96-well microtitre plate 
(Greiner Bio-one GmbH, Germany) was used for each of the fourteen strains of bacteria. Similarly 
a 0.1 mg/ml, two-fold serial dilution of neomycin (Sigma-Aldrich, Germany) was used as the 
positive control. Seventy percent ethanol and water were included as the negative/solvent controls. 
Mueller-Hinton (Oxoid, England) overnight broth cultures (incubated at 37 °C in a water bath with 
an orbital shaker) of the 14 strains of bacteria tested: seven Gram-negative strains and seven Gram-
positive strains (Table 2) were mixed in sterile MH broth and diluted to give a final dilution of 
approximately 106 cfu/ml (colony forming units). The wells were dispensed with one hundred 
microliters of each bacterial culture. Parafilm was used to cover the plates and they were incubated 
at 37 °C. Growth of the bacteria was assisted by adding 50 µl of 0.2 mg/ml p-iodonitrotetrazolium 
chloride (INT) (Sigma-Aldrich, Germany) and a supplementary incubation for a further 1 h at 37 
°C. The colourless tetrazolium salt was biologically reduced to a red end product if there was a 
presence of active microorganisms and the MIC values were logged. The MIC values were also 
recorded for the concentrations in the last wells in which no colour was observed after adding the 
INT indicator. Growth of bacteria in the wells was observed by a reddish-pink colour. Triplicate 
measurements were recorded for the MIC assay. Values were also recorded for the lowest 
concentration resulting in complete inhibition of bacterial growth.  
 
Of the medicinal plants selected, extracts from twenty plants yielded inhibitions of ≥ 10 mm. The 
minimum inhibitory concentrations (MIC) were determined in more detail using the microdilution 
bioassay against the seven Gram-negative and the seven Gram-positive strains of bacteria that are 
associated with skin conditions as defined by ELOFF (1998a; 1998b) and detailed in NCUBE et 
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al. (2011). Resuspension of all these extracts in 70% ethanol was done. A starting concentration 
of 0.1 mg/mL Neomycin (Sigma Aldrich, Germany) was used as a positive control for each 
bacterium. Water and ethanol (70%) was used as negative control and solvent. The negative control 
represented the growth of untreated organism during the test period. The addition of ethanol as a 
co-solvent to aid dissolution of the positive control and test sample had to be accounted for because 
ethanol could be toxic to microbes (OJALA et al., 2000). The negative control thus consisted of 
the bacterial suspension in the relevant broth and ethanol to correspond with the concentration of 
ethanol used to dissolve the test samples. The negative controls thus represented 100% viability 
for the microbes taking into account the corresponding concentration of ethanol that was used. The 
assay was carried out in triplicate per assay. 
 
2.5.3 Antifungal Activity 
 
2.5.3.1 Disc Diffusion Assay 
Preliminary screening using agar disc diffusion assays were conducted. Two mg/ml for each of 
the plant extracts were tested for antifungal activity. Fifty microliters of each extract was 
transferred on each of three sterile six mm discs made from Whatman No. 1 filter paper. These 
were used in phosphate buffer at a pH of six to determine the antifungal activity (ELOFF, 1998b). 
The solutions were tested for antifungal activity using the four fungal cultures using fluconazole 
as a positive control. The test organisms (Table 2.2) were selected on the knowledge of them being 
present on the skin and on wounds of patients. Plates with yeast malt agar were used as the controls. 
Zones of inhibition were measured and those >10 mm were considered as good activity and were 
selected for the MIC experiment. 
 
2.5.3.2 Antifungal Microdilution Minimum Inhibitory Concentration Activity 
Once disc-diffusion preliminary screening was completed, twenty extracts were selected for 
further assessments using the microplate dilution technique against four fungal strains (Candida 
albicans (ATCC 2670), Candida tropicalis (ATCC 66029), Trichophyton mentagrophytes (9533) 
and Trichophyton rubrum (28188) frequently related with skin conditions (Table 2.2). The MICs 
for the extracts were determined using the microdilution bioassay as described by ELOFF (1998b) 
and modified for fungi (MASOKO et al., 2007) as detailed in NCUBE et al. (2011a; 2011b). All 
extracts were re-suspended in 70% ethanol and Amphotericin B (Sigma Aldrich, Germany) at a 
starting concentration of 2.5 mg/ml was used as a positive control against each fungus. A fungal 
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culture incubated overnight was grown in Yeast Malt (YM) broth. A quantity of four hundred 
microlitres of the overnight culture was added to 4 ml of sterile saline and the values read at an 
absorbance of 530 nm. Adjustments were made for the absorbance using sterile saline to an 
equivalent of a 0.5 M McFarland standard solution. This standardised fungal stock was used to 
make a 1:1000 dilution with sterile YM broth and a final inoculum of approximately 106 cfu/ml. 
Known concentrations of the dried crude plant extracts (PE, ethanol and DCM) were resuspended 
in 70% ethanol. A two-fold serial dilution of one hundred microlitres of each extract was made 
with sterile water in a 96-well microtitre plate. Similarly, a two-fold serial dilution of 
Amphotericin B (Sigma-Aldrich, Germany) (2.5 mg/ml) was prepared for use as the positive 
control while 70% ethanol and water were used as solvents and negative controls respectively. 
Each well then received one hundred microlitres of the dilute fungal culture. These plates were 
then covered with parafilm and incubated at 37 °C for 24 h. Thereafter an amount of 50 μl (0.2 
mg/ml) INT was added and further incubated at 37 °C for 24 h. When the plate wells remained 
clear it served as an indication of the inhibition of fungal growth. The MIC values were recorded 
as the lowest concentrations that prevented fungal growth after 48 h. Fungicidal activity was 
determined by adding 50 μl of sterile YM broth to all the clear wells of the plates and extending 
the incubation at 37 °C for a further 24 h. Thereafter, the minimum fungicidal concentrations 
(MFC) were documented as the last clear wells detected. The assay was conducted in triplicate.  
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2.6 Description of Microorganisms  
The fourteen bacterial strains were Gram-positive (seven) and Gram-negative (seven) are 
commonly found associated with skin conditions. These test organisms (Table 2.1 with ATCC 
numbers and infectious activity) were tested on the probability of them being present in patients 
suffering with wounds and superficial skin disorders. Four fungal strains (Candida albicans 
(ATCC 2670), Candida tropicalis (ATCC 66029), Trichophyton mentagrophytes (9533) and 
Trichophyton rubrum (28188) frequently related with skin conditions (Table 2.2 infectious 
activities). 
Table 2.1 Bacterial strains used for screening antibacterial activity in this study 
Bacteria Gram 
test 
ATCC No. Infectious activities 
Proteus vulgaris - 49132 Nosocomial infections and urinary tract sepsis 
infections (UTI’s) caused by Proteus together with 
other bacteria like Enterobacter, Pseudomonas, 
Klebsiella, Enterococcus and Staphylococcus 
species (VAN HEES and NAAFS, 2009). 
Proteus mirabilis - 29245 Majority of Proteus infections cause wound 
infections, pneumonia, septicaemia and UTI’s; 
these are commonly occurring in hospitalized 
patients (VAN HEES and NAAFS, 2009). 
Shigella sonnei  - 9290 90% Shigella species invade the abdominal 
mucosa, cause inflammatory damage to the 
mucosal wall (VAN HEES and NAAFS, 2009). 
Klebsiella pneumoniae - 13882 Opportunistic pathogens, nosocomial infections, 
urinary and respiratory tract infections, intestinal 
to lethal septicaemia (WILLEY et al., 2011). 
Escherichia coli - 13706 Utero-toxigenic strain, urinary tract infection, 
gastro-intestinal diseases, haemorrhagic colitis 
(WILLEY et al., 2011). 
Pseudomonas aeruginosa - 9027 Deeper dermal abscesses (KUMAR et al., 2007a). 
Enterobacter aerogenes - 350029 Infections vary from the skin, eyes, soft tissues, 
UTI’s, bacteria infiltrate the blood, lower 
respiratory tract, endocarditis, to the intra-
abdominal area, septic arthritis, osteomyelitis and 
central nervous system (VAN HEES and NAAFS, 
2009). 
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Actinomycetes brasiliensis + 16404 Infections occur in the oral cavity, eye, and tissues 
next to dental implantation areas, tooth extraction 
wounds cervicofacial, thoracic, abdominal 
actinomycoses, the female genital organs (VAN 
HEES and NAAFS, 2009). 
 
Micrococcus species + 700405 Skin microflora, recurrent bacteria in blood, 
endocarditis, meningitis, septic shock, arthritis and 
cavitating pneumonia (VAN HEES and NAAFS, 
2009). 
Staphylococcus aureus + 29737 Superficial infections, skin and glands, mucous 
membranes, folliculitis, contagious impetigo, 
upper respiratory tract, pharynx, mouth, blood, 
mammary glands, intestines, potentially serious 
pathogen causing toxic shock syndrome 
(WILLEY et al., 2011). 
Streptococcus pneumoniae + 6301 Impetigo infectious blisters, pustules, oozing 
erosions and yellow crusts (KUMAR et al., 
2007a). 
Streptococcus pyogenes + 12384 Skin, nose and mouth macules, lesions (KUMAR 
et al., 2007a). 
Bacillus subtilis 
 
+ 6633 Diarrhoea, nausea, vomiting, powerful 
occupational allergen (WILLEY et al., 2011). 
Staphylococcus 
epidermidis 
+ 
 
12228 Infections of the lower urinary tract, common 
causes of skin infections such as pimples, boils, 
carbuncles, and abscesses (SINGER and 
TALAN, 2014). 
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Table 2.2 Fungal strains used for screening antifungal activity in this study 
Fungi ATCC No. Infections/diseases 
Candida albicans  2670 Candidiasis, thrush, infect the nails, skin, 
gastrointestinal tract, mucous membranes of oral and 
vulvo-genital areas, lips, corners of mouth, sores and 
systemic diseases (KUMAR et al., 2007a). 
 
Candida tropicalis  66029 Candidiasis, mucous membranes, and gastrointestinal 
tract, infections of the skin, nails and systemic diseases 
(KUMAR et al., 2007a).  
 
Trichophyton rubrum  28188 Dermatophytosis in keratinized tissue like skin, nails, 
hair, beard, scalp, causes athlete's foot, tinea, Athlete’s 
foot, crotch itch and ringworm (KUMAR et al., 2007a). 
 
Trichophyton 
mentagrophytes  
9533 Tinea, athlete's foot, ringworm infections, feeds on the 
keratin in nails, hair and dead skin (KUMAR et al., 
2007a). 
 
2.7 Results and Discussion 
 
Plant extracts from A. ferox, A. arborescens, H. aethiopicum and E. autumnalis were active against 
nearly all of the tested bacterial and fungal strains (Tables 2.3 and 2.4). All of the plant species 
exhibited some degree of antimicrobial activity. The observed antimicrobial efficacy demonstrated 
by some plant species on all the tested extracts provides significant and beneficial characteristics 
of these medicinal plant extracts in the treatment of skin diseases and wound healing. The two 
Aloe species and H. aethiopicum consistently exhibited significant antimicrobial activity and 
warrant further investigations and possible isolation of bioactive principles. Disc-diffusion assays 
are represented in Tables 2.3 and 2.4. Although the disc diffusion assay is still a valid technique, 
in general, it would not be recommended for anaerobic bacteria and fungi. Depending on the 
individual case to be investigated, it is recommended to use the disc diffusion assay for measuring 
the inhibition of a new drug. There are limitations to disc diffusion method which is why the 
method is done in triplicate to verify the results.  Results can be unexpected or borderline.  In such 
cases another method of testing may be required or the test may need to be repeated for 
confirmation. The possibility for some extracts to be inactive in the disc diffusion assay and active 
in the microdilution assay exists as the susceptibilities of the antibiotic vary. Susceptibility can 
vary even within a species also (with some strains being more resistant than others), antibiotic 
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susceptibility testing is usually carried out to determine which antibiotic will be most successful 
in treating a bacterial infection in vivo. 
The MIC’s values for antibacterial and antifungal activity are presented in Tables 2.5 and 2.6 
respectively. RÍOS and RECIO (2005) suggested that MIC values are of interest when MICs of 
0.1 mg/mL and 0.01 mg/mL for extracts and isolated compounds are recorded. FABRY et al. 
(1998) defined active crude extracts as those having MIC values < 8 mg/mL. In this study, MIC 
values of less than 1 mg/mL were considered to have significant activity. Of the different extracts, 
chloroform extracts showed the highest activity for the majority of the tested extracts. Overall, 
many of the extracts were effective across a wide range of both Gram-positive and Gram-negative 
bacteria. S. aureus (Gram-positive) and P. mirabilis (Gram-negative) being the most susceptible 
strains. The chloroform and DCM extracts of A. ferox and A. arborescens were the most effective 
against most of the tested bacterial strains (Table 2.5) as well as all the tested fungal strains (Table 
2.6), with A. ferox having MIC values of 0.31 mg/mL against all strains of bacteria except 
Micrococcus species, A. brasielensis and E. coli. Plant extracts with MIC values ranging from 0.31 
mg/ml to 0.63 mg/ml for antimicrobial activity included Z. aethiopica leaves, B. frutescens leaves, 
E. autumnalis bulbs and roots, T. riparia leaves, H. limifolia leaves, B. natalensis leaves and roots, 
M. plumbea roots, leaf extracts of A. aristata, A. ferox and A. arborescens, and H. aethiopicum 
leaves. The MIC’s values were also successful in highlighting those minimum concentrations at 
which medicinal plant extracts were most effective. The following crude plant extracts yielded 
effective minimum concentrations between 0.31 to 0.63 mg/ml for antibacterial activity; the Aloe 
species, Bulbine species, Tetradenia, Hypericum, Eucomis and Zantedeschia and Merwilla 
species. The antifungal minimum concentrations were good for the above-mentioned plant extracts 
also. 
 
The broad range activity of the plant extracts against the skin conditions associated with 
microorganisms suggests that these plant species may offer a degree of efficacy in treating skin 
conditions like ringworm, ulcers, boils, sunburn, blisters, venereal sores, eczema and 
inflammation. Traditionally, apart from treating wounds and various skin conditions, the two Aloe 
species had been reported to be used to treat a number of other ailments such as venereal sores, 
bruises, pimples, blisters, ringworm, boils, gastrointestinal ailments, asthma, constipation, 
oesophageal cancer, tuberculosis, colds and fever. These species are also used for treating 
HIV/AIDS opportunistic infections, stomach ache and in childbirth (HUTCHINGS et al., 1996; 
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CROUCH et al., 2006; DIEDERICHS et al., 2009; KLOS et al., 2009; VAN WYK et al., 
2009). The Aloe species contain many interesting secondary metabolites belonging to different 
classes of compounds and these may be contributing to their healing properties. These species 
contain many types of compounds, such as alkaloids, anthraquinones, pre-anthraquinones, 
anthrones, bianthraquinoids, chromones, flavonoids, coumarins and pyrenes. The numerous 
bioactive compounds isolated from the Aloe species include among others, aloe-emodin, coniine, 
aloesaponol I-IV, aloin A/B, (barbaloin), aloinoside A/B, feroxin A/B, aloesone, lupeol (DAGNE 
et al., 2000; GIRELLI et al., 2001). In addition, other extracts demonstrated good activity on at 
least two of the tested microorganisms. Extracts, in addition to chloroform for the three Aloe 
species showed significant activity for most of the tested microorganisms; hexane and chloroform 
extracts of H. limifolia and the DCM extract of H. aethiopicum (Table 2.5) exhibited good activity 
against all the fungal strains tested. The number of efficacious drugs available clinically for the 
treatment of fungal infections is very limited and antimicrobial resistance is one of the major 
challenges in the treatment of fungal infections (RUHNKE et al., 1994). Against this background, 
significant bioactivity displayed by these plant extracts provide new alternatives for the treatment 
of fungal infections and thus an opportunity to circumvent the often poorly efficient but expensive 
fungal treatments. 
 
The Gram-positive bacterium S. epidermidis is one of the common causes of skin infections such 
as pimples, boils, carbuncles, and abscesses (SINGER and TALAN, 2014). Resistant strains such 
as S. aureus have become a global challenge and S. epidermidis is likely to be added to the list. H. 
aethiopicum (Unsukumbili) is reported in a survey conducted on plants among communities in the 
Ungoye Forest in Northern KwaZulu-Natal, South Africa as the most used plant of choice for 
healing sores and wounds (MTHETHWA and DE WET, 2011). The effective activity shown by 
this species together with the Aloe species against such pathogenic strains as K. pneumoniae, S. 
epidermidis, S. aureus and all four tested fungi may provide significant information on their use 
against the skin diseases caused by these pathogens. A study on the stem bark of Drypetes klainei, 
a medicinal plant used for skin conditions and injuries, yielded good wound healing properties and 
for treatment of burns (BRUSOTTI et al., 2015). In a comprehensive review of African medicinal 
plants, AGYARE et al. (2016) noted that more than 61 plants belonging to 36 families have been 
evaluated for wound healing properties in varying models. Characterisation and isolation of the 
bioactive compounds remains one of the main areas to be explored in order to exploit the full 
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benefits of the plant extracts. In vitro screening for antibacterial activity of various extracts of plant 
samples of T. riparia was reported to have no inhibitory effects against B. subtilis, E. coli, S. aureus 
and K. pneumoniae (McGAW et al., 2000). However, this study showed good activity against a 
number of bacteria and fungi with MIC ranges of between 0.63 mg/ml and 0.31 mg/ml. Hypericum 
aethiopicum was reported to be the most used plant for treating wounds and sores in KwaZulu-
Natal (MTHETHWA and DE WET, 2011). The differences in results between the agar well 
diffusion and the disc diffusion assay results may be explained by the rate of growth of bacteria, 
solvents used to extract the plant compounds, the diverse susceptibility of the bacteria to the plant 
extracts and the rate of plant extract diffusion. 
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Table 2.3 Antibacterial activity (disc diffusion in mm) of the plant extracts examined 
Plant Extract 
  Se(+) Ec(-) M(+) Ea(-) Kpn(-) Spn(+) Ab(+) Sa(+) Spy(+) Bs(+) Ss(-) Pae(-) Pv(-) Pm(-) 
Zantedeschia aethiopica 
Leaves 
Hexane 8 8 8 10 8 0 0 8 0 0 8 0 0 0 
Chloroform 0 8 8 10 10 0 0 8 0 0 8 0 0 0 
DCM 8 8 8 10 0 0 0 8 0 0 10 0 0 0 
Acetone 0 8 8 10 0 0 0 8 0 0 10 0 0 0 
Methanol 0 8 8 10 10 0 0 8 0 0 10 0 0 0 
Zantedeschia aethiopica 
Stems 
Hexane 0 8 12 8 10 8 0 0 0 8 10 8 0 10 
Chloroform 0 8 8 8 10 8 10 0 0 8 10 8 0 12 
DCM 0 8 8 8 8 8 10 0 0 8 8 12 0 12 
Acetone 0 8 8 8 10 8 0 0 0 8 8 8 0 12 
Methanol 0 8 10 8 10 8 10 0 0 8 8 8 0 12 
Bulbine frutescens  
Leaves 
Hexane 10 0 10 8 0 0 0 10 0 0 8 0 8 8 
Chloroform 8 0 10 8 10 0 0 10 10 0 12 0 10 12 
DCM 10 0 10 8 0 0 0 10 8 0 8 0 8 8 
Acetone 12 0 10 8 0 0 0 8 0 8 8 0 8 8 
Methanol 10 0 10 8 15 0 0 8 0 8 8 0 8 8 
Bulbine frutescens  
Roots 
Hexane 8 0 8 8 0 0 0 0 0 8 8 0 12 8 
Chloroform 8 0 8 8 0 0 0 0 0 8 10 0 12 8 
DCM 8 0 14 8 0 0 0 0 0 8 8 0 10 8 
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Acetone 8 0 8 8 0 0 0 0 0 8 10 0 10 8 
Methanol 8 0 10 8 0 0 0 0 0 8 8 0 10 8 
Eucomis autumnalis  
Leaves 
Hexane 8 8 10 10 8 8 8 0 8 8 10 0 10 8 
Chloroform 8 0 8 8 10 8 8 0 8 8 8 0 10 8 
DCM 8 0 8 12 8 8 8 0 8 8 8 0 10 8 
Acetone 8 0 10 8 8 8 8 0 8 8 8 0 0 8 
Methanol 8 0 10 10 10 8 8 0 8 8 10 0 10 8 
Eucomis autumnalis  
Bulbs 
Hexane 8 0 8 8 0 8 0 8 8 0 0 0 8 0 
Chloroform 8 0 8 8 0 8 0 8 8 0 0 0 8 0 
DCM 8 0 8 8 0 8 0 8 8 0 0 0 8 0 
Acetone 8 0 12 8 0 10 0 8 8 0 0 0 8 0 
Methanol 8 0 8 8 0 8 0 8 8 0 0 0 8 0 
Eucomis autumnalis  
Roots 
Hexane 8 10 8 10 10 10 0 0 8 12 8 10 8 8 
Chloroform 8 10 8 10 10 10 0 0 10 10 8 8 10 8 
DCM 8 10 8 10 8 8 0 0 8 10 8 10 8 8 
Acetone 8 10 8 10 8 8 0 0 8 10 8 10 10 8 
Methanol 8 8 8 10 10 8 0 0 8 12 8 8 8 8 
Tetradenia riparia 
Stems 
Hexane 8 0 8 8 8 0 0 8 8 0 8 0 0 0 
Chloroform 8 0 8 8 8 0 0 8 8 0 8 0 0 0 
DCM 8 0 8 8 8 0 0 0 8 0 8 0 0 0 
Acetone 8 0 8 8 8 0 0 0 8 0 8 0 0 0 
Methanol 8 0 8 8 8 0 0 0 8 0 8 0 0 0 
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Tetradenia riparia 
Leaves 
Hexane 8 0 16 10 0 8 0 0 10 8 8 10 10 0 
Chloroform 8 0 12 10 0 10 0 0 10 8 8 10 8 0 
DCM 8 0 12 10 0 8 0 0 8 8 8 8 12 0 
Acetone 8 0 10 10 0 10 0 0 8 8 8 8 10 0 
Methanol 8 0 10 10 0 10 0 0 8 8 8 10 8 0 
Hypericum aethiopicum  
Leaves 
Hexane 8 8 10 8 0 8 8 0 10 8 0 12 8 8 
Chloroform 10 8 10 8 0 8 8 16 10 8 0 12 10 8 
DCM 8 8 10 8 0 8 8 8 10 8 0 12 10 8 
Acetone 10 8 10 8 0 8 8 10 10 8 0 8 12 8 
Methanol 8 8 10 8 0 10 8 8 10 8 0 8 10 8 
Merwilla plumbea  
Leaves 
Hexane 8 8 0 8 8 0 8 0 8 0 0 0 0 0 
Chloroform 8 0 0 8 0 0 8 0 8 0 0 0 0 8 
DCM 8 0 0 8 0 0 8 0 10 0 0 0 0 8 
Acetone 8 0 0 8 0 0 8 0 10 0 0 0 0 8 
Methanol 8 0 0 8 0 0 8 0 10 0 0 0 0 8 
Merwilla plumbea 
Roots 
Hexane 10 0 0 10 8 8 8 0 8 0 0 0 0 8 
Chloroform 10 0 0 10 8 8 8 12 8 0 0 10 8 8 
DCM 8 0 0 10 8 10 8 8 8 0 0 8 10 8 
Acetone 10 0 0 14 8 10 8 12 8 0 0 8 8 8 
Methanol 8 0 0 14 8 8 8 8 10 0 0 8 8 8 
Merwilla plumbea 
Bulbs 
Hexane 8 8 0 8 8 0 8 10 0 0 0 8 0 0 
Chloroform 8 10 0 10 8 0 8 10 0 0 0 10 0 0 
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DCM 8 8 0 8 0 0 8 8 0 0 0 10 0 0 
Acetone 8 10 0 8 0 0 8 8 0 0 0 8 0 0 
Methanol 8 8 0 10 0 0 8 0 0 0 0 8 0 0 
Bulbine natalensis 
Leaves 
Hexane 8 0 8 8 0 8 8 8 8 0 0 8 0 8 
Chloroform 8 0 8 8 0 8 8 8 8 0 0 8 0 8 
DCM 10 0 8 8 0 8 8 10 8 0 0 8 0 8 
Acetone  10 0 8 8 0 8 8 10 8 0 0 8 0 8 
Methanol 10 0 8 8 0 8 8 10 8 0 0 8 0 8 
Bulbine natalensis Roots Hexane 12 0 0 8 8 8 8 8 10 10 8 0 8 10 
Chloroform 12 0 0 8 8 8 8 8 8 10 8 0 8 10 
DCM 8 0 0 8 8 10 8 10 8 0 8 0 8 8 
Acetone 12 0 0 8 8 12 8 10 8 0 8 0 8 8 
Methanol 12 0 0 8 8 12 8 8 8 0 8 0 8 8 
Aloe aristata 
Leaves 
Hexane 8 0 0 8 0 8 0 8 10 0 0 0 0 8 
Chloroform 8 0 0 8 0 8 0 8 8 0 0 0 0 8 
DCM 8 0 0 8 0 8 0 8 8 0 0 0 0 8 
Acetone 8 0 0 8 0 8 0 8 8 0 0 0 0 8 
Methanol 8 0 0 8 0 8 0 8 10 0 0 0 0 8 
Haworthia limifolia 
Leaves 
Hexane 8 8 8 8 8 0 0 10 0 8 0 0 10 0 
Chloroform 8 8 8 8 8 0 0 10 0 10 0 0 8 0 
DCM 8 8 8 10 8 0 0 10 0 8 0 0 10 0 
Acetone 8 8 8 10 8 0 0 10 0 8 0 0 8 0 
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Methanol 8 8 8 10 8 0 0 10 0 8 0 0 10 0 
Aloe ferox  
Leaves 
 
Hexane 8 0 0 8 10 8 10 8 10 8 8 9 8 0 
Chloroform 8 0 0 10 10 10 8 8 10 8 8 9 10 0 
DCM 8 0 0 10 8 8 8 8 8 8 8 9 8 0 
Acetone 8 0 0 8 8 8 10 8 8 8 8 9 10 0 
Methanol 8 0 0 8 8 8 8 10 8 8 8 9 10 0 
Aloe arborescens 
Leaves 
Hexane 8 0 0 8 8 8 0 10 8 8 0 8 8 8 
Chloroform 8 8 0 10 10 8 0 10 8 8 0 10 8 8 
DCM 8 0 0 8 10 10 0 10 8 8 0 10 10 8 
Acetone  8 8 0 10 0 10 0 10 8 8 0 0 10 8 
Methanol 8 8 0 8 8 8 0 10 8 18 0 8 8 8 
DMSO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Neomycin  11 10 12 11 11 10 10 10 11 10 12 11 11 10 
*Bacterial species: Actinomycetes brasielensis (Ab), Bacillus spizizeni (Bs), Enterobacter aerogenes (Ea), Escherichia coli (Ec), Klebsiella 
pneumoniae (Kp), Mycobacterium spps (M), Proteus mirabilis (Pm), Proteus vulgaris (Pv), Pseudomonas aeruginosa (Pa), Shigella sonnei (Ss), 
Staphylococcus aureus (Sa), Staphylococcus epidermidis (Se), Streptococcus pneumoniae (Spn), Streptococcus pyogenes (Spy). 
(+) Gram-positive; (-) Gram-negative 
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Table 2.4 Antifungal activity (Disc Diffusion in mm) of the plant extracts examined 
Antifungal Activity                      *Fungal species (inhibition zones averages mm) 
 
Plant Extract Tr Tm Ca Ct 
Zantedeschia 
aethiopica  
Leaves 
Hexane 10 0 8 8 
Chloroform 8 8 8 8 
DCM 8 8 8 10 
Acetone 10 8 8 10 
Methanol 8 8 10 10 
Zantedeschia 
aethiopica  
Stems 
Hexane 8 10 8 0 
Chloroform 8 10 8 0 
DCM 8 8 8 8 
Acetone 8 8 8 8 
Methanol 8 8 8 8  
Bulbine  
frutescens  
Leaves 
Hexane 10 8 8 8 
Chloroform 10 8 10 8 
DCM 10 8 10 8 
Acetone 10 10 10 8 
Methanol 10 10 10 8 
Bulbine 
frutescens  
Roots 
Hexane 0 9 8 8 
Chloroform 0 8 8 10 
DCM 0 0 8 8 
Acetone 0 0 8 12 
Methanol 0 0 8 8  
Eucomis 
autumnalis  
Hexane 8 8 8 10 
Chloroform 8 8 8 8 
41 
 
Leaves DCM 8 8 8 8 
Acetone 8 8 10 8 
Methanol 8 10 10 10 
Eucomis 
autumnalis 
Bulbs 
Hexane 10 8 8 10 
Chloroform 10 8 8 10 
Acetone 8 8 8 8   
DCM 8 8 8 8   
Methanol 8 8 8 10   
Eucomis 
autumnalis 
Roots 
Hexane 0 8 10 8 
Chloroform 0 8 10 0 
DCM 0 8 10 8  
Acetone 0 8 10 0  
Methanol 0 8 10 0 
Tetradenia 
riparia 
Stems 
Hexane 10 8 8 8 
Chloroform 10 8 0 0 
DCM 8 8 0 0 
Acetone 10 10 8 0 
Methanol 10 10 10 8 
Tetradenia 
riparia 
Leaves 
Hexane 10 8 8 12 
Chloroform 8 8 8 8 
DCM 10 8 8 12 
Acetone 10 10 8 10 
Methanol 10 10 8 8 
Haworthia 
limifolia 
Leaves 
Hexane 0 8 10 10 
Chloroform 16 8 0 0 
DCM 8 8 14 0 
Methanol 8 10 8 0 
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Acetone 10 12 8 0 
Merwilla 
plumbea 
Leaves 
Hexane 10 0 8 8 
Chloroform 10 0 12 14 
DCM 8 8 8 8 
Acetone 8 10 8 8 
Methanol 0 0 8 8 
Bulbine 
natalensis 
Roots 
Hexane 8 8 10 8 
Chloroform 8 8 12 8 
DCM 10 8 10 10 
Acetone 10 8 8 0 
Methanol 8 8 10 0 
Merwilla 
plumbea 
Leaves 
Hexane 0 8 8 0 
Chloroform 0 8 10 10 
DCM 0 10 8 0 
Acetone 0 8 10 8 
Methanol 0 8 8 0 
Merwilla 
plumbea 
Roots 
Hexane 12 10 10 8 
Chloroform 12 12 12 8 
DCM 8 8 8 8 
Acetone 12 10 10 8 
Methanol 8 8 8 8 
Bulbine 
natalensis  
Leaves 
Hexane 8 8 16 12 
Chloroform 8 8 10 8 
DCM 10 10 10 12  
Acetone 10 8 14 8  
Methanol 10 8 10 8  
Aloe aristata Hexane 8 10 8 8 
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Leaves Chloroform 8 10 8 8 
DCM 8 8 10 8 
Acetone 8 10 8 8  
Methanol 8 10 8 10  
Haworthia  
limifolia 
Leaves 
Hexane 10 8 12 12 
Chloroform 10 10 8 8 
DCM 10 8 10 10  
Acetone 10 8 10 10 
Methanol 10 10 8 10 
Aloe ferox  
Leaves 
 
Hexane 8 0 8 8 
Chloroform 8 0 10 10 
DCM 8 8 10 10 
Acetone 8 8 10 8 
Methanol 10 8 10 8 
Aloe 
arborescens 
Leaves 
Hexane 10 0 8 0 
Chloroform 8 8 10 10  
DCM 8 0 8 8 
Acetone 8 8 10 8 
Methanol 10 8 8 0 
DMSO 0 0 0 0 
Amphotericin B 11 10 12 11 
*Fungal strains: Trichophyton rubrum (Tr), Trichophyton mentagrophytes (Tm), Candida 
albicans (Ca), Candida tropicalis (Ct). 
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Table 2.5 Antibacterial activity (MIC mg/mL) of the plant extracts examined 
*Bacterial strains 
 Gram-positive Gram-negative 
Plant Extract Part M Bs Spn Sa Se Ab  Spy Ea Kp Pv Pa Pm Ss Ec 
Zantedeschia 
aethiopica  
Chloroform Leaves 2.50 0.63 2.50 2.50 2.50 2.50 2.50 2.50 1.25 2.50 2.50 0.31 2.50 2.50 
Chloroform Stems 1.25 2.50 2.50 2.50 2.50 2.50 2.50 1.25 1.25 2.50 2.50 0.63 2.50 2.50 
Methanol Leaves 1.25 0.63 2.50 2.50 2.50 2.50 2.50 1.25 1.25 2.50 2.50 0.63 2.50 2.50 
Bulbine 
frutescens 
Chloroform Leaves 1.25 0.63 0.63 0.63 2.50 2.50 0.63 1.25 1.25 0.63 0.63 0.63 2.50 2.50 
Chloroform Bulbs 1.25 2.50 1.25 2.50 0.63 0.63 2.50 1.25 1.25 2.50 2.50 0.63 0.63 0.63 
Methanol Leaves 1.25 2.50 2.50 0.63 2.50 2.50 2.50 1.25 1.25 0.63 2.50 2.50 2.50 2.50 
Eucomis 
autumnalis 
Chloroform Bulbs 1.25 2.50 1.25 2.50 2.50 0.63 2.50 1.25 1.25 2.50 2.50 0.63 2.50 2.50 
Chloroform Roots 1.25 0.31 1.25 2.50 2.50 2.50 0.63 1.25 1.25 0.63 0.63 0.63 2.50 2.50 
DCM Leaves 1.25 2.50 1.25 2.50 2.50 0.63 2.50 1.25 1.25 2.50 2.50 0.63 2.50 2.50 
Acetone Leaves 1.25 2.50 1.25 2.50 0.63 0.63 2.50 1.25 1.25 2.50 2.50 0.63 0.63 0.63 
Acetone Bulbs 1.25 2.50 1.25 2.50 2.50 0.63 2.50 1.25 1.25 2.50 2.50 0.63 2.50 2.50 
Acetone Roots 1.25 0.63 1.25 0.63 2.50 2.50 0.63 1.25 1.25 0.63 0.63 2.50 2.50 2.50 
Tetradenia 
riparia 
Hexane Leaves 1.25 0.31 1.25 2.50 2.50 1.25 0.63 1.25 2.50 0.63 0.63 2.50 1.25 0.63 
Chloroform Leaves 2.50 0.63 1.25 0.63 2.50 1.25 0.63 2.50 0.63 2.50 2.50 1.25 1.25 2.50 
Chloroform Stems 1.25 2.50 1.25 2.50 2.50 0.63 2.50 1.25 1.25 2.50 2.50 2.50 2.50 2.50 
Acetone Stems 1.25 2.50 1.25 2.50 2.50 0.63 2.50 1.25 2.50 2.50 2.50 2.50 2.50 2.50 
Acetone Leaves 0.63 0.63 1.25 0.63 1.25 1.25 0.63 0.63 0.63 2.50 2.50 1.25 1.25 2.50 
Methanol Leaves 2.50 2.50 1.25 0.63 1.25 1.25 2.50 0.63 2.50 2.50 0.63 1.25 1.25 2.50 
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Haworthia 
aethiopicum 
Chloroform Leaves 0.31  0.31  0.63 0.31 1.25 1.25 0.31 0.63 0.31  2.50 2.50 1.25 1.25 2.50 
DCM Leaves 0.63 0.63 2.50 0.63 1.25 1.25 0.31 0.63 0.63 2.50 2.50 1.25 1.25 2.50 
Acetone Leaves 0.63 0.63 1.25 0.63 1.25 1.25 0.63 0.63 0.63 2.50 2.50 1.25 1.25 2.50 
Merwilla 
plumbea 
Hexane Leaves 0.63 0.63 1.25 0.63 1.25 1.25 0.16 2.50 2.50 0.63 0.63 1.25 1.25 2.50 
Chloroform Bulbs 1.25 2.50 1.25 0.63 1.25 1.25 2.50 1.25 1.25 1.25 2.50 0.63 1.25 2.50 
DCM Leaves 2.50 2.50 1.25 0.63 1.25 1.25 2.50 1.25 1.25 1.25 2.50 0.63 1.25 2.50 
Acetone Leaves 1.25 2.50 1.25 2.50 2.50 2.50 2.50 1.25 1.25 1.25 2.50 0.63 1.25 2.50 
Methanol Bulbs 2.50 2.50 1.25 2.50 1.25 1.25 0.63 1.25 1.25 1.25 2.50 1.25 1.25 2.50 
Bulbine 
natalensis 
Hexane Leaves 2.50 0.63 1.25 0.63 2.50 2.50 0.63 1.25 1.25 0.63 0.63 0.63 1.25 2.50 
Chloroform Bulbs 1.25 0.63 1.25 0.63 0.63 2.50 0.63 1.25 2.50 1.25 2.50 0.63 1.25 2.50 
Aloe aristata Hexane Leaves 2.50 2.50 1.25 0.63 0.63 2.50 1.25 1.25 2.50 1.25 2.50 0.63 0.63 0.63 
DCM Leaves 1.25 2.50 1.25 0.63 0.63 2.50 2.50 1.25 2.50 2.50 2.50 0.63 1.25 2.50 
Acetone Leaves 1.25 2.50 2.50 0.63 0.63 2.50 2.50 1.25 2.50 2.50 2.50 0.16 1.25 2.50 
Haworthia 
limifolia 
Hexane Leaves 2.50 2.50 2.50 0.63 0.63 2.50 0.63 2.50 2.50 2.50 2.50 0.63 2.50 2.50 
Chloroform Leaves 1.25 1.25 1.25 0.63 0.63 1.25 0.63 1.25 1.25 1.25 1.25 0.63 1.25 2.50 
Aloe ferox Chloroform Leaves 0.63 0.31  0.31  0.31 0.31  0.63 0.31 0.31  0.31 0.31 0.31  0.31 0.31 0.63 
Aloe 
arborescens 
DCM Leaves 1.25 0.31 0.63 0.63 0.63 0.63 0.31 0.63 1.25 0.63 0.63 0.63 0.63 0.63 
Neomycin 
µg/ml 
  0.16 0.16 0.16 0.16  0.16  0.08 0.16 0.08 0.16 0.16 0.16 0.16 0.16 0.16 
*Bacterial strains: Actinomycetes brasielensis (Ab), Bacillus subtilus (Bs), Micrococcus species (M), Staphylococcus aureus (Sa), Staphylococcus epidermidis (Se), 
Streptococcus pneumoniae (Sp), Streptococcus pyogenes (Spy), Enterobacter aerogenes (Ea), Klebsiella pneumonia (Kpn), Pseudomonas aeruginosa (Pa), Shigella sonnei 
(Ss), Proteus mirabilis (Pm), Proteus vulgaris (Pv), Escherichia coli (Ec). Values written in bold are considered active (< 1 mg/mL). 
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Table 2.6 Antifungal activity (MIC mg/mL) of the plant extracts examined 
   *Fungal strains 
Plant Extract Part Tr Tm Ca Ct 
Zantedeschia 
aethiopica 
Chloroform Stems 0.63 0.63 1.25 1.25 
Acetone Stems 1.25 0.63 1.25 1.25 
Methanol Leaves 0.63 1.25 1.25 0.63  
Eucomis 
autumnalis 
Chloroform Bulbs 1.25 1.25 1.25 0.63 
Acetone Leaves 1.25 1.25 1.25 0.63  
Tetradenia riparia Chloroform Stems 0.31 0.63 1.25 1.25 
Acetone Stems 1.25 0.63 0.63 1.25 
Methanol Leaves 0.63 0.63 1.25 1.25 
Merwilla plumbea Hexane Leaves 1.25 0.63 1.25 0.63 
Chloroform Leaves 0.63 0.63 1.25 0.63 
Chloroform Bulbs 0.63 0.63 0.31 1.25 
Acetone Bulbs 1.25 0.63 0.63 0.63 
Acetone Roots 1.25 0.63 1.25 0.63 
Methanol Roots 1.25 0.63 1.25 0.63 
Bulbine natalensis  Chloroform Leaves 1.25 0.31 0.63 0.63 
Bulbine frutescens Chloroform Leaves 1.25 0.63 0.63 0.63 
Aloe aristata Hexane Leaves 0.31 1.25 0.63 0.63 
DCM Leaves 0.63 0.63 0.63 0.63 
Acetone Leaves 0.63 0.63 0.63 0.63 
Haworthia limifolia Hexane Leaves 0.63 0.63 0.63 0.63 
Chloroform Leaves 0.63 0.63 0.63 0.63 
Aloe ferox Chloroform Leaves 0.63 0.31 0.63 0.63 
DCM Leaves 0.63 0.31  0.63 0.63 
Hypericum 
aethiopicum 
Chloroform Leaves 0.63 0.63 0.63 0.63 
Aloe arborescens DCM Leaves 0.63 0.63 0.63 0.63 
Amphotericin B 
(µg/ml) 
  0.93 0.93 0.93 0.93 
*Fungal strains: Candida albicans (Ca), Candida tropicalis (Ct), Trichophyton rubrum (Tr), 
Trichophyton mentagrophytes (Tm). Values written in bold are considered active (< 1 mg/mL) 
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2.8 Conclusions 
 
The study indicated the antimicrobial activity of the eleven medicinal plant extracts commonly 
identified by traditional doctors having a significant effect on wound healing and 
dermatological disorders. Various plant parts were screened in the disc diffusion and the 
minimum inhibitory concentration assays. Leaves were shown to have more activity and their 
activity are compared to the other plant parts like the stems, rhizomes, bulbs, and roots. The 
assays showed that many of the selected medicinal plants were effective as antibacterial and 
antifungal agents against a wide range of commonly occurring pathogens causing infection and 
interfering with effective wound healing and dermatological conditions. The extracts from the 
leaves of these plants are reported to be effective for wound healing by traditional healers and 
this may be due to their antimicrobial activity. Through scientific evidence and research it can 
be proven that all underground parts like roots, rhizomes and the stems could be left to grow 
and are sustainable promoting the harvesting of the leaves only rather than whole plants of 
which much is wasted and discarded when harvested for traditional medicinal health care. 
 
The eleven plant species were tested against 14 microorganisms and showed inhibition for most 
of these at varying levels. Inhibition zones above ten mm were used as a guideline to assess the 
MIC’s and concentration levels range from 0.31 mg/ml to 0.63 mg/ml for the highly active 
antimicrobial plant extracts. The following plant extracts showed these outcomes: Z. aethiopica 
leaves, B. frutescens leaves, E. autumnalis bulb and roots, T. riparia leaves, H. limifolia leaves, 
B. natalensis leaves and roots, M. plumbea roots, leaf extracts of A. aristata, A. ferox and A. 
arborescens, and H. aethiopicum leaves. The MIC’s were also successful in highlighting 
minimum concentrations at which medicinal plant extracts were most effective. The following 
crude plant extracts reported effective minimum concentrations between 0.31 to 0.63 mg/ml 
for antibacterial activity; the Aloe species, Bulbine species, Tetradenia, Hypericum, Eucomis 
and Zantedeschia and Merwilla. The antifungal minimum concentrations were good for the 
above-mentioned plant extracts also. Further investigations into antimicrobial screening for 
medicinal plants is necessary for future public health care as the rising costs of allopathic 
medicines become unaffordable to the majority of the country’s population. It is recommended 
that further, more intensive antimicrobial screening be conducted to identify bioactive 
compounds that are effective against multidrug resistant microbial strains that would be 
significant for clinical management of infectious pathogens. 
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CHAPTER THREE 
PHENOLIC CONTENT 
 
 
3.1 Introduction 
 
The sustainable advancement of infectious diseases and the progress of multi-drug resistance 
by pathogens to developed pharmaceuticals, have led to the extension of the exploration for 
new unique leads against parasitic, bacterial, fungal and viral infections (GIBBONS, 2004). 
Even with the recent advances in drug development, natural plant-derived compounds are still 
proving to be an invaluable source of treatments and management for human’s diseases 
(SALIM et al., 2008). Plant-derived antimicrobials have a long history of providing abundant 
desired novel therapeutics (AVILA et al., 2008). Plants continuously interrelate with the 
rapidly shifting and potentially detrimental external environmental factors. Plants have 
changed intricate alternative defence strategies that involve a massive variability of chemical 
metabolites as tools to overcome conditions of stress (NCUBE et al., 2012a). The ability of 
plants to carry out combinatorial chemistry by matching, mixing and evolving the gene 
products necessary for secondary metabolite biosynthetic pathways, produces an extension 
pool of chemical compounds, which humans have used to their benefit. The use of plants by 
humans in both traditional and allopathic medicinal systems, therefore, largely gains 
phenomenal accomplishments and successes (NCUBE et al., 2012a). 
 
A number of traditionally used medicinal plants have to date been screened for various 
biological activities in both in vivo and in vitro models. The chemical exploration and 
purification of plant extracts claimed to have medicinal capacities have produced an abundance 
of purified compounds proven to be essential in the practice of modern medicine 
(GOLDSTEIN et al., 1994; TYLER et al., 1988). However, in traditional medicine, these 
compounds are largely used in crude extracts in the form of herbal remedies (PUJOL, 1990). 
Considerations of the rapid development of newer emerging infectious diseases and the 
expansion of multi-drug resistance where existing curatives occur, one of the strategies 
employed in indigenous plant medicine is the mixture of herbal components in the remedies. 
Traditional remedies are often produced by combining several diverse plant species. The 
pharmacological effects of such mixtures could be as a result of the sum of different classes of 
compounds with diverse mechanisms of action. Reported studies on the total contents of a 
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herbal creation reveal a significantly improved effect than an equivalent dose of or a single 
constituent herb or one isolated active ingredient (WILLIAMSON, 2001; NAHRSTEDT and 
BUTTERWECK, 2010). These findings suggest that, the effects may arise from synergistic 
mechanisms of herbal ingredients. The relationship of synergism happens when more than two 
compounds cooperate in ways that mutually amplify, enhance, or potentiate each other’s effect 
more meaningfully than the modest effect of single ingredients (WILLIAMSON, 2001). 
 
There is noteworthy information on the bioactivity of screened medicinal plant extracts, 
however in most studies these findings are reported on the basis of isolated classes or groups 
of compounds extracted using diverse individual solvents. As indicated earlier many scientists 
perform extraction using solvents with different polarities, e.g. petroleum ether, ethyl acetate, 
ethanol chloroform and water (WILLIAMSON, 2001; NAHRSTEDT and 
BUTTERWECK, 2010). The quality and the overall quantity of the plants extracted 
compounds in any given species would vary largely as a function of the type of solvent used 
and the growing season. In light of the diversity of the phytochemical compounds formed 
within an individual plant, an examination into this aspect would possibly reveal the concealed 
potentialities of the therapeutic and medicinal values of the phytochemical compounds 
(WILLIAMSON, 2001; NAHRSTEDT and BUTTERWECK, 2010). Assessing the 
ethnopharmacological and ethnobotanical knowledge as a selection strategy gives priority to 
traditionally based medicinal plants used for skin, wound healing, isolating and identifying 
bioactive compounds. Pharmacological and phytochemical studies of the investigated eleven 
medicinal plant species was necessary to validate the usage of the plants in skin disorders and 
wound healing. Furthermore, this provides sufficient information for the separation and 
documentation of active compounds that are present in the investigated plants.  
 
In this study in order to understand the source of the plant’s pharmacological activities, total 
compounds of a phenolic nature including condensed tannins and proanthocyanidins were 
quantitatively investigated in terms of their amounts in extracts of the plant materials using 
spectrophotometric methods.  
 
3.1.1 Phenolic Compounds 
In organic chemistry, phenols, sometimes called phenolics, are a class of chemical compounds 
consisting of a hydroxyl group (-OH) bonded directly to an aromatic hydrocarbon group. The 
simplest of the class is phenol, which is also called carbolic acid C6H5OH. Phenolic compounds 
are classified as simple phenols or polyphenols based on the number of phenol units in the 
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molecule. Plant phenolics represent a very large group of defensive compounds defined as 
having a phenol moiety. The phenolics range in complexity from simple phenolics and 
quinines, through chalcones and stilbenes to a range of phenolics with three rings namely 
anthocyanins, anthochlors, benzofurans, chromones, coumarins, flavonoids, isoflavonoids, 
neoflavanoids, stibenoids and xanthones. More complex polycyclic phenolics exist, notably the 
hydrolysable tannins and condensed tannins (WILLIAMSON, 2001; NAHRSTEDT and 
BUTTERWECK, 2010). Notable simple phenol-related odorants include 4-
methoxybensaldehyde, guaiacol, 4-hydroxybenzalderhyde, phenyethyl alcohol, piperonal and 
vanilla. Some simple phenolics inhibit cyclooxygenate (COX) enzymes and 5-lipoxygenase 
(5-LOX), and have antimicrobial properties, particularly against phytopathogenic organisms 
(BRUNETON, 1995; POLYA, 2003). Phenolic compounds are of important pharmacological 
value which include antimicrobial and anti-inflammatory activities.  
 
In higher plants, hydrolysable and condensed tannins are the two groups distinguished based 
on their structure and biogenetic origin (BRUNETON, 1995). Hydrolysable tannins are esters 
of a sugar and of variable number of phenolic acid molecules, while condensed tannins or 
proanthocyanidins are polymeric flavans. Tannins dissolve in water to form colloidal solutions, 
but their solubility varies with their degree of polymerisation. Most of the biological properties 
of tannins are linked to their capacity to form multiplexes with proteins particularly and other 
macromolecules. Externally, they waterproof the external layers of the skin and the mucosa, 
thus protecting the underlying layers. They are also known to have anti-diarrheal properties. 
They also have blood vessel constriction effects on minor superficial vessels and heighten 
tissue restoration in the case where superficial wounds or burns lose fluid thus reducing fluid 
loss and inhibiting external antagonisms (BRUNETON, 1995). 
 
Plant flavonoids are known as nutraceutical compounds, as precursors for the food that provide 
medical or health benefits including the prevention and treatment of disease. These are non-
toxic food extract supplements scientifically proven for their antioxidant activity, antimicrobial 
activity and antiviral activity having effects on the gastrointestinal system/antiulcer activity, 
hepatoprotective activity, anti-inflammatory activity, antidiabetic effects, cardiovascular 
system/vasorelaxant, antiatheroschelorosis, antithrombogenic effects, cardio protective effects, 
antineoplastic activity and on the central nervous system (TAPAS et al., 2008). 
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3.2 Materials and Methods 
 
3.2.1 Preparation of Selected Plants for Phenolic Quantification 
Plant material was collected and processed as described in Chapter 2. Compounds that are 
phenolic in nature were extracted from plant material and as described by MAKKAR (1999) 
with minor adjustments. Plant material that had been dried (2 g) were extracted for 20 min 
using 20 ml of 50% (v/v) aqueous methanol by sonication on ice. The extracts were then filtered 
through Whatman No. 1 filter paper under vacuum and the extracted polyphenols were 
quantified from these filtered extracts. 
 
3.2.2 Determination of Phenolic composition 
 
3.2.2.1 Total Phenolics 
Total phenolic content in plant samples were determined using the Folin-Ciocalteu (Folin C) 
assay as described by MAKKAR (1999) with slight modifications. Fifty microliters of each 
extract were transferred into test tubes into which 950 µl distilled water were added followed 
by 1 N Folin C reagent (500 µl) and 2% sodium carbonate (2.5 ml). The test mixtures were 
incubated for 40 min at room temperature and the absorbance read at 725 nm using a UV- 
visible spectrophotometer (Varian Cary 50, Australia) against a blank consisting of aqueous 
methanol instead of extract. Total phenolic concentrations were expressed in mg gallic acid 
equivalents (GAE) per g dry weight (DW).  
 
3.2.2.2 Determination of Proanthocyanidins/Condensed Tannins 
The butanol-HCl assay (PORTER et al, 1985) was used to quantify proanthocyanidin content. 
Three millilitres of butanol-HCl reagent (95:5, v/v) were added to 500 µl of each extract, 
followed by 100 µl ferric reagent (2% ferric ammonium sulphate in 2 N HCl). The test 
combination was mixed by Vortex and placed in a boiling water bath for 60 min, absorbance 
was then read at 550 nm using a UV-vis spectrophotometer against a blank prepared in a similar 
way without heating. Each sample extract had three replicates. Proanthocyanidins (mg LCE/g 
DW) were calculated as leucocyanidin equivalents (LCE) using the formula developed by 
PORTER et al. (1985). 
 
3.2.2.3 Determination of Flavonoids 
The vanillin assay, as described by HAGERMAN (2002), was used to determine flavonoid 
content from plant samples. Extracts (50 µl), were made up to 1 ml with methanol in test tubes 
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before adding 2.5 ml methanolic-HCl (95:5, v/v) and 2.5 ml vanillin reagent (1 g/100 ml acetic 
acid). Similar preparations of a blank that contained methanol instead of plant extract were 
made. After 20 min incubation at room temperature, absorbance was read at 500 nm using a 
UV-Vis spectrophotometer. A catechin standard curve was prepared from 1 mg ml-1 catechin 
(Sigma-Aldrich) stock solution in methanol. The flavonoid content was expressed as µg 
catechin equivalents (CTE) per g DW. Each sample extract had three replicates. 
 
3.3 Results and Discussion 
 
Table 3 presents the total phenolic, flavonoid and proanthocyanidin contents of the eleven 
medicinal plants screened. Total phenolic levels, flavonoids and tannins were significant for 
the three Aloe species, Haworthia and Hypericum species. Phytochemical screening of natural 
products underpins the development of cosmetic and anti-ageing products. Phenolic 
compounds, particularly tannins and flavonoids are known to enhance rapid skin regeneration 
and antimicrobial effects. Although the bioactivity of the secondary metabolites, including 
phenolic compounds, is a function of both quality and quantity as well as interactions of these 
metabolites, their respective quantities in an extract sometimes gives a correlation with activity. 
In skin burns and wound healing processes, phenolic-protein complexes form a film that 
prevents dehydration and creates a physical barrier to damaged tissue thereby preventing 
microbial infection and chemical damage (LUSEBA et al., 2007). 
 
It is through the same mechanism (phenolic-protein complexing) that these groups of 
compounds are thought to exert their antimicrobial effects. The concentration of total phenolics 
in the investigated plant samples ranged from 0.05 to 4.69 mg/g DW. The highest 
concentrations of total phenolic compounds were found in the leaves of the three Aloe species 
(A. arborescens, A. aristata and A. ferox) followed by H. limifolia and H. aethiopicum. 
Coincidentally, the extracts from these five species also demonstrated good antimicrobial 
activity against a number of tested microorganisms. Although it is insufficient to draw solid 
conclusions from just one group of compounds tested in this study considering the multitude 
of compounds produced by plants, the correlation between the trend in the amount of phenolic 
compounds and antimicrobial effects, it is tempting to speculate on the involvement of these 
compounds. Phenolic compounds in plants are purported to serve defence roles against 
invading pathogens (DEY and HARBORNE, 1989; TREUTTER, 2001) and important 
pharmacological activities such as antioxidants, anticarcinogenic, antibacterial, and anti-
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inflammatory effects have been recorded (SHARMA et al., 1994; BRUNETON, 1995; 
KUDA et al., 2005).  
 
A similar trend to that of total phenolics were observed for flavonoids and condensed tannins 
(proanthocyanidins). Flavonoids are known for direct antibacterial properties, synergistic 
activity with antibiotics and the ability to suppress bacterial virulence; in addition to having 
anti-carcinogenic properties (TAPAS et al., 2008). Tannins are known for antibacterial, anti-
parasitic, anti-inflammatory and anti-ulcer properties. The proanthocyanidin content ranged 
from 0.09 to 9.85 µg/g DW with the highest content in H. aethiopicum, followed by A. ferox, 
A. aristata, H. limifolia, B. natalensis and A. arborescens respectively. Tannins are reported to 
be the key candidates in the phenolic-protein complexes. The hydroxyl groups in phenolic 
compounds are excellent hydrogen donors that forms strong hydrogen bonds with protein 
carboxyl groups. Apart from wound healing, the phenolic-protein properties could exert the 
antimicrobial and enzyme inhibitory properties by forming hydrophobic interactions with the 
protein regions of the bacterial cell wall (NCUBE and VAN STADEN, 2015).  
 
All the plant extracts evaluated showed considerable amounts of phenolic compounds that 
could in one way or another be attributed to the pharmacological activities observed in Table 
3.1. It is however noted that plant extracts with high phenolic contents showed moderate to 
high antimicrobial and anti-inflammatory activities. This suggest that the value of the 
compounds of phenolic nature plays a major role in skin disorders and wound healing.  
 
Condensed tannins are measured as leucocyanidin (flavan-3, 4-diol) equivalents which are 
products of the breakdown of condensed tannins in the assay (SHARON et al., 2002; 
CROZIER et al., 2006a; 2006b). According to BRUNETON (1995), condensed tannins are 
reported to accumulate in leaf and root tissues of many plants, probably as a defence 
mechanism against microorganisms. Condensed tannins or proanthocyanidins essentially 
contain positive gallocatechin and negative epicatechin, positive catechin and epigallocatechin 
and their derivatives via carbon- carbon links. These compounds are primarily responsible for 
inhibiting the generation of chemiluminescence by activated human polymorphonuclaer 
neutrophil (PMN) indicating that these compounds inhibit the oxidative outburst of PMN 
inflammation (POLYA, 2003).  
 
Several flavonoids and bioflavonoids are potent inhibitors of lipoxygenase or cyclooxygenase 
(BRUNETON, 1995; POLYA, 2003). According to TALHOUK et al. (2007), the flavonoids 
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are known to act on the inflammatory response via many routes and block molecules like COX, 
iNOS, cytokines, nuclear factor-kB and matrix metalloproteinases. Some flavonoids have been 
described to be active against acute inflammation in vivo using a carcinogenic-induced mouse 
paw oedema model (PELZER et al., 1998). Flavonoids could be major bioactive compounds 
responsible for the anti-inflammatory properties exhibited by plant extracts. Furthermore, 
flavonoid derivatives are reported to inhibit the development of fluids that result in diarrhoea 
and abdominal pains (SCHUIER et al., 2005). 
 
Polyphenols or phenolic compounds are characterised by at least one aromatic ring bearing one 
or more hydroxyl substituents and other functional derivatives such as methyl esters, esters and 
glycosides (DEY and HARBORNE, 1989). These are a diverse group of higher secondary 
metabolites, with derivatives of the shikimate pathway, phenylpropanoid metabolism pentose 
phosphate and phenylalanine as the pioneer molecules (RYAN et al., 1999; 
BALASUNDRAM et al., 2006). The phenylpropanoid pathway is a very important metabolic 
pathway in plant metabolism in terms of carbon flux, with more than 20% of the cell total 
metabolism going through this process (DIXON and PAIVA, 1995). Polyphenol pathways 
yield lignans, lignins flavonoids and anthocyanins. The enzyme PAL transforms phenylalanine 
into trans-cinnamic acid using a non-oxidative deamination process. The enzyme shows an 
important part in the pathways fluidity. Basic phenol is the unit of polyphenols and are 
ubiquitous in plants. The type and compound produced differ amongst plants (CROZIER et 
al., 2006a; 2006b). Phenolic compounds are integral in cell wall structure as polymeric 
materials like lignins which provide mechanical strength and support forming a barrier against 
invading microorganisms (WALLACE and FRY, 1994). The complexes display a significant 
free radical scavenging ability which is determined fundamentally by their reactivity as 
electron- or hydrogen- donating agents and the steadiness of the resulting anti-oxidant derived 
radicals, which prevents oxidation of several food ingredients, particularly oils and fatty acids 
(RICE-EVANS et al., 1997; SUBBA RAO and MURALIKRISHNA, 2002). Tannins and 
flavonoids are among the most comprehensive assemblies of phenolic compounds. 
 
Flavonoids are the most well-known and varied class of phenolics with low molecular weight 
(HEIM et al, 2002). They are derived biosynthetically from an arrangement of the acetate and 
shikimic acid pathways (WATERMAN and MOLE, 1994). They are elements of plant parts 
with innumerable variants (HEIM et al., 2002; CROZIER et al., 2006a; 2006b) and have 
high concentrations in leaf epidermal tissue and fruit peels (HRAZDINA, 1992; CROZIER 
et al., 2006a; 2006b). Minor variances in basic substitution patterns gives rise to several 
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groups, with the main subclasses being flava-3-ols, isoflavones, flavanones flavonols, flavones, 
and anthocyanicidins (HEIM et al., 2002). Chemical and structural assortment of flavonoids 
is related to their varied properties and functions in plant protection from radiation of the sun, 
herbivores and invading pathogens (HARBORNE and WILLIAMS, 2000). Environmental 
factors seem to add significantly to the content of phenolic acids and flavonoids in plants. 
Anthocyanin co-pigments in flowers serve to attract pollinating insects (HARBORNE and 
WILLIAMS, 2000) and are accountable for the blue colours of berries, wines and vegetables 
all of which are chief bases of flavonoids in the human diet (CARANDO et al., 1999; 
STEWART et al., 2000; LOPEZ et al., 2001). 
 
A main purposes of flavonoids in plants is their defensive character against microbial invasion 
(WATERMAN and MOLE, 1994; HARBORNE and WILLIAMS, 2000). The presence of 
flavonoids as phytoalexins are important in response to microbial attack (GRAYER et al., 
1994; HARBORNE, 1999). Much research on flavonoids in the pharmaceutical and 
pharmacological areas report antitumor, anti-hepatotoxic, anti-lipolytic, vasodilator, 
antimicrobial, anti-inflammatory, antioxidant, immunostimulant and antiallergic agents 
(IINUMA et al., 1994; ALIAS et al., 1995; WILLIAMS et al., 2013; BURDA and 
OLESZEK, 2001). HIV research is also considering the role of plant flavonoids as potential 
drug agents for the immunodeficiency virus as many traditional healers claim medicinal plant 
treatment and healing for HIV/AIDS (HARBORNE and WILLIAMS, 2000). 
 
Tannins are phenolic compounds that display multifaceted and exceedingly variable chemical 
arrangements. They are broadly characterised into hydrolysable and condensed tannins, based 
on whether acids or enzymes can hydrolyse the components or whether they condense the 
components to polymers (SCHOFIELD et al., 2001). Both groups of tannins are abundant in 
highly reactive hydroxyl groups occurring from the benzene rings, and they form multiplexes 
with proteins including enzymes (WALLACE and FRY, 1994) and polymers such as 
cellulose and hemicellulose (HASLAM, 1989). Hydrolysable tannins are based upon the 
fundamental structural unit of gallic acid (3, 4, 5-trihydroxyl benzoic acid) and are almost 
invariably found as multiple esters with D-glucose to form gallotannins (HASLAM, 1989). 
By-products of hexahydroxydiphenic acid (ellagitannins) are derived from oxidative coupling 
of adjacent galloyl ester groups in a polygalloyl D-glucose ester (MUELLER-HARVEY, 
2001). The fundamental compound, pentagalloylglucose is the start of various tannin 
structures. The compound consists of polyols such as glucose, surrounded by several gallic 
acid units. Gallic acid and its metabolites are widely distributed in plants, particularly 
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herbaceous dicotyledons (MUELLER-HARVEY, 2001). In plant tissues like galls, 
metabolites of gallic acids accumulate in large quantities (HASLAM, 1989). 
 
Proanthocyanidins or condensed tannins are oligomers of 3-flavonols (catechins) and 3, 4 
flavan-diols (leucoanthocyanidins) connected together by single interflavan carbon to carbon 
bonds (HAGERMAN, 1998; XIE and DIXON, 2005). The flavan-3-ol units are 
interconnected principally through the 4 and 8 positions. The term proanthocyanidin is a 
derivative of the acid-catalysed oxidation reaction that yields red anthocyanidins upon heating 
in an acidic alcohol solution (PORTER et al., 1986). Reactions that form the basis of the 
butanol-HCl assay for proanthocyanidins. Their arrangements are subject to the nature 
(hydroxylation and stereochemistry pattern) of the flavan-3-ol starter and location, the degree 
of polymerisation and the presence of modifications such as esterification of the 3-hydroxyl 
group extension units and stereochemistry of the linkage lower unit. Most proanthocyanidins 
are built from catechin, epicatechin and flavan-3-ols, (XIE and DIXON, 2005). They are 
widespread polyphenols in plants after lignins and occur in high concentrations in various plant 
parts (MATTHEWS et al., 1997). In plants, condensed tannins act as feeding deterrents in 
reproductive tissues and developing fruit and also impart astringency to fruit and fruit products 
(HASLAM et al., 1989). According to FEENY (1970) tannins are characteristic of the 
chemical defence of plants and act as quantifiable dosage dependent barricades to marauders 
that feed on plants. The effects physiologically of tannins on predation is assumed to derive 
from their ability to combine with proteins (SCHULTZ et al., 1992; HASLAM, 1996). VAN 
DEN BERGHE et al. (1985) reported that tannins are responsible for binding to the virus 
and/or protein of the host cell membrane and affect adsorption of the virus and similarly in 
fungal and bacterial enzymes that are bound by tannins (SCHULTZ et al., 1992). The 
antibiotic, biostatic and antioxidant effects on a variety of microorganisms that ingest them 
(HASLAM, 1989) have several medicinal properties (HASLAM, 1989; OKUDA et al., 1992; 
GURIB-FAKIM, 2006).   
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Table 3.1 Total phenolic, flavonoid and proanthocyanidin content of the nineteen extracts from the 
screened medicinal plants 
Plant species Plant part Total phenolics 
(mg GAE/ g DW) 
Flavonoid content 
(mg CTE/g DW)  
Proanthocyanidin content 
(µg LCE/g DW) 
Aloe 
arborescens 
Leaves *4.69 ± 0.07 *3.41 ± 0.30 1.80 ± 0.02 
Aloe aristata Leaves *4.53 ± 0.09 *3.43 ± 0.22 *3.51 ± 0.83 
Aloe ferox Leaves *4.64 ± 0.10 *5.28 ± 0.80 *5.28 ± 0.25 
Bulbine 
frutescens 
Leaves 0.29 ± 0.01 0.66 ± 0.11 0.34 ± 0.04 
 Bulbs 0.70 ± 0.03 0.64 ± 0.03 0.37 ± 0.08 
Bulbine 
natalensis 
Leaves 0.22 ± 0.04 0.23 ± 0.04 0.28 ± 0.06 
 Bulbs 1.19 ± 0.11 1.06 ± 0.08 1.89 ± 0.07 
Eucomis 
autumnalis 
Leaves 1.61 ± 0.09 1.34 ± 0.03 0.65 ± 0.11 
 Roots 0.15 ± 0.06 0.14 ± 0.03 0.19 ± 0.01 
 Bulbs  0.53 ± 0.02 1.21 ± 0.01 0.90 ± 0.05 
Haworthia 
limifolia 
Leaves *4.46 ± 0.10 *3.11 ± 0.84 *3.04 ± 0.25 
Hypericum 
aethiopicum 
Leaves *3.35 ± 0.04 *4.56 ± 0.30 *9.85 ± 0.20 
Merwilla 
plumbea 
Leaves 0.80 ± 0.06 1.01 ± 0.04 0.45 ± 0.01 
 Bulbs 0.59 ± 0.02 0.78 ± 0.07 *2.04 ± 1.75 
 Roots 0.05 ± 0.02 0.45 ± 0.13 0.37 ± 0.08 
Tetradenia 
riparia 
Leaves 1.39 ± 0.10 0.89 ± 0.04 0.43 ± 0.05 
 Stems 0.56 ± 0.09 0.27 ± 0.05 0.09 ± 0.02 
Zantedeschia 
aethiopica 
Leaves 0.56 ± 0.03 *2.13 ± 0.04 0.61 ± 0.02 
  Stems 0.16 ± 0.01 0.63 ± 0.06 0.24 ± 0.00 
Each value in the table represent mean ± standard error (n = 3). *Bold indicates the 
significant plant extracts for total phenolics, flavonoid content and proanthocyanidin content. 
58 
 
3.4 Conclusions 
 
The production of phenolic compounds in the eleven plant species and their plant parts were 
analysed in this study. Understanding the phytochemical concentrations in each medicinal plant 
species will help medicinal plant research and users to better understand the beneficial and 
harmful compounds and their effective concentration levels. This will guide users when 
harvesting plant parts rather the whole plant as an important conservation practice to eliminate 
the extinction of these commonly used medicinal plants. Total phenolics, flavonoids and 
proanthocyanidins were determined for the selected plants and some positive results were 
obtained which suggest their roles as anti-inflammatory and antioxidant agents in the processes 
essential for the management of wound healing and dermatological diseases from medicinal 
plants. Further research on the identification and isolation of bioactive compounds responsible 
for these effects is necessary as plants contain multi-complex secondary metabolites which 
may have synergistic effects and not function independently of each other. Through scientific 
investigations the key to unlock these compounds and their exact functions will be a significant 
contribution to traditional public health care.  
 
In the phytochemical assessment for total phenolics, flavonoids and proanthocyanidins of the 
screened medicinal plants; seven of the plants stood out with results that scored high content 
of phytochemical compounds. These are the Aloe species across all three assays (4.53+0.09 to 
4.69+0.07 mg GAE/gDW for total phenolics; 3.41+0.30 to 5.28+0.80 mg CTE/gDW for 
flavonoid content; 3.51+0.83 to 5.28+0.25 µg LCE/gDW for proanthocyanidin content), 
Haworthia (4.46+0.10 mg GAE/gDW for total phenolics, 3.11+0.84 mg CTE/gDW for 
flavonoid content, 3.04+0.25 µg LCE/gDW for proanthocyanidin content) and Hypericum 
(3.35+0.04 mg GAE/gDW for total phenolics, 4.56+0.30 mg CTE/gDW for flavonoid content, 
9.85+0.20 µg LCE/gDW for proanthocyanidin content), Merwilla 2.04+1.75 µg LCE/gDW for 
proanthocyanidin content and Zantedeschia 2.13+0.04 mg CTE/gDW for flavonoid content.   
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CHAPTER FOUR 
CYTOTOXICITY 
 
 
4.1 Introduction 
 
The safety and efficacy of traditional medicines for wound healing and skin disorders of plant 
extracts are of high importance and raises considerable concerns for their applicability and use 
on humans. Plants frequently used in indigenous medicinal systems are assumed to be safe. 
Recent scientific evidence shows that many plants are potentially toxic, mutagenic and 
carcinogenic (KASSIE et al., 1996). Many assays that are biological need a measurement of 
living and/or flourishing mammalian cells. Treating human cells with cytotoxic compounds 
present in plant extracts can result in a variety of cell fates. The cells may undergo necrosis, in 
which they lose membrane integrity and die rapidly as a result of cell lysis. The cells can stop 
actively growing and dividing (a decrease in cell viability), or can activate a genetic program 
of cell death (apoptosis) (KASSIE et al., 1996). Cells that undergo rapid necrosis in vitro do 
not have sufficient time or energy to activate the apoptotic machinery. Cells in cultures 
undergoing apoptosis eventually undergo secondary necrosis. They shut down metabolism, 
lose membrane integrity and lyse. It is therefore prudent to measure cytotoxicity and cell 
viability effects of medicinal plant extracts (KASSIE et al., 1996). Many active plant 
components are toxic at elevated doses and thus an approach to carry out effective screening 
at different concentrations is essential. Brine shrimp is a convenient probe for pharmacologic 
activities in plant extracts which may be manifested as toxicity towards the newly hatched brine 
shrimp.  
 
Various methods are available for screening the safety of plant extracts, two of which were 
applied in the present study to evaluate the cytotoxicity of the eleven traditional medicinal plant 
extracts under investigation. Brine shrimp lethality bioassay is based on the ability to kill 
laboratory cultured brine shrimp (Artemia nauplii). The assay serves as a preliminary 
assessment of toxicity and has been used for detecting fungal toxins, plant extract toxicity, 
heavy metals, pesticides and cytotoxicity testing of various materials used by humans 
(HARWING and SCOTT, 1971; McLAUGHLIN et al., 1991; MARTINEZ et al., 1998; 
BARAHONA and SANCHEZ-FORTUN, 1999; PELKA et al., 2000). A study by 
HOSSAIN et al. (2012) reports on the use of leaves of Caloptropsis gigantean, used 
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traditionally for the external application of eczema, skin eruptions, old sores and ulcers. The 
LC50 values or concentrations at which 50% death rates of brine shrimp occurred were reported. 
A review by FENNELL et al. (2004), reports an assessment of African medicinal plants used 
for various illnesses focusing on their efficacy and safety, where poisoning from traditional 
medicines were indicated; and this occurred frequently because the plants were misidentified 
when sold, or preparation and administration by incompetently trained personnel was 
erroneous. 
 
The tetrazolium-based colorimetric assay 3-(4,5-dimethylthiazol)-2,5-diphenyltetrazolium 
bromide (MTT), has several favourable characteristics for assaying cell proliferation and 
survival. This assay measures the number and activity of living cells at the end of the assay 
(KAPPLER et al., 1981). MTT is tested and known to be cleaved by all living, metabolically 
active cells. The amount of formazan generated is directly proportional to the cell numbers in 
a homogeneous cell population. Activated cells produce more formazan than resting cells, 
which could allow the measurement of activation even in the absence of proliferation. These 
properties are all consistent with the cleavage of MTT only by active mitochondria. The main 
advantage of the colorimetric assay is the speed with which samples can be processed. The 
substrate does not interfere with measurement of the product. This allows the assay to be read 
with no removal or washing steps, which increases the speed of the assay and helps to minimize 
variability between samples. The ultimate phases of the assay namely adding the MTT, reading 
the plates and printing of the data takes minimal time compared to the setting up of the assay 
which includes growth factor dilutions and mixing cells. The assay can be read minutes after 
the addition of acid-isopropanol and the colour is constant for a few hours at room temperature. 
The results are also clearly seen visually. According to FENNELL et al. (2004), genotoxicity 
research revealed that multiple medicinal plants are responsible for detrimental effects to the 
genetic components and should be used cautiously. DU PLOOY et al. (2001) reported a study 
on Boophane disticha scales that are used for dressing circumcision wounds and also used in 
oral concoctions. The effects on the human body include sedation, analgesic effects, visual 
hallucinations, irrational behaviour, coma and/or death. The objectives of this study were to 
evaluate the cytotoxicity properties of the extracts of the selected plants using Brine shrimp 
and MTT assays. 
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4.2 Material and Methods 
 
4.2.1 Brine Shrimp Assay 
The Brine shrimp assay (MEYER et al., 1982) was used to determine the extract toxicity of 
Artemia salina. Brine shrimp eggs (Ocean NutritionTM PET 152) obtained from Northlands 
Pets, Durban, South Africa were hatched under light in a 500 ml beaker containing sea water 
for 36 - 48 h. The eggs were ready once swimming Brine shrimp nauplii had hatched. Two 
mg/ml of each plant extract were two-fold serially diluted into five concentrations (2 mg/ml; 1 
mg/ml; 0.5 mg/ml; 0.25 mg/ml and 0.125 mg/ml). Ten to 15 live Brine shrimps were transferred 
from the hatching beaker to each test tube using a Pasteur pipette with sea water and the water 
topped up to 10 ml with sea water. This was done in triplicate for every diluted plant extract. 
Each plant extract (100 µl) was added to the test tubes and allowed to stand at room temperature 
for 24 h. DMSO and an organophosphate served as negative and positive controls respectively. 
For the plant extract to be lethal, shrimp death of greater than 50% had to be recorded after 24 
h. 
 
4.2.2 MTT colorimetric assay 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide) 
The method described by MOSMANN (1983) was used to determine the cytotoxicity of the 
extracts. The plant extracts were tested for cytotoxicity against African green monkey Vero 
kidney cells obtained from the Department of Veterinary Tropical Diseases (University of 
Pretoria). The cells were maintained in Minimal Essential Medium (MEM, Whitehead 
Scientific) supplemented with 0.1% gentamycin (Virbac) and 5% foetal calf serum (Highveld 
Biological). Cell suspensions were prepared from confluent monolayer cultures and plated at a 
density of 5 x 104 cells into each well of a sterile 96-well microtitre plate. Plates were incubated 
for 24 h at 37 °C in a 5% CO2 incubator until the cells were in an exponential phase of growth 
and the subconfluent cells in the microtitre plate were used in the cytotoxicity assay. Stock 
solutions of the plant extracts (200 µl) were prepared by serial dilutions in ethanol and prepared 
in MEM and added to the cells. The viable cell growth after 120 h incubation with plant extracts 
was determined using the tetrazolium-based colorimetric assay (3-(4,5-dimethylthiazol)-2,5-
diphenyltetrazolium bromide (MTT), (Sigma) described by MOSMANN (1983). Untreated 
cells and a positive control (Doxorubicin chloride, Pfizer Laboratories) were included. The 
amount of MTT reduction was measured immediately by detecting absorbance using a 
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Chromate 4300 microplate reader at 540 nm and a reference wavelength of 630 nm. The wells 
in column 1, containing medium and MTT but no cells, were used to standardize the plate 
reader. The LC50 values were calculated as the concentration of test compound resulting in a 
50% reduction of absorbance as compared to untreated cells. The intensity of colour was 
directly proportional to the number of surviving cells and viable cell growth. Tests were carried 
out in quadruplicate and each experiment was repeated three times. 
 
4.3 Results and Discussion 
 
In addition to evaluating the plant extracts for pharmacological properties, it is as important to 
ascertain the safety of medicinal plant extracts for human use. Cytotoxicity assays are some of 
the important tools for this purpose as they shed light on the potential toxic or mutagenic effects 
of plant extracts. Toxicity effects of most medicinal plant extracts are not well documented 
largely because of the widely held belief that traditional medicinal plants are safe due to 
continuous use over long periods (ELGORASHI et al., 2003). An evaluation of the toxicity 
and cytotoxicity are an important part of ethnopharmacological validations (VAN DYK et al., 
2009). The severity of toxicity of extracts are often related to concentration, exposure time and 
physiological parameters (MEYER et al., 1982). The Brine shrimp assay determines the 
relationship between brine shrimp lethality and cytotoxicity and a positive correlation exists 
between brine shrimp lethality and cytotoxicity (AYO et al., 2007). The MTT assay on the 
other hand evaluates the survival and proliferation of mammalian cells upon exposure to the 
extracts. The results of the plant extracts tested in this study using the Brine shrimp lethality 
assay (Table 4.1) indicated lack of cytotoxicity after 24 h. For an extract to be considered lethal 
it must demonstrate more than 50% Brine shrimp death. The effectiveness of plant extracts is 
often measured as LC50, which represents the concentration of the extract that is able to affect 
50% cell death (cytotoxicity). The MTT assay further substantiated the Brine shrimp results 
with LC50 values of >1 mg/ml for all extracts (Table 4.1). An LC50 value of less than 0.5 mg/ml 
for an extract would be of cytotoxic concern in this assay while that of below 0.1 mg/ml is 
considered highly cytotoxic. The results of the cytotoxicity assay on the tested extracts show 
safe levels, however, further mutagenic and toxicological tests with different mechanisms of 
action and targets would be necessary to ascertain the complete safety of these plant extracts. 
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Table 4.1 Brine Shrimp Lethality and Cytotoxicity effects (MTT assay) of the different plant 
extracts used in this study 
Plants extract  LC50 (mg/ml) Brine 
shrimp lethality 
LC50 (mg/ml) MTT 
assay 
Aloe arborescens leaves >2 >1 
Aloe aristata leaves >2  >1 
Aloe ferox leaves 1.93 >1 
Bulbine frutescens leaves >2 >1 
Bulbine frutescens bulbs >2 >1 
Bulbine natalensis leaves >2 >1 
Bulbine natalensis bulbs >2 >1 
Eucomis autumnalis leaves >2 >1 
Eucomis autumnalis bulbs >2 >1 
Eucomis autumnalis roots >2 >1 
Haworthia limifolia leaves >2 >1 
H. aethiopica leaves >2 >1 
Merwilla plumbea leaves >2 >1 
Merwilla plumbea bulbs >2 >1 
Merwilla plumbea roots >2 >1 
Tetradenia riparia leaves >2 >1 
Tetradenia riparia stems >2 >1 
Zantedeschia aethiopica leaves >2 >1 
Zantedeschia aethiopica stems >2 >1 
DMSO >2  
Organophosphate - Doxorubicin LC50 (uM) 
4.654 ± 0.971 
 
The cytotoxicity results (LC50) of the plant extracts were all greater than 2 mg/ml except for 
Aloe ferox leaves in the Brine shrimp assay. The cytotoxicity results of the plant extracts at all 
concentrations were greater than 2 except for Aloe ferox leaves in the Brine shrimp assay. 
Extracts considered lethal would demonstrate greater than half shrimp death. The MTT 
cytotoxicity test yielded LC50 values of > 1 mg/ml on all extracts indicating that they are not 
cytotoxic. The observed general lack of cytotoxic effects on all the tested extracts presents 
some promising and beneficial aspects of these medicinal plant extracts in the treatment of skin 
diseases and thus in potential for wound healing. The two Aloe species and H. aethiopicum 
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were among the best extracts that exhibited consistently good antimicrobial activity and 
warrant further investigations and possible isolation of bioactive principles. This would require 
further investigations into the application into potential bioactive compounds for 
dermatological use.  
 
Cytotoxicity may result in genotoxicity and mutagenicity of cells. The induction of permanent 
transmissible variations in the assembly of the genetic material in cells or organisms is known 
as mutagenicity. These alterations or mutations may involve a single gene or a block of genes. 
Genotoxicity is comprehensive and entails the ability of the compounds to interact with the 
DNA and cellular apparatus such as topoisomerase enzymes and spindle apparatus which 
regulates the fidelity of the genome. Isolated compounds from plants like quercetin, 
fluoroquinolone alkaloids and isothiocyanates are considered to be mutagens. Isolating 
compounds that are responsible for mutagenic effects detected with plant extracts are complex 
due to the mixture of organic compounds (SRIVIDYA et al., 2012). Therefore, safety of plants 
and their continued extensive use in health care is very important. There are studies that have 
confirmed that some phytochemicals might possess anti-mutagenicity and anticarcinogenic 
effects. The intake of plant materials in various epidemiological studies also support the 
chemo-preventive effects in which plant chemicals display genotoxic/mutagenic effects by 
themselves or perpetuate the effect of various xenobiotics (RANI et al., 2005). Multifaceted 
chronic disease pathology of cancer, cardiovascular disease, diabetes, hypertension, immune 
and neuro-degenerative disorders and the ageing process as well as skin conditions and wound 
healing can be modulated by polyphenols derived from plants. Oxidative stress occurs in cells 
and tissues which lead to human disease when the ROS generated exceeds the antioxidant 
capability causing toxic shock. Protective antioxidant plant derivatives are reported due to 
radical scavenging, inhibition of oxidase, alteration of gene expression and metal chelation to 
the antioxidant response elements and various multidimensional effects of phenolic 
compounds. VAN ZYL and VILJOEN (2002) found limited data on antiplasmodial activity 
and Aloe species toxicity. VAN DYK et al. (2009) reported the importance of including assays 
for toxicity when screening; they used fifty-nine different plant extracts from six plant species 
and found that only one extract isolated from Combretum erythrophyllum showed a favourable 
safety index of 0.03 µg/ml. 
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4.4 Conclusions 
 
Cytotoxicity screening on all plant extracts for both Brine shrimp lethality and the MTT assay 
exhibited no cell toxicity effects having LC50 values larger than two mg/ml and greater than 
one mg/ml respectively. However, further investigations using different models and 
mechanisms are necessary as many of the selected medicinal plants are reported to be toxic and 
misuse may result in mortality.   
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CHAPTER FIVE 
ANTI-INFLAMMATORY ACTIVITY: 
IN VITRO NITRIC OXIDE (NO) AND 5-LIPOXYGENASE 
INHIBITION (LOX) 
 
 
5.1 Introduction 
 
The mammalian immune system is comprised of many interactive, specific types of cells that 
cooperatively safeguard the mammalian body from pathogenic infections and other sources of 
stimuli. Chronic inflammation is pivotal to skin pathologies and delayed healing of wounds in 
diseases like leprosy and sexually transmitted infections (ALLEN, 2003). According to 
IWALEWA et al. (2007), plants do contain an extensive array of natural compounds which 
have effects on the healing process and the potential to inhibit or reduce the inflammatory 
process. A study conducted by JOHNSON (2009) emphasised the importance of research in 
alleviating the lack of alternative drugs, the promotion and the development of new drugs as 
well as the management of therapeutic processes like inflammation and related metabolic 
conditions. EDWARDS (2005) indicated that the process of inflammation is a huge burden to 
human health care and involves many diseases. Even though there are multiple drugs available, 
many of the drugs that are anti-inflammatory come with extensive side-effects and have limited 
clinical use (VIOLA et al., 2008). The demand for safe and effective drugs that are anti-
inflammatory is essential for the future of dermatological and wound healing care.  
 
Inflammation can be defined as a localized protective, non-specific immune response of 
vascular tissues to harmful stimuli such as damaged cells or irritants and pathogens 
(FERRERO-MILIANI et al., 2007). Inflammation is a series of initial responses from the 
immune system to infection transferring immune cells to the site of injury. In addition, 
inflammatory reactions serve to establish a physiological barrier against the spread of infection 
and to promote healing of any damaged tissue following the clearance of the stimuli (COHN 
and LANGMAN, 1996). A defence mechanism of inflammation is evoked by body tissues in 
response to chemical perturbation and microbial infection that results in cell injury or death 
(O’BYRNE et al., 2000; O’BYRNE and DALGLEISH, 2001). The inflammation 
mechanisms involve various events involving the metabolism of arachidonic acid which has 
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an important role. The defensive response is characterised on the skin as redness, pain, heat 
and swelling resulting in a loss of function in the injured area. When tissue cells become injured 
they release kinins, prostaglandins and histamine (O’BYRNE et al., 2000; O’BYRNE and 
DALGLEISH, 2001). Collectively, these compounds increase vasodilation and permeability 
of the capillaries leading to increased blood flow to the injured site. Short term inflammation 
is the early reaction of the body to detrimental stimuli and is an outcome of the amplified 
movement of plasma and leukocytes especially granulocytes from the blood into injured tissues 
(O’BYRNE et al., 2000, O’BYRNE and DALGLEISH, 2001). Numerous biochemical 
events unfold, increasing the inflammatory response. These include the immune system, 
various cells within the injured tissues and the local vascular system. Long term inflammation 
occurs with an advanced shift in the type of cells present in the site of inflammation 
characterised by simultaneous destruction and healing of the tissue from the inflammatory 
process (TORTORA et al., 2016). Prostaglandins and leukotrienes are produced from 
arachidonic acid and are responsible for the complex process of inflammation and pain. 
JÄGER et al. (1996); FOEGH et al. (1998) and GRAF et al. (2005) reported that flavonoids 
such as quercetin inhibit lipoxygenase enzymes which impact on pro-inflammatory 
prostaglandins and leukotrienes (Figure 5.1). These are metabolised by the pathway of LOX to 
hydroperoxy-eicosatetraenoic acids and leukotrienes that are imperative biologically active 
mediators in a variety of inflammatory processes (PIPER et al., 1994; ALITONOU et al., 
2006). Stimuli of neutrophils causes the cleavage of arachidonic acid from the membrane 
phospholipids which are then transformed into leukotrienes and prostaglandins through LOX 
pathways (BOURICHE et al., 2005). Prostaglandins have numerous effects on physiological 
processes such as muscle relaxation, vasodilation, aggregation of blood platelets, cell 
protection, pain and fever control (GRAF et al., 2005; BEDINI et al., 2009). The processes 
of inflammation include processes with reactive oxygenation that are initiated by the 
stimulation of leucocytes.  
 
Myrtle and eucalyptus essential oils caused temporary leucocyte activation by scavenging 
hydroxyl radicals and consequently interfering with the process of inflammation by acting as 
antioxidants (GRABMANN, 2000). Antioxidant properties also provide significant evidence 
about the possible activity of a drug on inflammatory processes (NJENGA and VILJOEN, 
2006). A combination of studies on LOX and antioxidant assays (Chapter 6) is a good sign of 
the potential ant-inflammatory activity of medicinal plant extracts (ALITONOU et al., 2006). 
Polyphenols are carbon-based aromatic phenyl ring compounds which oxidize to quinones by 
reactive oxygen species, a characteristic responsible for the antioxidant activity and anti-
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inflammatory activity (SREEJAYAN and RAO, 1996). The structural and functional 
diversity of phytochemicals are the underlying pharmaceutical capacity for inflammatory 
activity in medicinal plants. The benefits of inflammation are the increasing levels of 
inflammatory signals simply, it's the body's response to outside threats like stress, infection, or 
toxic chemicals.  When inflammation occurs, chemicals from the body's white blood cells are 
released into the blood or affected tissues to protect the body from foreign substances. This 
release of chemicals increases the blood flow to the area of injury or infection, and may result 
in redness and warmth which ultimately initiates the healing process. Inflammation pathway 
(Figure 5.1) below and the relationship to selecting LOX and NO inhibition in this study. 
 
Figure 5.1 Pathway of the Inflammation Process. (PEDERSEN, COSKUN,  
SOENDERGAARD,  SALEM, HAAGEN NIELSEN. 2014). 
 
5.1.1 5-Lipoxyegnase and the Inflammatory Process 
The LOX enzymes are non-haem in nature and contain ferric iron catalytic ability with an 
increased reduction potential. A study by DAILY and IMMING (1999) report that iron 
chelators like hydroxamic acid derivatives and catechols are able to reduce iron from active to 
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its inactive form, preventing the transformation of fatty acids to pro-inflammatory lipid 
mediators. Compounds like arachidonate 5-lipoxygenase inhibitors reduce or inhibit the 
activity of the arachidonate 5-LOX enzyme, these are responsible for the production of 
inflammatory leukotrienes. The excessive production of leukotrienes is a chief consequence of 
inflammation in allergic rhinitis, osteoarthritis and asthma (LAUFER, 2003; NELSON and 
COX, 2008).  Examples of 5-LOX inhibitors include drugs such as zileuton and sodium 
meclofenamate (BISHAYEE and KHUDA-BUKHSH, 2013). 
 
A wide variety of agents have been reported as 5-LOX inhibitors with the majority appearing 
to be reducing agents that are lipophilic including partially saturated aromatics, phenols and 
compounds with heteroatom-heteroatom bonds. Many are not selective 5-LOX inhibitors, but 
often affect COX and other LOXs as well. In vivo systemic activity for many of these has in 
general been disappointing, probably because of poor bioavailability caused by lipophilicity 
and metabolic instability (oxidation, and conjugation of phenolic compounds). However, 
topically a number of agents have shown promise for skin inflammation, with Syntex's 
lonapalene being the most advanced of these (BISHAYEE and KHUDA-BUKHSH, 2013). 
Many results published to date appear more disappointing in the allergy/asthma field. More 
excitingly, a few structural types of anti-inflammatory agents are selective 5-LOX inhibitors 
which have shown systemic activity in vivo in some clinical studies. There are certain 
chemicals occurring in trace amounts of food products, and in dietary supplements shown to 
inhibit 5-LOX; these include caffeic acid, curcumin and baicalein (BISHAYEE and KHUDA-
BUKHSH, 2013; DE MELO et al., 2014; WÖLFLE et al., 2014). 
 
LOX enzymes are an iron-containing family of enzymes many of which catalyse the 
deoxygenation of polyunsaturated fatty acids in lipids with a cis,cis-1,4- pentadiene structure 
(CHARLIER and MICHAUX, 2003; FOURIE, 2009; POECKEL and FUNK, 2010). 
These plant enzymes are most common and are involved in various diverse aspects of plant 
physiology in relation to pest resistance, senescence or responses to wounding growth and 
development. Mammalian tissues show that a number of lipoxygenase isozymes are involved 
in the production of eicosanoids (such as leukotrienes, nonclassic eicosanoids and 
prostaglandins) (CHARLIER and MICHAUX, 2003; FOURIE, 2009; POECKEL and 
FUNK, 2010). 
 
The LOX enzymes are successful in the management of diseases like atherosclerosis, cancer, 
asthma and inflammation (CHARLIER and MICHAUX, 2003; FOURIE, 2009; 
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POECKEL and FUNK, 2010). Studies report the blocking of arachidonic acid (AA) 
metabolism with LOX inhibition leading to generating pro-inflammatory leukotrienes and 
lipoxins in the LOX pathway. These intermediary products are reported to be the cause of the 
side effects of inhibitors. A number of small molecule COX/LOX inhibitors are known to 
overcome this. REDDY et al. (2008), reported on indolylpyrazoline agents as dual COX/LOX 
inhibitors but with no in vivo anti-inflammatory activities. A study using virtual selection to 
recognize ring frameworks as double COX/LOX inhibitors showed that a thiazolidinone ring 
framework may be successfully used for developing anti-inflammatory agents which would be 
a significant discovery and progress for medicinal plant compounds (GERONIKAKI, 2008). 
Many hybrid COX/LOX inhibitors have an N-difluoromethyl-1, 2-dihydropyridine-2-1 LOX 
pharmacophore (CHOWDHURY et al., 2009; YU et al., 2010). In another study, virtual 
screening identified a based ring framework benzo-dithiazoliumylide as double COX/5-LOX 
inhibitor (YU et al., 2010). No reports or information for these agents has been presented of in 
vivo anti-inflammatory activity.  
 
5.1.2 Nitric Oxide as an Anti-Inflammatory Agent 
Nitric oxide (NO) is one of many oxides of nitrogen, a colourless gas, a free radical with an 
unpaired electron on the nitrogen atom. It is a heteronuclear diatomic molecule. The molecules 
may be produced during fossil fuel combustion at power plants and by automobile engines. 
Excess NO in high air temperatures is needed for combustion of the fuel. Natural production 
occurs by high air temperatures produced during lightning in thunderstorms (SHARMA et al., 
2006; SHARMA et al., 2007). NO is a signalling molecule with an important function in 
inflammation pathogenesis and provides an anti-inflammatory effect in normal physiological 
conditions. Nitric oxide is an inflammatory mediator that induces inflammation as it is 
overproduced in irregular physiological circumstances (SHARMA et al., 2007). When 
exercising, the muscles require higher levels of oxygen which are supplied by the blood. When 
the heart drives blood under pressure the lining in the arteries releases nitric oxide into the 
blood which relaxes and widens the walls of the blood vessels permitting blood to flow through 
freely. The production of NO allows the release into the endothelial cells which convert 
arginine into citrulline (SHARMA et al., 2007; RAO et al., 2010). NO’s main function is to 
improve bactericidal and tumoricidal activity of macrophages (STUEHR and NATHAN, 
1989; NATHAN and HIBBS, 1991). It induces vascular dilatation in the heart and blood 
vessels and is further involved in immunity through cytokine-activated macrophages, releasing 
NO in elevated concentrations. Researchers have reported that NO is a powerful 
neurotransmitter effectively at the neuron synapses, contributing to apoptosis regulation and is 
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involved in inflammatory pathogenesis of disorders in joints, the gastrointestinal and 
respiratory systems (SHARMA et al., 2007; RAO et al., 2010). NO inhibitors are effective in 
the management of inflammatory diseases. Arginine analogues and discerning biosynthesis 
inhibitors of NO are known to reduce inflammation. Excessive production could lead to tissue 
damage, vasoconstriction and stimulation of mediators for inflammatory activity (SHARMA 
et al., 2007; RAO et al., 2010).  
 
In all mammals, NO is a cell-signalling molecule and a part of physiological and pathological 
processes and a strong vasodilator. Pharmaceuticals like nitro-glycerine and amyl nitrite are 
commonly used in wound healing and are precursors to nitric oxide (SHARMA et al., 2007; 
RAO et al., 2010). Small quantities of nitric oxide protect organs like the liver from ischemic 
damage. NO production is involved in non-alcoholic liver fatty disease and is important in  
lipid hepatic or liver fatty acid metabolism under malnourishment (SHARMA et al., 2007; 
RAO et al., 2010).  
 
Nitric acid production is increased in those populations residing at high altitudes, and this 
assists these people in avoiding hypoxia by increasing pulmonary vasculature vasodilation. 
Some of the effects known to occur from high NO levels include neurotransmission modulation 
of the hair cycle, production of reactive nitrogen intermediates vasodilatation, and penile 
erections (through its ability to vasodilate) (STUEHR and NATHAN, 1989; NATHAN and 
HIBBS, 1991). Amyl nitrite and nitro-glycerine serve as vasodilators as they are transformed 
into NO in the body. The antihypertensive drug Minoxidil induces vasodilating and comprises 
an NO moiety and exhibits itself as an NO agonist. NO is known to obstruct and inhibit smooth 
muscle growth and contraction, leukocyte adhesion and platelet aggregation to the endothelium 
(STUEHR and NATHAN, 1989; NATHAN and HIBBS, 1991). Hypertension, 
atherosclerosis and diabetes physiology demonstrated compromised NO pathways. High salt 
intake increases NO production in patients with hypertension (STUEHR and NATHAN, 
1989; NATHAN and HIBBS, 1991). 
 
The NO synthesis pathway in phagocytes generates high levels of NO that induces apoptosis. 
Studies conducted in vitro have reported that phagocyte-dependent NO production at 
applications higher than 400-500 mg/ml induces cellular apoptosis. The effect is like mediators 
that reverse inflammatory responses by neutralizing and clearing of inflammatory cells from 
inflamed tissues (STUEHR and NATHAN, 1989; NATHAN and HIBBS, 1991). NO’s role 
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in inflammation is not simple, signifying that the gaseous mediator can also encourage 
inflammation (STUEHR and NATHAN, 1989; NATHAN and HIBBS, 1991).  
 
Bacterial pathogens have developed mechanisms for NO resistance (RAO et al., 2010). Nitric 
acid serves as a measure of inflammation in conditions like asthma. Nitric oxide can contribute 
to perfusion injury by interacting with a superoxide to form detrimental oxidant peroxynitrite. 
Inhaled nitric oxide helps survival and recovery from a chemical called paraquat which causes 
poisoning, causing lung tissue-damaging superoxides and interferes with NOS metabolism 
(RAO et al., 2010). In plants, it is a signalling molecule, acting against stress caused by 
oxidation and is active in plant pathogen collaborations. The treatment of cut flowers and plants 
producing NO is known to result in reducing time to wilting and the delay in senescence (RAO 
et al., 2010).  
 
Investigations into medicinal plant material that can be used as natural inflammatory mediators 
of inhibitors and enzymes like LOX and NO may be alternatives to the detection of original 
healing agents against inflammatory diseases (HARVEY, 2000). The present study evaluated 
selected plant extracts using anti-inflammatory LOX activity and NO production inhibition. 
 
5.1.3 LOX and NO Enzymes in Inflammation 
LOX (lipoxygenase) and NO synthase enzymes are accountable for the manufacture of 
prostaglandin H2 (PGH 2). The expression of the two LOX isozymes is differently regulated 
but the enzymes are moderately similar in their amino acid sequences (FLETCHER et al., 
1992). The constitutive enzyme, LOX, encoded by a 2.8-kilobase transcript located on human 
chromosome 9, serves certain physiologic housekeeping functions, such as thrombogenic 
thromboxane A2 generation by platelets, antithrombogenic PGI2 production by endothelial 
cells, generation of cytoprotective prostanoids in the gastric mucosa, and regulation of renal 
blood flow by prostanoids (FLETCHER et al., 1992; MURAKAMI et al., 2000). In contrast, 
expression of the inducible LOX, encoded by a 4.4-kilobase transcript from human 
chromosome 1, is found almost exclusively in inflamed tissues responding to inflammatory 
stimuli such as pro-inflammatory cytokines, growth factors, mitosis stimulants, bacterial 
lipopolysaccharide, and tumour promoters (FLETCHER et al., 1992). The view that the two 
iso-forms of the LOX enzyme facilitate inflammatory processes and physiological processes, 
respectively, indicates individual pathways of AA metabolism with various advantages to the 
organism. There are reports that the two enzyme isoforms use different AA pools in response 
to different cellular stimuli for prostaglandin synthesis (REDDY and HERSCHMAN, 1994; 
MURAKAMI et al., 2000). Lipoxygenases (LOXs) are a ubiquitous family of non-heme iron 
enzymes involved in the stereo- and regio-specific peroxidation of arachidonic acid (AA) or 
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linoleic acid (LA), in the presence of molecular oxygen. One clear difference between the 
lipoxygenases was in their free sulfhydryl group content. The uv-visible absorption spectrum 
of each native isoenzyme was consistent with expectations for the experimental aromatic amino 
acid content. All of the isoenzymes contained one non-heme iron atom per molecule of protein 
(DRAHEIM, CARROLL, MCNEMAR, DUNHAM, SANDS, FUNK. 1989).  
 
The main enzymes that have been described include 5, 8, and 15-LOX and they depend on the 
oxidation site of fatty acids (PORTA and ROCHA-SOSA, 2002). The LOX and NO gene has 
the structure typical of an “immediate-early” gene product that is rapidly up-regulated during 
inflammation and other pathologic processes (CROFFORD, 1997; CROFFORD et al., 2000; 
BOTTING, 2003; 2006). LOX is thought to contribute to the generation of prostanoids at 
positions of inflammation (CROFFORD et al., 2000). LOX and NO are consistently conveyed 
in a wide variety of tissues and produces prostanoids involved in the regulation of normal 
kidney and stomach functions as well as vascular homeostasis (MORITA et al., 2002). The 
concentration of the LOX and NO enzymes fundamentally remains constant, but minor 
increases in manifestation occurs in response to encouragement from hormones or growth 
factors (BOTTING, 2003; BOTTING, 2006). There are, however, no examples of separate 
stimulus-specific regulation of LOX and NO in the same cell at a time when both enzymes are 
expressed and functioning. 
 
5.1.4 Anti-Inflammatory Agents 
Evidence has shown that the LOX and NO enzymes are important in the inflammatory 
practises. The research focus of these enzymes are drug developments in the treatment of 
inflammation. YUAN et al. (2006) reported that the biosynthesis of prostanoid is inhibited by 
nonsteroidal anti-inflammatory drugs which are recommended as anti-inflammatory agents and 
analgesics. The treatment with these nonsteroidal anti-inflammatory drugs prevents the 
production of prostaglandins and down-regulates inflammation-related pathological symptoms 
such as pain and swelling. Their mechanism of action, particularly aspirin and ibuprofen 
includes inhibition of both the LOX and NO enzymes thereby preventing the pathological 
synthesis of prostaglandins (MORITA et al., 2002). Inhibition of LOX may result in the 
removal of the cytoprotection function, leading to damaging side effects in the gastrointestinal 
tract (GILROY et al., 1998). The use of the drugs resulted in key changes to the 
pathophysiological responses of the body, which has led to side effects like bleeding, gastric 
renal ulceration and irritation (BOTTING, 2003; BOTTING, 2006). It was later elaborated 
that these side effects are associated with inhibition of LOX while the anti-inflammatory 
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activity is due to inhibition of NO (COPELAND, 2005). The negative effects associated with 
the use of the non-steroidal anti-inflammatory drugs has initiated much interest in research to 
substitute the use of anti-inflammatory drugs. Selective inhibition of LOX and NO enzymes 
has been shown to significantly lower the development of gastro toxicity and related side 
effects (FERRERO-MILIANI et al., 2007). Traditional health care provides extensive 
resources for exploitation in the discovery of new anti-inflammatory agents. Many indigenous 
plant-derived natural compounds like alkaloids, tannins, flavonoids, saponins, and essential 
oils offer activities that are anti-inflammatory (JUST et al., 1998; GURIB-FAKIM, 2006). 
 
A South African study by IWALEWA et al. (2007) reported on greater than 100 plant species 
within 60 families that were used for the management of pain related inflammatory disorders 
in mammals. Bioactivity was found to be related to secondary metabolites like phenols, 
alkaloids, saponins and terpenoids. Therapeutic and biological properties associated with these 
metabolites include antimicrobial, anticancer, antioxidant and anti-inflammatory activities 
(HODZIC et al., 2009). The mechanism of action of diverse compounds of a phenolic nature 
such as curcumins, flavonoids and tannins and occur through activities of free radical 
scavenging and inflammatory enzyme inhibition like COX and LOX inflammatory cascades 
(LEE and MOON, 2003; SPEED and BLAIR, 2011). 
 
Plant-derived products are important in the advancement of developing anti-inflammatory 
agents. In this study, different plant parts of eleven medicinal plants were evaluated for their 
inhibition of LOX and NO enzymes. The study aimed to determine and provide evidence if the 
selected medicinal plant extracts used for dermatological management have anti-inflammatory 
activity as part of their mechanism of action. 
 
5.2 Materials and Methods 
 
5.2.1 Collection and Preparation of Plant Material 
Plant material were prepared as described in Chapter 2, Sections 2.4.1 and 2.4.2. 
 
5.2.2 The Nitric oxide (NO) Production and Cytotoxicity of LPS-activated RAW 
264.7 Macrophages 
 
5.2.2.1 Cell Culture Preparation 
The RAW 264.7 macrophage cell lines were purchased from the American Type Culture 
Collection (Rockville, MD, USA) and cultured in plastic culture flasks in DMEM containing 
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L-glutamine supplemented with 10% foetal calf serum (FCS) and 1% PSF 
(penicillin/streptomycin/fungizone) solution under 5% CO2 at 37 °C. The solution was split bi-
weekly and all cells were seeded in 96-well microtitre plates. The cells were then activated by 
incubation in a medium containing LPS (1 µg/ml) and various concentrations (100, 50, 25, and 
12.5 µg/ml) of the methanol plant extracts dissolved in DSMO with a final DMSO 
concentration of 0.2%. 
 
5.2.2.2 Quantification of NO Release 
The concentration of NO in culture medium was evaluated using the Griess reagent assay 
(HUNTER et al., 2013). A 96-well plate was used to seed the RAW 264.7 cells at 105 
cells/well. Seeding the wells at 105 or 100 000 cells per well is done by quantifying the number 
of cells in the cell culture medium first. An aliquot of cells is counted using a haemocytometer 
which enables the calculation of the number of cells/ml. Then the cell suspension was diluted 
to the required concentration using fresh medium before pipetting the known number of cells 
into the wells at a density of 4 X 104 cell/ml. 
 
The cells were washed with a buffer solution, Phosphate Buffer Solution (PBS), frequently 
used in research of a biological nature, a water-based salt solution containing disodium 
hydrogen phosphate 1.42 g/l, sodium chloride 8 g/l, potassium chloride 0.2 g/l and potassium 
dihydrogen phosphate 0.24 g/l. The osmolality and ion concentrations of the solutions match 
those of the human body (isotonic). The pH was adjusted to 7.4 with HCl and distilled water 
added to form a total volume of 1 litre. The resultant 1x PBS had a final concentration of 10 
mM PO4
3−, 137 mM NaCl, and 2.7 mM KCl. If used in cell culturing, the solution can be 
dispensed into aliquots and sterilized by autoclaving or filtration. PBS was stored in the 
refrigerator until further use. The concentrated stock solutions may become precipitous upon 
cooling and were thus maintained at room temperature until the precipitate had completely 
dissolved prior to use. 
 
The cells were then pre-treated with several concentrations of plant extracts and 1 µg/ml of 
LPS for 24 h. When pre-treating the cells, defined concentrations of plant extract (100, 50, 25 
and 12, 5 µg/ml) together with LPS stimulates NO production in the medium in which the cells 
are incubated. The supernatant (100 µl) was combined with the equivalent volume of Griess 
reagent and placed into an incubator for 15 min in the dark. The absorbance of the water-soluble 
purplish-red product was read on a BioTek Synergy microplate reader after 10 min at 550 nm. 
The amount of NO was calculated by a calibration curve established with 0.15-100 µM NaNO2. 
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The inhibition percentage was calculated based on the ability of the extracts to inhibit NO 
formation by cells compared with the control (cells in media without compounds containing 
triggering agents and DMSO), which was considered as 0% inhibition. A graph of percentage 
inhibition against the concentration of the different compounds were used to calculate the IC50 
values. 
 
5.2.2.3 Cytotoxicity Assay 
The cytotoxicity assay used in the study followed a method described by MOSMANN (1983) 
and McGAW et al. (2000), with slight modifications as indicated in Chapter Four in Section 
4.2.2. 
 
5.2.3 Lipoxygenase (LOX) Inhibition Assay 
This evaluation was conducted using the guidelines of a procedure described by PINTO et al. 
(2007) with minor modifications. The assessments were based on measuring the production of 
the composite Fe3+/xylenol orange using a spectrophotometer at 560 nm. The enzyme 15-
lipoxygenase from Glycine max was incubated with plant extracts or a standard inhibitor at 25 
°C for 5 min. Then linoleic acid (final concentration 140 µM) in Tris-HCl buffer (50 mM. pH 
7.4) was added and the mixture was incubated at 25 °C for 20 min in the dark. The reaction 
was terminated by the addition of 100 µL of FOX reagent consisting of sulphuric acid (30 
mM), xylenol orange (100 µM), iron (II) sulphate (100 µM) in methanol/water (9:1; v/v). For 
the control, only LOX solution and buffer were pipetted into the wells. The enzyme LOX was 
present in the blanks during incubation and the substrate (linoleic acid) was added after the 
FOX reagent. The inhibitory activity of lipoxygenase was determined by calculating the 
inhibition percentage of hydrogen peroxide produced from the modifications in absorbance 
values at 560 nm after 30 min at 25 °C. Inhibition percentage was calculated as follows: 
Percentage inhibition = ((Acontrol – Ablank) – (Asample – Ablank)/ (Acontrol – Ablank)) X 100 
Where, Acontrol is the absorbance of control well, Ablank is the absorbance of blank well and 
Asample is the absorbance of sample well.  
 
5.3 Results and Discussion 
 
5.3.1 Inhibition of NO activity 
The calculated concentration of an inhibitor known as the IC50 is known to be determined where 
the response (or binding) is condensed by half. It applies to the inhibition of targets like an 
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isolated enzyme and is a quantity of the efficiency of a substance that is required to inhibit a 
specific biochemical or biological function. The values are typically expressed as micrograms 
per millilitre. It is often used as a measure of adverse drug potency in ethnopharmacological 
research. Potency is a measure of drug activity expressed in terms of the amount required to 
produce an effect of given intensity. A highly potent drug induces a given response at low 
concentrations, while a drug of lower potency evokes the same response only at higher 
concentrations. The potency depends on both the affinity and efficacy. According to the FDA, 
IC50 represents the concentration of a drug that is required for 50% inhibition in vitro 
(ADEBAYO et al., 2013; ADEBAYO et al., 2015).  
 
Values of the IC50 for the flavonoid control, quercetin was 6.30 µg/ml (Table 5.1). All plant 
extract values were considered in relation to the control. Values greater than 100 µg/ml 
indicated less active anti-inflammatory agents and plant extracts that fell in this category from 
this study were the leaf extracts of the three Aloe species (A. arborescens, A. aristata, and A. 
ferox) and H. limifolia. There seem to be a marked difference between the leaf and the stem 
extracts of T. riparia in terms of the inhibition potential of NO with the stem demonstrating an 
almost seven-fold efficacy to that of the leaf extract at an IC50 value of 13.99 µg/ml. Further 
significant IC50 values were observed for H. aethiopicum leaf extract (22.47 µg/ml) and M. 
plumbea extract for the leaf at 29.35 µg/ml, the bulb at 22.04 µg/ml and the root extract at 
26.93 µg/ml). In addition, the Bulbine species were observed to have an IC50 value for B. 
natalensis root extract at 28.64 µg/ml and B. frutescens leaf extract at 26. 32 µg/ml were also 
significant showing active anti-inflammatory characteristics towards NO inhibition.  
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Table 5.1 IC50 (µg/ml) of Nitric oxide of different medicinal plant extracts used for skin 
disorders and wound healing 
Plant Extracts IC50 (µg/ml) 
Aloe arborescens leaf ˃ 100 
Aloe aristata leaf ˃ 100 
Aloe  ferox leaf ˃ 100 
Bulbine frutescens leaf *26.32 ± 0.69 
Bulbine frutescens root 42.51 ± 1,69 
Bulbine natalensis leaf 54.79 ± 13,47 
Bulbine natalensis root *28.64 ± 4.58 
Eucomis autumnalis leaf 38.09 ± 2.21 
Eucomis autumnalis bulb/root 63.10 ± 6.59 
Haworthia limifolia leaf ˃ 100 
Hypericum aethiopicum leaf *22.47 ± 3.87 
Merwilla plumbea leaf  *29.35 ± 0.55 
Merwilla plumbea bulb *22.04 ± 0.20 
Merwilla plumbea root *26.93 ± 2.60 
Tetradenia riparia leaf *13.99 ± 2.47 
Tetradenia riparia stem 2.05 ± 1.18 
Zantedeschia aethiopica leaf 57.94 ± 2.22 
Zantedeschia aethiopica stem 46.22 ± 5.52 
Quercetin 6.30 ± 0.41 
*Bold indicates the plant extracts with active anti-inflammatory activity. 
 
The inflammation process is a highly complex pathophysiological process which occurs when 
various processes of various molecules and mediators that are signalling, occur in a series of 
catalytic enzymatic reactions (WHITE, 1999). Many plant extracts are known to exert their 
inhibitory enzyme effects via a range of diverse action mechanisms and target sites (CAPONE 
et al., 2007). Many studies with various plant species have reported good inhibitory activity 
(JÄGER et al., 1996; TAYLOR and VAN STADEN, 2001; JÄGER and VAN STADEN, 
2005; FAWOLE et al., 2009). Superoxide and nitric oxide (NO) production are associated 
with the development of several diseases. Recently it has been shown that interactions between 
them may also be important in disease pathology. The central hypothesis emerging is that the 
balance between nitric oxide and superoxide generation is a critical determinant in the etiology 
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of many human diseases including atherosclerosis, neurodegenerative disease, ischemia-
reperfusion and cancer. These are important in the context of the current and future status of 
therapies which could modulate the balance between nitric oxide and superoxide. Nitric oxide 
and reactive oxygen species exert multiple modulating effects on inflammation and play a key 
role in the regulation of immune responses. They affect virtually every step of the development 
of inflammation. Low concentrations of nitric oxide produced by constitutive and neuronal 
nitric oxide synthases inhibit adhesion molecule expression, cytokine and chemokine synthesis 
and leukocyte adhesion and transmigration. Large amounts of NO, generated primarily by 
iNOS can be toxic and pro-inflammatory. Actions of nitric oxide are, however, not dependent 
primarily on the enzymatic source, but rather on the cellular context, NO concentration 
(dependent on the distance from NO source) and initial priming of immune cells (DARLEY-
USMAR, WISEMAN, HALLIWELL, 1995; GUZIK, KORBUT, ADAMEK-GUZIK, 
2003). The results of this study show that the enzyme inhibitory activity of stem, bulb, leaf and 
root extracts of the different plant parts were significant in their anti-inflammatory capacity.  
In Figure 5.2 below, the percentage of NO inhibition is represented for the four different 
concentrations (12.5, 25, 50 and 100 µg/ml) at which each of the plant extracts were tested. A 
dose-dependent trend was observed for all the plant extracts. Low levels of inhibition were 
observed for all concentrations of the three Aloe species leaves and the H. limifolia leaf. This 
can be explained as low percentage NO inhibition activity for these plant extracts. The high 
percentage inhibition (at 100 µg/ml) was observed for many of the other plant extracts and 
ranged from above 50% to just below 90% comparable to that of the quercetin control which 
yielded around 85-88% NO inhibition. The medicinal plant extracts for M. plumbea, T. riparia, 
Z. aethiopica, H. aethiopicum and E. autumnalis were significant for all concentrations. 
Unstimulated macrophages in culture medium produce background levels of nitrite in the 
culture medium of around 0.09 µg/ml. The treated cells with different concentrations of 
extracts have significant inhibition of nitrite production. Although the results in Figure 5.2 are 
of less significance in this context as they were used to calculate the IC50 values in Table 5.1. 
The IC50 values represent the effective concentration of the extracts that inhibit 50% of the NO.  
Figure 5.3 below represents the µM NO production at various concentrations (12.5, 25, 50 to 
100 µg/ml) of the plant extracts. The quercetin positive control values of NO production (µM) 
showed a pattern or trend. At the lower concentrations of plant extracts the cell viability values 
were higher. This pattern was seen for all the plant extracts. The leaves of the three Aloe 
species, H. limifolia leaf and H. aethiopicum and Z. aethiopica leaf were observed to have high 
production of NO. At the higher concentration of plant extracts, NO production was lower. 
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What does this mean for medicinal use in skin disorders and wound healing? DZOYEM and 
ELOFF (2015) reported that cytotoxicity and inflammation occur when over-production of 
NO occurs in the body. NO production is important as an anti-inflammatory agent. Quercetin 
as a positive control, significantly reduces NO production in the LPS-stimulated RAW 264.7 
murine macrophage cell lines (DZOYEM and ELOFF, 2015). 
 
Figure 5.4 below are the outcomes of the MTT assay used to determine the percentage of cell 
viability for the different cell extracts. NO inhibition of the plant extracts was associated with 
their cytotoxicity on RAW 264.7 macrophages. A percentage of the control cells compared to 
viable cells that were incubated in fresh culture medium. The results of cell viability levels 
were high for most of the extracts at the lower concentration. The capacity for medicinal plants 
to be used in the management and the healing process during wounds and skin diseases may 
be supported by this assay. Its importance as tool in identifying the effects of the various plant 
extract concentrations on the viability and/or survival of mammalian cells was observed. The 
plant extract activity which is inhibitory on NO production by induced RAW 264.7 
macrophage cell lines indicated good activity for low cytotoxicity and production of NO for 
plants used in wound healing and skin conditions (ADEBAYO et al., 2013; 2015). The release 
of NO promotes inflammation, and so the extracts act as foragers of NO and production 
inhibitors, together with low cytotoxicity which is indicative of mitigating the proliferation of 
inflammation by NO. The NO production inhibition in medicinal plants may be due to 
inducible nitric oxide synthase activity expression. The effects of both nitric oxide and 
superoxide in immune regulation are exerted through multiple mechanisms, which include 
interaction with cell signaling systems like cGMP, cAMP, G-protein, JAK/STAT or MAPK 
dependent signal transduction pathways. They may also lead to modification of transcription 
factors activity and in this way modulate the expression of multiple other mediators of 
inflammation (DARLEY-USMAR, WISEMAN, HALLIWELL, 1995; GUZIK, KORBUT, 
ADAMEK-GUZIK, 2003; LEE et al., 2003; 2007; 2010). 
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Figure 5.2 Percentage of NO inhibition at different concentrations of plant extracts. 1 - Aloe arborescens leaf, 2 - Aloe aristata leaf, 3 - Aloe  ferox leaf, 
4 - Bulbine frutescens leaf, 5 - Bulbine frutescens root, 6 - Bulbine natalensis leaf, 7 - Bulbine natalensis root, 8 - Eucomis autumnalis leaf, 10 - Eucomis 
autumnalis bulb/root, 11- Haworthia limifolia leaf, 12 - Hypericum aethiopicum leaf, 13 - Merwilla plumbea leaf, 14 - Merwilla plumbea bulb, 15 - 
Merwilla plumbea root, 16 - Tetradenia riparia leaf, 17 - Tetradenia riparia stem, 18 - Zantedeschia aethiopica leaf, 19 - Zantedeschia aethiopica 
stem. 
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Figure 5.3 Concentration of NO Production in µM for the different plant extracts. 1 - Aloe arborescens leaf, 2 - Aloe aristata leaf, 3 - Aloe 
ferox leaf, 4 - Bulbine frutescens leaf, 5 - Bulbine frutescens root, 6 - Bulbine natalensis leaf, 7 - Bulbine natalensis root, 8 - Eucomis 
autumnalis leaf, 10 - Eucomis autumnalis bulb/root, 11- Haworthia limifolia leaf, 12 - Hypericum aethiopicum leaf, 13 - Merwilla plumbea 
leaf, 14 - Merwilla plumbea bulb, 15 - Merwilla plumbea root, 16 - Tetradenia riparia leaf, 17 - Tetradenia riparia stem, 18 - Zantedeschia 
aethiopica leaf, 19 - Zantedeschia aethiopica stem. 
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Figure 5.4 Percentages of cell viability with MTT assay at different concentrations of plant extracts. 1 - Aloe arborescens leaf, 2 - Aloe aristata leaf, 3 - 
Aloe  ferox leaf, 4 - Bulbine frutescens leaf, 5 - Bulbine frutescens root, 6 - Bulbine natalensis leaf, 7 - Bulbine natalensis root, 8 - Eucomis autumnalis leaf, 
10 - Eucomis autumnalis bulb/root, 11- Haworthia limifolia leaf, 12 - Hypericum aethiopicum leaf, 13 - Merwilla plumbea leaf, 14 - Merwilla plumbea 
bulb, 15 - Merwilla plumbea root, 16 - Tetradenia riparia leaf, 17 - Tetradenia riparia stem, 18 - Zantedeschia aethiopica leaf, 19 - Zantedeschia aethiopica 
stem. 
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5.3.2 LOX Inhibitory Activity 
One of the important objectives of this study was to determine the activity of the selected 
extracts for anti-inflammatory capacity using a LOX model of inhibition. Table 5.2 provides 
details of the IC50 (µg/ml) values using the quercetin control inhibition of 15.91 µg/ml against 
which all plant extracts were compared. All the plant extracts in the study, except the three 
Aloe species extracts, the two Bulbine species extracts, as well as extracts of H. limifolia, M. 
plumbea and Z. aethiopica showed significant biological activity at low concentrations. T. 
riparia plant part extracts ranged from 3.55 to 8.50 µg/ml, H. aethiopicum leaf extract at 4.45 
µg/ml and E. autumnalis plant extracts from 6.73 to 9.52 µg/ml and Z. aethiopica extract at 
9.05 µg/ml for the LOX inhibitory activity assay. These results indicate significantly positive 
anti-inflammatory activity. Values greater than 100 µg/ml indicate less activity. Those lower 
than the standard control values are T. riparia (leaf extract - 8.50 µg/ml, stem extract - 3.55 
µg/ml), H. aethiopicum (4.45 µg/ml), E. autumnalis (leaf extract - 6.73 µg/ml, bulb/root extract 
- 9.52 µg/ml), B. natalensis leaf extract (6.93 µg/ml) and Z. aethiopica stem extract (9.05 
µg/ml).  
 
A study on E. autumnalis leaves detected between 80-90% which is high activity for COX-1 
inhibition in vitro with plant lectins contributing to the anti-inflammatory properties 
(GAIDAMASHVILLI and VAN STADEN, 2006). FAWOLE et al. (2009; 2010), reported 
A. ferox leaves as having the highest COX-2 anti-inflammatory activity. The LOX group of 
enzymes plays an important role in many inflammatory disorders (CHEDEA and JISAKA, 
2005; SCHEINDER and BUCAR, 2005). Hypericum species have been reported by various 
researchers as having positive antimicrobial activity (SIDDIQUE et al., 2010), the presence 
of phenolic compounds and terpenoids and the in vivo wound healing activity in rats 
(MUKHERJEE et al., 2003) were comparable to the effects of a standard allopathic drug 
called nitrofurazone ointment. Z. aethiopica is known for its sterols and triterpenoids which 
may attribute to its anti-inflammatory activity (VAN WYK et al., 2009). T. riparia is one of 
the maximally utilized and widespread medicinal plants in Rwanda and various new bioactive 
substances were isolated from its leaves including a diterpene diol with high antimicrobial 
activity (VAN PUYVELDE et al., 1986). In M. plumbea extracts, the flavonoid content may 
be the reason for its anti-inflammatory properties and usage by traditional healers (DYSON et 
al., 1998; VAN WYK et al., 2009). Researchers in a South African study have reported H. 
limifolia as having good antimicrobial activity (COOPOOSAMY and NAIDOO, 2011a). 
Another study on E. autumnalis by MASONDO et al. (2014), reports ethnopharmacological 
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potential including anti-inflammatory activity. VAN WYK et al. (2009) reported the presence 
of lectin-like proteins with anti-inflammatory activity in Eucomis species, with the bulb having 
significant COX-2 inhibitory action (TAYLOR and VAN STADEN, 2001) and triterpenoids 
beneficial in wound healing therapy (REYNEKE, 1980). The need for conservation of these 
plants is critical as trade and demand increase (MANDER, 1997; DOLD and COCKS, 2002). 
Bulbine species, E. autumnalis, H. limifolia are some of the over-harvested medicinal plants in 
the Eastern Cape while in KwaZulu-Natal H. aethiopicum, E. autumnalis, M. plumbea and H. 
limifolia are in great demand. Eucomis species in Limpopo Province is also one of eight most 
frequently traded medicinal plants (MOENG and POTGIETER, 2011). According to a recent 
report on a wide range of South African plants by WILLIAMS et al. (2013), the usage of 
medicinal plants that are endangered and threatened include all species of Haworthia, Aloe, 
Eucomis and Tetradenia. It is due to demands for medicinal use, marketability and export that 
lead to extensive harvesting pressures in the field to the extent that some of these plants can be 
reduced to possible total extinction and are currently on the red data list in South Africa. The 
education of the people towards effective conservation is essential for sustainability 
WILLIAMS et al. (2013).  
This study may contribute to overcoming the conservation concerns for these species. The 
ethnopharmaceutical activities of the various plant parts tested can be used for conservation 
information through evidence-based systems. Plant protection, promotion and education with 
scientific evidence is essential for sustainability and the conservation of red data listed plants 
in South Africa.  
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Table 5.2  IC50 (µg/ml) levels detected for Lipoxygenase in the different plant extracts 
Plant Extracts IC50 (µg/mL) 
Aloe arborescens leaves ˃ 100 
Aloe aristata leaves ˃ 100 
Aloe  ferox leaves ˃ 100 
Bulbine frutescens leaves ˃100 
Bulbine frutescens roots 81.54 ± 6.76 
Bulbine natalensis leaves *6.93 ± 0.28 
Bulbine natalensis roots 98.54 ± 2.10 
Eucomis autumnalis leaves *6.73 ± 0.11 
Eucomis autumnalis bulbs/roots *9.52 ± 0.11 
Haworthia limifolia leaves ˃ 100 
Hypericum aethiopicum leaves *4.45 ± 0.23 
Merwilla plumbea leaves 32.57 ± 0.37 
Merwilla plumbea bulbs 64.95 ± 3.40 
Merwilla plumbea roots ˃100 
Tetradenia riparia leaves *8.50 ± 0.44 
Tetradenia riparia stems *3.55 ± 0.11 
Zantedeschia aethiopica leaves ˃100 
Zantedeschia aethiopica stems *9.05 ± 1.61 
Quercetin 15.91 ± 3.02 
*Bold indicates significant plant extracts with lipoxygenase content. 
 
The LOX enzyme is considered to produce prostaglandins in acute inflammation (VANE and 
BOTTING, 1987; VANE and BOTTING, 1995; VANE et al., 1998). Research showed that 
in some muscles and tissues such as the reproductive organs of the female, brain, placenta, 
kidneys, the enzyme is manufactured at a consistent rate, and synthesises prostanoids are 
accountable for regulation and homeostasis in these muscles and tissues (HINZ and BRUNE, 
2002; MITCHELL and WARNER, 2006). Selective inhibition of some anti-inflammatory 
compounds are the most favourable because they diminish the detrimental side effects 
associated with inhibition. 
 
The medicinal plants investigated in many instances showed good LOX and NO inhibition 
activity. Those with moderate activity are preferable to use rather than the ones with high 
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activity. Prolonged use of plant extracts with high inhibition activity causes the expression of 
damaging symptomatic side effects. The plant extracts that were significantly positive for both 
NO and LOX screening for anti-inflammatory activity in relation to quercetin include T. 
riparia, E. autumnalis, H. aethiopicum and H. limifolia. The IC50 values for the NO and the 
LOX inhibition in plants like T. riparia and H. aethiopicum in particular had significant 
outcomes in both assays. T. riparia and H. aethiopicum are the two plant species which also 
showed consistent skin and wound healing properties.  
 
5.4 Conclusions 
 
Developing safe and effective anti-inflammatory agents from medicinal plants showing LOX 
and COX-2 inhibition are acknowledged as safer medicines with minimum side effects in vivo. 
Some of the plants screened in this study exhibited some good anti-inflammatory activity, 
however, further research is needed to isolate the bioactive compound/s. This may provide 
valuable leads towards the discovery of agents that have anti-inflammatory abilities. The plants 
screened in this study are utilized by traditional healers as a management tool or natural 
resource for healing wounds and for skin disorders. The mode of action for the dermatological 
use of medicinal plants is sometimes determined by their phenolic content, positive anti-
inflammatory, antioxidant activity and protein interaction properties. These are complex yet 
intricate pathways, each contributing a part to the whole or bigger picture in the important role 
medicinal plants have to play in traditional health care. Medicinal plants may not display 
activity at one pharmacological site but may act at several potential targets, hence the various 
biological assays assist with proper evaluation of the mode of action of the selected medicinal 
plants. 
88 
 
CHAPTER SIX 
ANTIOXIDANT ACTIVITY AND WOUND HEALING 
PROPERTIES OF PLANT EXTRACTS 
 
 
6.1 Introduction 
 
Antioxidants are substances or compounds which, at reduced concentrations slow down or 
prevent oxidation, counteracting free radicals thereby preventing oxidative damage (BECKER 
et al., 2004). They are known to occur in various medicinal plants and are usually related to 
the presence of phenolics which are the most abundant class of antioxidants (SCALBERT et 
al., 2005). Polyphenols such as tannins and flavonoids, tocopherols and catechins are amongst 
the documented antioxidants (SCALBERT et al., 2005). Organic acids, carotenoids and 
protein hydrolysates also exhibit antioxidant or synergistic effects with other antioxidants 
(DAPKEVICIUS et al., 1998). Free radicals are linked to the inflammation processes; so when 
the immune system is compromised they are found to recruit inflammatory cells (ALLEN, 
2003; AYYAGARRI et al., 2003). Several biochemical reactions are known to provide free 
radicals to the body and these are associated with many diseases, increased ageing and poor 
healing of wounds and injuries to the skin. The resulting consequences are due to unregulated 
production of oxygen free radicals and an unstable mechanism of antioxidant security (TSAO 
and DENG, 2004; AL-DABBAS, 2006; AKULA and ODHAV, 2008; HAYET et al., 2008). 
While in other studies when oxidants are present at low concentrations compared to that of 
oxidizable substrates, delays or inhibition of oxidation of the substrates occur (PERCIVAL, 
1998; YOUNG and WOODSIDE, 2001; ATOUI et al., 2005). Free radical and hydroxyl free 
radical scavengers’ physiological role is to prevent damage to cellular components due to 
chemical reactions. Most importantly, free radicals contribute to the physiological processes of 
ageing, disease progression, degeneration diseases and prolonged lifespan (AMES et al., 1990; 
PERCIVAL, 1998; YOUNG and WOODSIDE, 2001; GUTTERIDGE and 
HALLIWELL, 2010). Antioxidants are known to naturally control free radical formation 
(PERCIVAL, 1998). When the availability of antioxidants is reduced the damage increases 
and stressful oxidation occurs. Antioxidants are recognized as having the ability to stabilize 
and deactivate free radicals before they cause damage to cells and biological structures and are 
critical in overall well-being and for the maintenance of optimum cellular and general systemic 
health (PERCIVAL, 1998). Thus the role of free radicals has to be balanced and may 
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contribute to both pro- and contra-indicatory consequences in the human body. LOBO et al. 
(2010) reported an extensive study on free radical chemistry. These free radicals are reactive 
oxygen and nitrogen species that are generated by the body through multiple endogenous 
systems, which are the result of exposure to various physiochemical conditions. A form of 
effective balance between free radicals and antioxidants are important for the mammalian body 
to function physiologically normal (LOBO et al., 2010). Should circumstances arise for free 
radicals to overwhelm the body's ability to regulate them, then an oxidative stress situation will 
arise. The free radicals will negatively alter the bodies’ lipids, proteins and DNA thereby 
triggering various human diseases. Synthetic antioxidants like butylated hydroxytolulene and 
butylated hydroxyanisole are reported to be harmful to human health. Hence there is a need for 
research for effective, nontoxic natural compounds with antioxidative activity (LOBO et al., 
2010).  
 
According to KURAHASHI and FUJII, 2015; oxygen plays a fundamental role in the wound 
healing process. These functions include oxidative bacterial killing, collagen synthesis, 
angiogenesis and epithelialization. The wound healing process is impaired under hypoxia, 
however the exact role of oxygen in wound healing is not understood as yet. Although oxygen 
is used to produce energy via oxidative phosphorylation, reactive oxygen species (ROS) are 
produced and cause oxidative injury. The cells of aerobic organisms constantly produce ROS 
during normal metabolic processes and their production is elevated under pathological 
conditions. Although ROS supports various physiological processes, they also impact on life-
threatening damage. In the wound healing process, the physiological role and the molecular 
mechanisms of ROS-involved reactions have been investigated for individual aspects. In 
particular, the pathological role of ROS in the inflammatory phase is known. In the 
inflammatory phase, neutrophils and macrophages arrive at a wound lesion and start to secrete 
large amounts of ROS along with pro-inflammatory cytokines and proteolytic enzymes such 
as matrix metalloproteinase (MMP). NADPH oxidase (NOX2) is expressed at high levels in 
plasma membranes of inflammatory cells and activated during phagocytosis, which results in 
the production of large amounts of superoxide radical anions. The generated ROS directly 
attack invading pathogens, and finally kill them to aid phagocytosis. Excessively produced 
superoxide is known to damage the surrounding tissues. Superoxide is dismutated to hydrogen 
peroxide (H2O2) and molecular oxygen by either superoxide dismutase (SOD) or a spontaneous 
reaction (KURAHASHI and FUJII, 2015). H2O2 is detoxified by peroxidases such as 
catalase, glutathione peroxidase (GPX), and peroxiredoxin (PRDX) to avoid the Fenton 
reaction that occurs in the presence of transition metal ions such as iron or copper and generates 
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hydroxyl radicals, the most harmful ROS. Compared to immune cells, ROS are produced by 
other cells at much lower levels. Low levels of ROS play a physiological role, notably as 
cellular signaling in response to stimuli. The role of ROS signaling in angiogenesis has been 
well studied. Moderate levels of H2O2 up-regulate the production of the vascular endothelial 
growth factor (VEGF), the key angiogenic growth factor, in keratinocytes, and result in 
accelerating angiogenesis. Both NO2 and NO4 play pivotal roles in modulating vascular 
endothelial cell proliferation, but they function differentially in vasculogenesis via ROS 
generation. ROS are also involved in re-epithelialization. Excessive ROS have decelerating 
effects on angiogenesis. In some enzymes involved in signaling pathways, such as 
phosphotyrosine phosphatase, sulfhydryl residues that act as the catalytic center are highly 
sensitive to oxidative modification, and tend to suffer from oxidative inactivation 
(KURAHASHI and FUJII, 2015). Thus, excess ROS strain signaling networks through 
creating an imbalanced redox homeostasis, resulting in impaired wound healing. Diabetes, 
aging, immunodeficiency, and malnutrition are typical causes for delayed wound healing. 
Under these pathological conditions, redox imbalance occurs, and elevated oxidative injury is 
observed (KURAHASHI and FUJII, 2015).  
 
Research shows that many isolated antioxidants from plants are polyphenols, with additional 
biological activities that range from anti-inflammatory, antimicrobial, anti-carcinogenic, anti-
allergic, immune-stimulatory and oestrogenic activity (LARSON, 1988). Antioxidant activity 
of phenolic compounds is mainly due to their redox properties allowing them to function as 
reducing agents, hydrogen donors and singlet oxygen quenchers; as well as metal chelators. 
Some food products are known to contain synthetic antioxidants like tertbutyl-hydroquinone 
(TBHQ), butylated hydroxyanisole (BHA) and butylated hydroxytolulene (BHT) however 
concerns about the safety of synthetics have led to the progress of research in natural 
antioxidants (LARSON, 1988). Polyphenols are known for a wide variety of other related 
beneficial effects such as lipoxygenase inhibitory properties and the treatment of anti-
inflammatory diseases (SREEJAYAN and RAO, 1996).  
 
Antioxidant assays have been routinely used for many years (NDHLALA et al., 2010; 
NDHLALA et al., 2014; NDHLALA et al., 2015) and provide reliable outcomes on the 
activity of medicinal plants. In this study, three in vitro methods, the electron transfer based 
assays namely the ferric reducing antioxidant power (FRAP), the 2,2-Diphenyl-1-
picryhydrazyl (DPPH) radical scavenging activity and a hydrogen transfer based assay; β- 
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carotene linoleic acid bleaching assay (CLAMS) were used to screen the medicinal plants 
investigated.  
The DPPH antioxidant assay involves the use of a stable free radical that reacts well with other 
free radicals which are unstable and are more reactive. The DPPH antioxidant method was 
developed from the mechanism of searching of DPPH by antioxidants resulting in a reduction 
reaction causing decolourization of deep purple DPPH methanol solutions. In the DPPH assay 
intensity of yellow colour depends on the amount and nature of radical scavenger present in 
the samples. The method measures the reducing capability of the DPPH antioxidants radical 
using a spectrophotometric reading. This is a simple, commonly used method with accurate 
results and quantifies extracts with hydrophilic or lipophilic antioxidants (NDHLALA et al., 
2010; NDHLALA et al., 2013).  
 
The FRAP method is a simple, fast and robust method based on the redox reaction of 
compounds and quantifies extracts with hydrophilic and lipophilic antioxidants (NDHLALA 
et al., 2010). One limitation of this method is that a compound with a redox potential less  than 
0.70 Volts can decrease iron despite not performing as an antioxidant in vivo (PEREZ-
JIMENEZ et al., 2008). Some antioxidants such as proteins and thiols are not measured by 
the FRAP assay, however, the method is accomplished at a non-physiological pH and the ferric 
ion may then be irrelevant physiologically (PEREZ-JIMENEZ et al., 2008; NDHLALA et 
al., 2010; NDHLALA et al., 2013). 
 
The β-carotene linoleic acid bleaching (CLAMS) assay measures the inhibition capacity of 
volatile organic production and the formation of combined diene hydro peroxidase due to 
linoleic acid oxidation which lightens the β-carotene in the extracts. Temperature regulation 
which is critical for induced oxidation and discolouration is inhibited by the antioxidants that 
donate hydrogen atoms to supply radicals (NDHLALA et al., 2010). 
 
6.1.1 The Role of Phenols as Antioxidants 
Research showing the beneficial roles of phenolic compounds as natural antioxidants have 
identified and/or led to the isolation of potent simple and polymeric phenolic compounds 
(BIEWENGA et al., 1997; NENADIS et al., 2003; ATOUI et al., 2005; DE ALMEIDA-
MELO et al., 2005; SOUZA et al., 2007; KUMAR and NAIK, 2010; MEGHASHRI et al., 
2010). Epidemiological studies have reported phenolic compounds as natural antioxidants that 
neutralise free radicals and function as metal chelators (KIM et al., 1997; VELIOGLU et al., 
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1998; MUCHUWETI et al., 2006; CHITINDINGU et al., 2007; KHALIL et al., 2007a; 
2007b; NDHLALA et al., 2007; NDHLALA et al., 2008; ALI et al., 2008; ANDUEZA et 
al., 2009; KIM et al., 2009; MOYO et al., 2010). Hydroxyl groups in the chemical structure 
of polyphenols make them suitable for free radical scavenging reactions and as metal chelating 
agents (LOPEZ et al., 2003). The organization of the hydroxyl groups around the phenolic 
molecule is important for antioxidant reactions (MOURE et al., 2001). HAGERMAN et al. 
(1998) reported that the phenolic acid antioxidant potential improves as the number of 
methoxyl and hydroxyl groups increases and greater antioxidant ability of condensed and 
hydrolysable tannins is observed. Phenolic compounds are a major group of compounds that 
are abundant in plants (NDLALA et al., 2010). 
 
The study objectives were to determine and assess the antioxidant properties of the selected 
medicinal plant extracts frequently used for wound healing and skin disorders using three in 
vitro model systems (DPPH, FRAP, CLAMS) as well as protein precipitation properties.  
 
6.2 Materials and Methods 
 
6.2.1 Collection and Preparation of Plant Material 
Plant material extracts were prepared as indicated in Chapter 2, Sections 2.4.1 and 2.4.2. 
 
6.2.2 Antioxidant Activity of Plant Extracts 
 
6.2.2.1 2, 2-Diphenyl-1-Picryhydrazyl (DPPH) Radical Scavenging Activity 
The DPPH free radical scavenging activity of the 19 plant extracts were determined using the 
assay as described by KARIOTI et al. (2004). Dried plants extracts were redissolved to 10 
mg/ml in 50% (v/v) aqueous methanol. Various concentrations (1, 0.5, 0.25, 0.125, 0.0625, 
0.031, 0.015, 0.0008 mg/ml) of the dilutent plant extract were tested.  Fifteen microliters of 
each plant extract were diluted in a test tube with 735 µl of methanol and 750 µl of 0.1 mM 
DPPH (Sigma-Aldrich, Germany) of freshly prepared methanolic DPPH solution. The reaction 
mixture was incubated in the dark for 30 min at room temperature; thereafter the absorbance 
was read at 517 nm with an ultraviolet visible spectrophotometer (Varian-Carey 50). Ascorbic 
acid and butylated hydroxytolulene (5, 10, 20, 40, and 80 mg/ml), were used as positive 
controls while the reaction mixture with 50% methanol instead of the extract was used as a 
negative control. Correction of the colour of the extract was done by taking the absorbance 
reading of the samples without DPPH and the difference from readings of the samples in the 
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presence of DPPH. Each sample extract was evaluated in triplicate. Radical scavenging activity 
(RSA) of plant extracts was determined by the decolouration of the DPPH solution and was 
calculated according to the following formula: 
% RSA = (1 – AE / AD) x 100  
Where AE represents the absorbance of the reaction mixture containing the plant extract or 
positive controls and AD represents the absorbance of the DPPH solution only (KARIOTI et 
al., 2004). 
 
6.2.2.2 Ferric-reducing Antioxidant Power (FRAP) Assay 
The ferric reducing power of the plant extracts were evaluated according to NDHLALA et al. 
(2013) and MOYO et al. (2010) with slight modifications from KIM et al. (2009). The dried 
plant extracts together with butylated hydroxytolulene were dissolved in 50% aqueous 
methanol to a concentration of 10 mg/ml. In a 96-well microplate, 30 µl of each extract were 
serially diluted two-fold with 30 µl of distilled water. Forty microliters of potassium phosphate 
buffer (0.2 M, pH 7.2) and potassium ferricyanide (1% w/v, BDH Biochemicals Ltd. Poole, 
England) were each then added to the wells. The reaction mixture was incubated at 50 °C for 
20 min in the dark after which 40 µl of trichloroacetic acid (10% w/v), 150 µl of distilled water 
and 30 µl ferric chloride (0.1% w/v, Merck, Darmstadt, Germany) were added to each well. 
The plate was incubated for a further 30 min at room temperature in the dark and the absorbance 
measured at 630 nm using an Opsys MRTM micro-plate reader (Dynex Technologies Inc., 
Chantilly VA). 
 
6.2.2.3 β-Carotene Linoleic Acid Model System (CLAMS) Assay 
The method used by MILLER (1971), MILLER et al. (1993) and modified by 
AMAROWICZ et al. (2004) and NDHLALA et al. (2014) with minor changes was used. 
Sample extracts were dissolved in 50% aqueous methanol to stock solutions of 5 mg/ml 
concentrations. The process involves autoxidation of β-carotene from the extracts during 
incubation in a water bath at 50 °C. Ten mg β-carotene, was prepared in 10 ml chloroform in a 
brown Schott bottle which limits photo-oxidation. The excess chloroform was evaporated 
under vacuum so that the thin film of β-carotene which remained behind could be turned into 
a solution by the addition of linoleic acid (200 µl) and 2 ml Tween 20. Distilled water (497. 8 
ml) was aerated and added to a final β-carotene concentration of 20 µg/ml. The mixture was 
oxygen saturated by vigorously shaking it to form an orange coloured emulsion. This emulsion 
(4.8 ml) was transferred into test tubes with a known concentration (200 µl) of the extract at 
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6.25 mg/ml and standard antioxidant which serves as a positive control. Quercetin, BHT (6.25 
mg/ml) or ascorbic acid were selected as positive controls. The reaction mixtures contained a 
final concentration of 250 µg/ml. The negative control used was 50% aqueous methanol in 
place of the sample. Tween 20 solution served as a blank for the spectrophotometer. The 
absorbance for each reaction was measured straight away (t = 0) at 470 nm and incubated at 50 
°C, and absorbances were recorded for each reaction mixture measured at 470 nm every 30 
min for 180 min. The β-carotene bleaching rate was calculated by using the following equation:  
The rate of β-carotene bleaching = In (At=0/At=t) x 1/t 
where At=0 is defined as the absorbance of the emulsion at 0 min and At=t is the absorbance at 
time t. the average rate of β-carotene bleaching is measured based on the rates at time t. The 
calculated average rates used to define the antioxidant activity (ANT) of the extracts and 
expressed as percentage inhibition of the rate of β-carotene bleaching using: 
% ANT = (Rcontrol – Rsample)/Rcontrol x 100 
where Rcontrol and Rsample represent corresponding average rates of β-carotene bleaching for the 
negative control and plant extracts. Antioxidant activity can be further expressed as the 
oxidation rate ratio (ORR) based on the equation: 
ORR = Rsample / Rcontrol  
Antioxidant activity (AA) was calculated based on the inhibition of coupled oxidation of β-
carotene and linoleic acid against the negative control at t = 60 min and t = 120 min using as 
described by BRACA et al. (2003) and MOYO et al. (2010): 
%AA = [1 – {A0 - At/AO0 - AOt}] X 100 
where A0 is the extract absorbance found at the commencement of incubation, At is the 
absorbance at time = t = 60 min or 120 min for the extract and AO0 and AOt  denotes the 
absorbance of the negative control (without extract) at the beginning of incubation and at time 
t = 60 or 120 min, respectively.  
 
The constraint with this assay is the staining of β-carotene at 470 nm which can complicate the 
interpretation of the results (PRIOR et al., 2005). An advantage of this assay is its relevance 
and application to both hydrophilic and lipophilic environments to identify the pro-antioxidant 
and antioxidant activity of a compound (FRANKEL et al., 1993; PRIOR et al., 2005). 
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6.3 Wound Healing Properties of Plant Extracts 
 
6.3.1 Protein Precipitable Phenolics Capacity Assay as a Wound Healing Model 
The protein-precipitating capacity of the phenolics assay as outlined by MAKKAR et al. 
(1999) was used to determine the in 50% aqueous methanolic plant extracts. Of the 19 plant 
extracts, 13 were selected to be tested for their wound healing ability from a comparison of all 
the results of previous assays (Table 6.2). The method is explained below: 
 
6.3.2 The Formation of the Phenolic-Protein Complex 
Fifty percent aqueous methanol extracts were added to 2 ml of bovine serum albumin (BSA) 
solution (with 1 mg BSA/ml acetate buffer), to produce a 3 ml solution (in increasing 
concentration of 50% aqueous methanol extract vs 50% aqueous methanol as follows: 0.95, 
0.90, 0.85, 0.80, 0.75, 0.70 ml of 50% methanol with various concentrations (0.05, 0.10, 0.15, 
0.20, 0.25, 0.30 ml) of the plant extracts. This was done in triplicate in centrifuge tubes. A 
vortex was used to mix the solution and it was then allowed to stand overnight at 4 °C in a 
centrifuge tube in the refrigerator. The tubes were centrifuged at 1370 x g for 10 min. The 
supernatant was carefully removed while the precipitate remained at the base of the tube. The 
precipitate was then constituted with 1.5 ml of 1% sodium dodecyl sulphate (SDS) solution 
and vortexed until fully dissolved. The dissolved phenolic-protein complex was measured and 
determined at 510 nm.  
 
6.3.3 The Determination of Phenolics in the Phenolic-Protein Complex 
One ml aliquots of soluble phenolic-protein complex dissolved was placed into clean test tubes. 
A 3 ml solution of SDS-triethanolamine (1% SDS (w/v) and 7% (v/v) triethanolamine in 
distilled water) was added followed by 1 ml ferric chloride reagent (0.01 M FeCl3 in 0.1 M 
HCl). 
 
The measurements were recorded using absorbance readings at 510 nm after 30 min of 
incubation at room temperature using a UV-Visible spectrophotometer. These readings were 
taken in triplicate and the average converted into gallic acid equivalents using a standard curve. 
A linear regression curve was plotted using GraphPad Prism V6 (Graph PadR software Inc. 
CA). The graph plotted phenolics precipitated as gallic acid equivalents and mg dry plant 
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extracts. The slope (mg phenolics precipitated/mg plant samples = x) represented the protein-
precipitating phenolics in the medicinal plant extracts (MAKKAR, 1999). 
 
6.3.4 The Protein-Precipitating Capacity as a Percentage of Total Phenolics 
Aliquots of 0.05 to 0.30 mg/ml of the 50% aqueous methanol extracts prepared to 1 ml with 
1% of SDS and 3 ml of the SDS-triethanolamine solution to which 1 ml ferric chloride reagent 
was added. Incubation of the solution at room temperature for 30 min was allowed followed 
by the measurement of absorbance readings at 510 nm. The graph constructed was a linear 
regression curve with phenolic acid equivalents and mg extract prepared using GraphPad Prism 
software. The slope of the curve (mg phenolics equivalent /mg extract = y) represented total 
phenolics. The protein-binding precipitating phenolics were measured as x. 
The percentage (%) of total phenolics which can precipitate protein = (x/y) x 100   
 
6.4 Results and Discussion 
The antioxidant activity of the nineteen selected plant extracts are presented below in Tables 
and Figures after detailed evaluations using the DPPH scavenging assay, the β-carotene linoleic 
acid (CLAMS), the FRAP models and the protein precipitating/binding assay with reference to 
the results for each below. 
6.4.1 DPPH Assay 
The EC50 of plant extracts with bold values (µg/ml) (Table 6.1) are considered strong DPPH 
radical scavengers. The effective concentrations at EC50 were determined and compared to 
ascorbic acid as a positive control (0.070 µg/ml). The plant extracts with significantly high 
DPPH scavenging activity with lower EC50 than the control were A. arborescens leaf (0.043 
µg/ml), B. frutescens leaf (0.053 µg/ml), B. natalensis root (0.006 µg/ml) and E. autumnalis 
root (0.062 µg/ml). The lower the EC50 value, the more speedily the DPPH radical was 
lightened; therefore, the more powerful the antioxidant. The results indicate that at lower 
concentrations the antioxidant activity for these extracts was higher. All extracts at varying 
concentrations showed the capacity to release a hydrogen atom or an electron that leads to a 
reduction in the absorbance of the reaction mixture. The activity varied markedly between the 
various plant parts with leaf and root extracts generally showing the strongest radical 
scavenging activity in most plant species tested. 
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The metal chelation, total antioxidant activity, reducing power and radical scavenging (DPPH) 
effects as well as those events that are destructive to active oxygen groupings such as the 
hydroxyl radical, superoxide anion radical and hydrogen peroxide are widely used as 
antioxidant radicals (SHARMA and BHAT, 2009). DPPH is commonly known as a radical 
and a trap ("scavenger") for other radicals. The rate of reduction of a chemical reaction when 
one adds DPPH is a good indication of the sudden changes in nature of the radicals in the 
reaction (SHARMA and BHAT, 2009). The strong absorption band is around 520 nm. The 
DPPH radical has a deep violet color in solution, becoming colourless or pale yellow when 
neutralized. This characteristic feature of DPPH is visually prominent and assists with 
monitoring any reactions, as well as the number of primary radicals by counting from the initial 
changes of the optical absorption at 520 nm (ALGER, 1997; COWIE and ARRIGHI, 2008). 
 
6.4.2 CLAMS Assay 
In the CLAMS assay, the activity of the antioxidants (ANT - %) was determined using 
calculations on the basis of the rate of β-carotene bleaching at t = 60 min as each reaction 
mixture is recorded every 30 min to observe the changes in the reaction mixture. The ORR 
values (Table 6.1) less than those of butylated hydroxytolulene (BHT) value of 0.232 and 
transcribed in bold are considered as very potent antioxidants. The percentage activity of 
antioxidants based on the average proportion of heat-induced β-carotene bleaching was high 
for several of the tested plant extracts ranging from 29% to 96% relative to 76% BHT standard 
for the CLAMS assay. In order to reach 50% quenching activity, lower concentrations of plant 
extracts were seen to be greater than that of the control value of 76%. The lowest activity was 
29% recorded from M. plumbea root extract. The medicinal plant extracts with strong 
antioxidant activity included A. ferox leaf extract, B. frutescens leaf extract, B. frutescens root 
extract, B. natalensis leaf extract, B. natalensis root extract, E. autumnalis leaf extract, H. 
limifolia leaf extract, H. aethiopicum leaf extract, T. riparia leaf extract, Z. aethiopica leaf and 
Z. aethiopica stem extracts.  
 
The extracts from the A. arborescens leaf, B. frutescens leaf, B. natalensis root, E. autumnalis 
root had significant antioxidant activity for DPPH. In addition A. ferox leaf extracts, B. 
frutescens leaf and root extracts, B. natalensis leaf and root extracts, E. autumnalis leaf extracts, 
H. limifolia leaf extracts, H. aethiopicum leaf extract, T. riparia leaf extract, Z. aethiopica leaf 
and stem extract were significant for the CLAMS model. The extracts from E. autumnalis root 
extracts for DPPH were 0.062 ±  0.029 µg/ml and the the leaf extracts had an ORR of = 0.197. 
The plant extracts for H. limifolia (ORR 0.184), H. aethiopicum (ORR 0.175), T. riparia (ORR 
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0.159 ± 0.136) and Z. aethiopica (ORR leaf extract 0.138, stem extract 0.075 ) also presented 
high activity of the antioxidants for the CLAMS assay in relation to the controls (DPPH 
0.070  µg/ml, ORR 0.232) respectively. Polyphenol concentrations found in the plant extracts 
are related to the observed antioxidant activities (Chapter 3). DALL'AGNOL et al. (2003), 
AVATO (2005), SUNTAR et al. (2010) and SUNTAR et al. (2011), reported on the medicinal 
use of Hypericum species as a balm with unique wound healing properties and also effective 
against stings and bites. These authors reported that Hypericum is a wound herb that healed 
bruises, opened obstructions, dissolved swellings, and closed up the lips of wounds, sores and 
for stings and bites. The plant is also known for its antimicrobial activity and that it contains 
hyperforin and hypericin. According to various researchers, many of the active constituents in 
Hypericum species are polyphenols like flavonoids, phenolics and tannins as well as conjugated 
phloroglucinol derivatives and benzopyrans (DALL'AGNOL et al., 2003; MUKHERJEE et 
al., 2003; AVATO, 2005; SUNTAR et al., 2010; SUNTAR et al., 2011; GUEDES et al., 
2012). H. aethiopicum exhibits significant antioxidant activity while Z. aethiopica has been 
screened for its active compounds and found to contain α-linoleic acid, a number of 
phenylpropanoids and triterpenoids, sterols and lignans (VAN WYK et al., 2009). 
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Table 6.1 Antioxidant activity of nineteen therapeutic plant species used for wound healing and skin 
disorders in KZN, South Africa as evaluated by the β-carotene linoleic acid models and the DPPH 
scavenging assay. 
Antioxidant Activity 
Plant Species DPPH EC50 (µg/ml) 
CLAMS 
ANT (%) ORR 
Aloe arborescens leaves *0.043 ± 0.009 73.971 ± 7.437 0.260 ± 0.074 
Aloe aristata leaves 0.604 ± 0.059 70.299 ± 5.509 0.297 ± 0.055 
Aloe  ferox leaves 0.273 ± 0.091 87.594 ± 1.778 *0.124 ± 𝟎. 𝟎𝟏𝟖 
Bulbine frutescens leaves *0.053 ± 0.015 91.354 ± 5.191 *0.086 ± 𝟎. 𝟎𝟓𝟐 
Bulbine frutescens roots 1.309 ± 0.065 78.372 ± 4.603 *0.216 ± 𝟎. 𝟎𝟒𝟔 
Bulbine natalensis leaves 0.601 ± 0.012 96.187 ± 2.751 *0.038 ± 𝟎. 𝟎𝟐𝟖 
Bulbine natalensis roots *0.006 ± 0.000 80.833 ± 1.536 *0.192 ± 𝟎. 𝟎𝟏𝟓 
Eucomis autumnalis leaves 2.160 ± 0.139 80.266 ± 0.890 *0.197 ± 𝟎. 𝟎𝟎𝟗 
Eucomis autumnalis roots *0.062 ± 0.029 71.982 ± 1.467 0.280 ± 0.015 
Eucomis autumnalis bulbs 0.897 ± 0.112 67.172 ± 0.767 0.328 ± 0.008 
Haworthia limifolia leaves 0.300 ± 0.023 81.584 ± 0.325 *0.184 ± 𝟎. 𝟎𝟎𝟑 
Hypericum aethiopicum leaves 0.777 ± 0.071 82.468 ± 0.338 *0.175 ± 𝟎. 𝟎𝟎𝟑 
Merwilla plumbea leaves 0.258 ± 0.025 58.271 ± 4.922 0.417 ± 0.049 
Merwilla plumbea bulbs 0.322 ± 0.031 68.952 ± 2.161 0.310 ± 0.022 
Merwilla plumbea roots 1.179 ± 0.020 29.012 ± 0.671 0.709 ± 0.007 
Tetradenia riparia leaves 5.531 ± 0.321 84.055 ± 13.620 *0.159 ± 𝟎. 𝟏𝟑𝟔 
Tetradenia riparia stems 2.918 ± 0.016 75.573 ± 3.927 0.244 ± 0.039 
Zantedeschia aethiopica leaves 1.838 ± 0.189 86.216 ± 3.784 *0.138 ± 𝟎. 𝟎𝟑𝟖 
Zantedeschia aethiopica stems 0.652 ± 0.090 92.469 ± 0.655 *0.075 ± 𝟎. 𝟎𝟎𝟕 
Ascorbic Acid 0.070 ± 0.010   
Butylated Hydroxytolulene  76.727 ± 6.171 0.232 ± 0.062 
*Bold indicates the plant extracts with significant antioxidant activity. 
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6.4.3 FRAP Assay 
Figure 6.1 represents the capacity of the plant extracts at variable concentration ranges to 
reduce Fe3+ solution. Figures 6.1A-C indicate an increase in the absorbance as the 
concentration levels of the extracts were increased. This depends on the extracts reducing 
power. The preliminary yellow colour of the reaction mixture changes to various shades of blue 
and green. The more effective the antioxidant or reductant reducing capacity to increase the 
ferricyanide complex Fe3+ to a blue/green ferrous form, the higher the absorbance values at 630 
nm recorded.  All the plant extracts showed chelating ability at concentrations below 0.1 mg/ml 
comparable to that of the ascorbic acid control. Phenolic compounds (Chapter 4) can be 
correlated with the antioxidant and anti-inflammatory activity of the plant extracts. T. riparia, 
popular for its medicinal use in Rwanda has been screened by VAN PUYVELDE et al. (1986) 
for many active diterpenediols, in this study shows significant antioxidant activity. M. plumbea 
is rich in homoisoflavones, saponins and glycosides (VAN WYK et al., 2009) and the plant 
extracts are commonly used for wound healing and skin disorders and are also reported for 
their antimicrobial, anti-inflammatory properties (VAN WYK et al., 2009). Consistent to these 
findings, the same extracts, showed significant antioxidant activity in this study. The FRAP 
reducing assay changes the ferric ion to ferric oxide and the activity of the plant extract on the 
reaction causes a change from a yellow to a blue/green colour. The measuring of this change 
or the optical density readings for each plant extract provides a good indication of their 
antioxidant activity. As can be seen in Figures 6.1A-C, All 19 extracts tested in this study 
showed some degree of antioxidant activity as indicated (Figure 6.1A-C). Of significance, with 
higher absorbance are Merwilla plumbea (0.65), Tetradenia riparia (0.6) and the Aloe species 
(0.75-0.84) at 1 mg/ml. The other tested medicinal plant extracts yielded absorbance ranges 
from 0.24 to 0.57 at the same concentration of 1 mg/ml. For effective wound healing and 
dermatological conditions, plant extracts with higher antioxidant activity and the capacity to 
be effective anti-inflammatory agents in the healing process are important attributes. 
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Figure 6.1 Ferric-reducing power (FRAP) of nineteen medicinal plant extracts used for skin 
disorders and wound healing in South Africa. (1) Aloe arborescens leaf, (2) Aloe aristata leaf, 
(3) Aloe ferox leaf, (4) Bulbine frutescens leaf, (5) Bulbine frutescens root, (6) Bulbine 
natalensis leaf, (7) Bulbine natalensis root, (8) Eucomis autumnalis leaf, (9) Eucomis 
autumnalis root, (10) Eucomis autumnalis bulb, (11) Haworthia limifolia leaf, (12) Hypericum 
aethiopicum leaf, (13) Merwilla plumbea leaf, (14) Merwilla plumbea bulb, (15) Merwilla 
plumbea root, (16) Tetradenia riparia leaf, (17) Tetradenia riparia stem, (18) Zantedeschia 
aethiopica leaf, (19) Zantedeschia aethiopica stem. Values represent mean ± standard error (n 
= 3). 
 
6.4.4 Protein Precipitation/Binding Assay 
The protein binding capacity of the 13 most active plant extracts are presented in Table 6.2. 
Various levels of protein precipitation capacity were reported and are indicated in the following 
ranges of scales from 70-100% high, 40-70% moderate, 20-40% low and 0-20% indicating 
insignificant activity (NDHLALA et al., 2014; NDHLALA et al., 2015). The H. limifolia 
extract exhibited high affinity for protein (83%) while moderate affinity was found in E. 
autumnalis and B. natalensis and the activity was either low or insignificant in the rest of the 
tested extracts. The healing of wounds is a highly intricate physiological development and 
multiple overlying phases range from formation of granular tissue, inflammation, inhibition of 
microbial infections and re-epithelialisation, extracellular matrix formation and remodelling of 
the wounded area or corrective activity at the damaged site (PERINI et al., 2015). Tissue 
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regeneration due to phenolic compounds is reported in superficial skin, wound and burn healing 
combined with antimicrobial and antioxidant capacities (BRUNETON, 1995; LUSEBA et al., 
2007). Phenols have hydroxyl groups that are hydrogen donors and form very strong hydrogen 
bonds with the proteins particularly the carboxyl groups. High protein affinity or binding 
capacity occurs when the phenols which are small enough to penetrate inter-fibrillar peptide 
chains at many positions on the molecules result in the formation of a film that becomes a 
physical barrier which is very important in the wound healing process. This capacity extends 
to bonding with microbial cell walls causing inhibition (MULAUDZI et al., 2012). There are 
also adverse effects of protein binding affinity where phenols rich in tannins interact with 
protein uptake in the mammalian physiological processes and precipitate functional enzymes 
for biochemical metabolism hence causing a reduction in availability of nutrients and efficacy 
and value of the medicinal plants. According to MASONDO et al. (2014). E. autumnalis has 
extensive pharmacological potential, exhibits anti-inflammatory, antimicrobial activity and is 
rich in flavonoids. VAN WYK et al. (2009) reported that the presence of triterpenoids may 
account for the species’ wound healing capacity. The plant extracts showed moderate protein 
binding capacity and good antioxidant activity. H. limifolia has a very high protein binding 
capacity of 83% and good antioxidant ability. A study by COOPOOSAMY and NAIDOO 
(2011a) reported significant antimicrobial activity for H. limifolia extracts and the species is 
known to contain significant amounts of phenolics. However, more research on this plant is 
necessary. Other than these six significant antioxidant and/or protein-precipitating active plant 
extracts (M. plumbea, T. riparia, E. autumnalis, H. limifolia, H. aethiopicum and Z. 
aethiopica), all Aloe and Bulbine species presented throughout the screening showed moderate 
protein binding capacity and good antioxidant activity.  
 
Tannins are nature’s form of polyphenolic compounds with high molecular weight protein 
complexes. There are two groups of tannins formed by their structural type variances and 
include the condensed tannins and the hydrolysable tannins. Tannin quantification method is 
based on their chemical capacity or their capability to form bonds with protein substrates. 
Tannin-protein complexes (tannins in the plant extract and the protein, bovine serum albumin) 
are the basis used to determine protein precipitable phenolics (NDHLALA et al., 2015). The 
ferric chloride assay for total phenolics determines the tannins present in the complex. 
Measurements done spectrophotometrically will indicate when iron complexes form with 
phenols to give a pink chromophore. The five medicinal plants mentioned have a consistent 
pattern of significant activity throughout this study. 
  
Table 6.2 Protein-precipitating capacity as a wound healing model of phenolic-rich methanolic medicinal plant extracts from KwaZulu-Natal, 
South Africa. 
Protein- precipitating capacity 
Plant species 1 2 3 4 5 6 7 
Protein-precipitating 
phenolics(x)* 
11.58 ±0.99 17.69 ± 0.35 10.83 ± 1.87 18.22 ± 0.39 97.82 ± 1.97 3.44 ± 0.12 9.74 ± 0.45 
Total phenolics (y)* 76.24 ± 2.72 64.64 ± 1.46 76.11 ± 0.89 66.71 ± 0.52 118.30 ± 3.44 16.68 ± 0.05 20.04 ± 1.21 
Protein-precipitating 
capacity (%) 
15.19 ± 0.71 27.39 ± 1.15 14.21 ± 2.29 27.31 ± 0.36 82.71 ± 0.74 20.62 ± 0.79 48.91 ± 5.21 
 
Plant species 8 9 10 11 12 13 
Protein-precipitating 
phenolics(x)* 
2.77 ± 0.04 2.85 ± 0.17 3.24 ± 0.46 4.66 ± 0.25 3.96 ± 0.18 3.91 ± 0.25 
Total phenolics (y)* 5.44 ± 0.08 7.41 ± 0.02 45.15 ± 1.12 30.11 ± 0.79 23.93 ± 0.06 11.87 ± 0.22 
Protein-precipitating capacity (%) 50.87 ± 0.02 38.51 ± 2.43 7.15 ± 0.84 15.46 ± 0.43 16.53 ± 0.73 32.93 ± 1.46 
1 - Aloe arborescens leaf, 2 - Aloe aristata leaf, 3 - Aloe ferox leaf, 4 - Hypericum aethiopicum leaf, 5 - Haworthia limifolia leaf, 6 - Merwilla plumbea leaf, 7 - Bulbine 
natalensis bulb, 8 - Eucomis autumnalis bulb/root, 10 - Tetradenia riparia leaf, 11- Eucomis autumnalis leaf, 12 - Zantedeschia aethiopica leaf, 13 - Bulbine frutescens leaf. 
x* and y* are the curve slopes (mg phenolics precipitating/mg plant extracts) representative of the protein-precipitating and the phenolic totals in the extracts respectively.  
 
104 
 
   
  105 
 
6.5 Conclusions 
 
Oxidative damage is key to accelerated pathogenesis in numerous human diseases and natural 
therapies particularly from phenolic compounds demonstrating good antioxidant and anti-
inflammatory activity and many of the plant extract results as discussed are indicative of these 
medicinal and healing capacities. An extensive evaluation of plant extracts from South African 
medicinal plants with potent antioxidant activities is required to determine the mechanisms of 
action that extracts have from various assay models. The antioxidant activities may be 
enhanced through synergistic effects of the natural products. The study results do present some 
good anti-inflammatory and antioxidant activities in a number of the selected medicinal plants. 
The results lend scientific credence in support of the research is particularly on Aloe and 
Bulbine species. In addition, the use of E. autumnalis, H. limifolia, H. aethiopicum, T. riparia 
and Z. aethiopica as antioxidant medicinal plants for treating skin disorders and for wound 
healing is observed through the research. The moderate to good protein binding capacity 
exhibited by some of the tested medicinal plants could be used as a predictive wound healing 
model for these medicinal plants.  
 
Having considered the outcomes of the results and the relationship of the phytochemicals and 
antioxidants the following medicinal plants showed a correlation that was significant: Aloe 
species, B. frutescens, B. natalensis and H. aethiopicum, H. limifolia and Z. aethiopica had 
high levels of total phenolics, flavonoids and proanthocyanidins correlated to significant 
antioxidant activity. Further work on the isolation, identification and characterization of the 
biologically active compounds responsible for the events are necessary. Once isolated the 
active compounds can further be used to determine and examine the mechanism of activity. 
The overall results indicate that plant extracts do have the capacity and potential to be used in 
wound healing and skin care management. 
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CHAPTER SEVEN 
GENERAL CONCLUSIONS AND RECOMMENDATIONS  
 
 
The study investigated eleven medicinal plant species, used by traditional practitioners, for 
treating dermatological diseases and wound healing. According to HOUGHTON et al. (2007) 
“it is important in research to note that in vivo models tend to give a more accurate reflection 
of the activity of substances used in traditional medicine, their use in many countries is severely 
restricted due to economic and ethical concerns and this has led to the widespread use of in 
vitro tests in ethnopharmacological studies”. These tests are extremely useful where the identity 
of compounds responsible for the biological activity of an extract is being investigated and 
where limited supplies of material are available, but it is more significant to consider various 
factors before making over-predictive claims of that activity in one particular system to explain 
traditional use. The use of only one bioassay gives a very incomplete picture of the effect of 
the extract on the whole system involved. A symptom may be due to a number of disease states 
and, consequently, a variety of mechanisms may serve as targets for bioassays. Similarly, it is 
very rare for there to be only one target for a particular disease so a variety of test systems must 
be employed. Numerous test systems are used to assess plants and other plant materials having 
the capacity of being useful in wound-healing, diabetes, cancer and in the treatment of 
cognitive decline associated with old age. In addition, consideration must be given to factors 
such as the absorption into the body and the metabolism of any plant substances present, either 
to decrease or increase the effect of the activity on health care.   
 
Despite the extensive health care practices using medicinal plants in KwaZulu-Natal and South 
Africa, a very limited number of science-based studies, nor clinical trials have been published 
to date recognizing the practical use of indigenous flora for skin care and wound healing. The 
science fraternity needs to increase the number of studies and investigations which could lead 
to clinical trials being conducted with preparations from the diverse species of plant taxa that 
have been used traditionally over many centuries. The mechanisms of action by which plant 
extracts and their active compounds exert their bioactivity need to be further investigated. In 
addition, the undiscovered uses of plants will open up potential areas for research. Further 
exploration of currently used preparations may well result in the discovery of dermatological 
health care products and effective wound care and healing creams. Ethnobotanical studies show 
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that the use of traditional plants for dermatological use and wound healing is still prevalent in 
many communities across the globe. The preservation of local culture, heritage and the practice 
of traditional health care represents important strategies for the sustainability of popular 
knowledge of plants and must be maintained. There is growing interest in South Africa in the 
health benefits of indigenous plants.  
 
The antimicrobial screening of the selected plants was extensive and the outcomes of the basic 
disc diffusion assay served as a basis for the selection of the plants for the minimum inhibitory 
concentration (MIC) assays. Those plant extracts that were tested against the seven Gram-
negative bacteria and seven Gram-positive bacteria as well as the four fungal strains were based 
on known dermatological effects. Many of the plant extracts expressed good inhibitory 
potential against a widespread range of the bacteria.  The outcomes from disc diffusion 
screening for the extracts whose inhibition activity zones were 10 mm and more were further 
investigated using the MIC assay. Interestingly, the same plant parts screened for both bacteria 
and fungi were similar. The plant part extracts showing these outcomes were Z. aethiopica leaf, 
B. frutescens leaf, E. autumnalis bulb and root, T. riparia leaf, H. limifolia leaf, B. natalensis 
leaf and root, M. plumbea root and leaf extracts of A. aristata, A. ferox, A. arborescens and H. 
aethiopicum. The MIC values were important in highlighting minimum concentrations at 
which medicinal plant extracts were most effective. The following extracts yielded effective 
inhibitory concentrations of between 0.31 to 0.63 mg/ml for antibacterial activity; Aloe species, 
Bulbine species, T. riparia, H. aethiopicum, E. autumnalis, Z. aethiopica and M. plumbea. The 
antifungal minimum concentrations were also significant for the above-mentioned plant 
extracts. 
 
In the phytochemical assessment of total phenolics, flavonoids and proanthocyanidins of the 
screened medicinal plants; seven of the abovementioned medicinal plants are significant and 
the results were high for the concentration of phenols for all three groups of tested compounds. 
These are the Aloe species across all three assays (4.53 to 4.69 mg GAE/g DW for total 
phenolics; 3.41 to 5.28 mg CTE/g DW for flavonoid content; 3.51 to 5.28 µg LCE/g DW for 
proanthocyanidin content), H. limifolia (4.46 mg GAE/g DW for total phenolics, 3.11 mg 
CTE/g DW for flavonoid content, 3.04 µg LCE/g DW for proanthocyanidin content) and H. 
aethiopicum (3.35 mg GAE/g DW for total phenolics, 4.56 mg CTE/g DW for flavonoid 
content, 9.85 µg LCE/g DW for proanthocyanidin content), M. plumbea 2.04 µg LCE/g DW 
for proanthocyanidin content and Z. aethiopica 2.13 mg CTE/g DW for flavonoid content.  
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Cytotoxicity screening on all plant extracts for both Brine shrimp lethality assay and the MTT 
assay indicated no cytotoxic effects with LC50 values more than 2 mg/ml and larger than 1 
mg/ml respectively. Further investigations are necessary as many of the selected medicinal 
plants are toxic and misuse may result in mortality. Although the results detect no cytotoxicity 
in the selected plants, some authors have found some to be poisonous; further intensive toxicity 
investigations would be recommended using water and other solvents in order to determine 
minimum toxicity levels. Traditional medicine has been used for treating diseases over 
centuries, scientific studies have revealed that many of them are potentially toxic. The use of 
herbs may mimic, magnify or oppose the effect of drugs and should therefore be used with care 
and proper consultation and information should be provided by health care practitioners when 
mixing herbs and pharmaceutical drugs as interaction with most drugs is not known. Other 
examples of identified herb-drug interactions include bleeding when warfarin is combined with 
ginkgo (Ginkgo biloba), mild serotonin syndrome in patients who mix St John’s wort 
(Hypericum perforatum) with serotonin-reuptake inhibitors and potentiation of oral and topical 
corticosteroids by liquorice (Glycyrrhiza glabra) and soluble bres (including guar gum and 
psyllium) which can decrease the absorption of drugs. An example of South African herb-drug 
interactions is the use of devil’s claw with the use of warfarin resulting in puprura. In addition, 
H. hemerocallidea and S. frutescens showed a negative interaction with antiretroviral 
medication, thus patients may be at risk from treatment failure, viral resistance, or drug toxicity.  
The anti-inflammatory IC50 concentrations for the nitric oxide assay was less active and the 
results were greater than 100 µg/ml for four of the medicinal plant extracts, namely the three 
Aloe species and H. limifolia but significant for all other extracts with values ranging from 
13.99 to 29.35 µg/ml. In the LOX assay, in addition to the above four plants, the findings for 
M. plumbea had less activity whilst five of the medicinal plant extracts, Bulbine natalensis, E. 
autumnalis, H. aethiopicum, T. riparia and Z. aethiopica were effective agents with IC50 values 
below those of the quercetin control and ranged from 3.55 to 9.52 µg/ml.  
 
Antioxidant screening for all medicinal plants revealed significant activity with the FRAP 
assay. In the DPPH assay model, EC50 values showed significant activity for the three Aloe 
species, two Bulbine species, E. autumnalis, H. limifolia, H. aethiopicum, T. riparia and Z. 
aethiopica while the CLAMS results were similar to those of DPPH for the same plant species. 
The protein-precipitating capacity as a wound healing model was high for H. limifolia leaf at 
82.7% while the other ten medicinal plants (A. arborescens - 15.2%, A. aristata - 27.4%, A. 
ferox - 14.2%, H. aethiopicum - 27.3%, M. plumbea - 20.6%, B. natalensis - 32.9%, T. riparia 
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- 7.15%, E. autumnalis - 15.5%, Z. aethiopica - 16.5% and B. frutescens - 32.9%) had moderate 
to low values. Overall, the results from this multi-dimensional medicinal plant research study 
provide extensive information on the potential of 11 plant species on wound healing and skin 
diseases.  
 
Plant extracts are associated with several antimicrobial properties including anti-inflammatory 
and antioxidant. The use of bioactive extracts or phytochemicals from a variety of plants 
contributes to public health care. The interaction of the antioxidants and the free radicals is an 
important process for maintaining good health, and reducing age-related conditions and 
diseases. Those free radicals generated in excess of the normal may accumulate and outweigh 
the protective effects of antioxidants. Science needs to strengthen the multidisciplinary 
research mechanisms to support the evaluation of medicinal plants and effectively facilitate 
collaboration between traditional and conventional health practitioners. National regulatory 
frameworks on indigenous medicinal practices and various strategic plans for policy 
implementation on traditional health care and medicines are integral to enhancing traditional 
medicine research and the continual outcomes of science based evidence on the efficacy, 
quality and safety of traditional medicines. The use of National, WHO and International 
research protocols and guidelines are essential. Intensifying the aspects of traditional medicine 
into higher education curricula, syllabi and training programmes to bring traditional medicines 
into Primary Health Care systems could be effective strategies that can provide breakthroughs 
in understanding traditional health care management systems. The defence of indigenous 
knowledge and intellectual property rights and the protection and conservation of plant species 
that are at risk of extinction in South Africa is crucial. Actively promoting collaboration across 
research centres and amongst partners who are strong in the field of ongoing research on 
traditional medicinal plants could accelerate development of traditional medicine into the 
mainstream health system.  
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